Design, Syntheses and Biological Applications of Through-bond Energy Transfer Cassettes and Novel Non-covalently Cell Penetrating Peptides by Han, Junyan
  
DESIGN, SYNTHESES AND BIOLOGICAL APPLICATIONS OF THROUGH- 
BOND ENERGY TRANSFER CASSETTES AND NOVEL NON-COVALENTLY 
CELL PENETRATING PEPTIDES  
 
 
A Dissertation 
by 
JUNYAN HAN  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
 
August 2009 
 
 
Major Subject: Chemistry 
  
 
DESIGN, SYNTHESES AND BIOLOGICAL APPLICATIONS OF THROUGH-
BOND ENERGY TRANSFER CASSETTES AND NOVEL NON-COVALENTLY 
CELL PENETRATING PEPTIDES  
 
A Dissertation 
by 
JUNYAN HAN  
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
DOCTOR OF PHILOSOPHY 
 
Approved by: 
Chair of Committee,  Kevin Burgess 
Committee Members, Jean-Philippe Pellois  
 Daniel Romo  
 Daniel Singleton 
Head of Department, David Russell 
 
August 2009 
 
Major Subject: Chemistry 
 iii
ABSTRACT 
 
Design, Syntheses and Biological Applications of Through-bond Energy Transfer 
Cassettes and Novel Non-covalently Cell Penetrating Peptides. (August 2009) 
Junyan Han, B.S., Shandong University, P. R. China 
Chair of Advisory Committee: Dr. Kevin Burgess 
 
A xanthene-BODIPY cassette is used as a ratiometric intracellular pH reporter 
for imaging protein-dye conjugates in living cells.  A model was hypothesized to explain 
the pH-dependent energy transfer efficiencies from the donor to the acceptor based on 
the electronic chemistry data.   
Sulfonation conditions were developed for BODIPY dyes to give water-soluble 
functionalized monosulfonation and disulfonation donors. A water-soluble TBET 
cassette, which has good photophysical properties, was synthesized using a bissulfonated 
BODIPY dye as the donor, and their applications for in vitro protein labeling is 
achieved.  Chemoselective cross-coupling reactions were demonstrated for C-S bonds in 
the BODIPY dye, and similar reactions were applied to make the acceptor of the water-
soluble cassette.  
Chemiluminescent energy transfer cassettes based on fluorescein and Nile Red 
were synthesized and their spectral properties were studied. 
Pep-1 (also known as Chariot), R8 (which is not often used as a non-covalent 
protein carrier), and a new synthesized compound, Azo-R8, was used for the study of 
 iv
non-covalent delivery of four different proteins into mammalian cells.  Data from 
confocal spectroscopy revealed that all three carriers are effective for translocating 
protein cargos into live cells.  At 37oC, import into endocytic compartments dominates, 
but at 4°C weak, diffuse fluorescence is observed in the cytosol indicative of a favorable 
mode of action. 
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CHAPTER I  
INTRODUCTION: THE IMPORTANCE AND CHALLENGES OF THE RESEARCH  
 
My research focuses on the synthesis and biological applications of through-bond 
energy transfer cassettes.  Intramolecular energy transfers have been studied using 
molecules containing two fluophores, i.e. D-A. When the donor (D) is brought to an 
excited state, emission is observed from the acceptor (A) portion of the molecule.  The 
energy can be transferred via non-conjugated linkers (through-space), or a π-conjugated 
system (through-bond).  
The efficiency of energy transfer through space, fluorescence resonance energy 
transfer (FRET), is dependent on the overlap of donor emission with the absorption of the 
acceptor.  The smaller the overlap, the less efficient the energy transfer.  However, there 
is no known requirement for Förster rule for through-bond energy transfer (TBET).  This 
process seems to involve the physical contact of orbital of the donor and acceptor.  Our 
group has proved that efficient energy transfer through bonds does not require the overlap 
of donor emission with acceptor absorbance.  Therefore, TBET cassttes could process 
desired photophysical properties for cell imaging, e.g. large Stoke shifts, long-wavelength 
excitation and emission wavelengths.  Our group focuses on the synthesis and biological 
applications of through-bond energy transfer cassettes.  We are particularly interested in 
applying TBET cassettes for studying multiple proteins’ interaction in vivo,  
____________ 
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determination of intracellular pH values, and detection of H2O2 in living cells.  In order to 
study the protein interaction in water, we have to synthsize water-soluble TBET cassettes, 
which should have high quantum yields and a handle to attach to proteins. Please read the 
chapter II to chapter IV for detailed description of the study.  I hope I will convince you 
that how useful the TBET cassettes in biological chemistry after knowing the advantages 
of TBET cassettes compared to regular dyes. 
There are many exhisting methods for uptaking proteins into living cells, e.g. 
microinjection, electroporation.  Conjugation of proteins to carrier peptides is also 
another commonly used method.  The well-known carriers of this type are TAT and 
polyarginine derivatives.  These to methods are either disruptive to cells or time 
consuming.  We are interested in non-covalent proteins carries, which can translocate 
proteins in life cells relatively easy and noninvasive.  The Pep-1, also called carrier 
peptide, is commercialized and widely used.  However, it is very expensive and not easy 
to synthesize in large scale since it involved solid-state prepation.  We are interested in 
developing novel non-covalent protein carriers for transferring cassette-labeled protein 
inside living cells.  Please see the chapter V for the details of our discovery in this area. 
   
 
 
 
 
 
  
3
CHAPTER II 
AN RATIOMETRIC PH INDICATOR FOR IMAGING PROTEIN-DYE 
CONJUGATES IN LIVING CELLS BASED ON THROUGH-BOND ENERGY 
TRANSFER  
 
A. INTRODUCTION: INTRACELLULAR PH INDICATORS 
1. Introduction 
Intracellular pH (pHi) can influence many critical cell, enzyme and tissue 
activities, including apoptosis,1-3 proliferation, multidrug resistance (MDR),4 ion 
transport,5,6 endocytosis,3 and muscle contraction.7,8  Changes of pHi effect the nervous 
system too, by influencing synaptic transmission, neuronal excitability, cell-cell 
coupling via gap junctions, and signal cascades.9,10  Abnormal pHi values are associated 
with inappropriate cell function, growth, and division, and are observed in some 
common disease types such as cancer11 and Alzheimer’s.12  Some organelles, e.g. 
endosomes13 and plant vacuoles,14 have intracompartmental pHs of 4 - 6.  In cell 
biology, low intracompartmental pH values can serve to denature proteins, or to activate 
enzyme and protein functions that would be too slow around pH 7.0.  For instance, the 
acidic environments in lysosomes (4.5 – 5.5)15,16 can facilitate the degradation of 
proteins in cellular metabolism.  Thus, cellular dysfunction is often associated with 
abnormal pH values in organelles.13 
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Intimate connections between the cell functions with intracellular pH means that 
precise measurement of intracellular pH can provide critical information for studying 
physiological and pathological processes down to a single organelle.  Good resolution in 
the space and time dimensions, ie spatial and temporal, is highly desirable.  Compared to 
other pHi measurement methods (e.g. microelectrodes, NMR, and absorbance 
spectroscopy) fluorescence spectroscopy has advantages with respect to spatial and 
temporal observation of pHi changes.  Moreover fluorescence techniques have high 
sensitivities, they tend to be operationally simple, and they are in most cases non-
destructive to cells.  
Qualitative measurements of pHi can be achieved using fluorescent indicators 
that switch on or off at sharply defined pH values.  However, such measurements may be 
influenced by many factors, including optical pathlength, changes of temperature, altered 
excitation intensities, and varied emission collection efficiencies.   The alternative is to 
use “ratiometric detection”.  
Ratiometric spectroscopic methods require fluorescent sensors that are 
differentially sensitive to the analyte (ie protons for pH probes) for at least two 
excitation or emission wavelengths (see Figure 2.1).  For instance, for a suitable 
fluorescent dye, emission at one carefully chosen wavelength may be enhanced or 
diminished relative to the emission at another.  Ratios between these signals then can be 
calibrated to indicate pHi values.  Advantages in using ratiometric methods are accrued 
because parameters such as optical pathlength, local probe concentration, 
  
5
photobleaching, and leakage from the cells are irrelevant.  This must be so since both 
signals come from the probe in exactly the same environment. 
 
+
analyte sensor
(i) 
activated
on binding
location of sensor
may be unclear
 
+
sensor
(ii) 
changed
on binding
sensor and complex both observable  
Figure 2.1 Fluorescent sensors may be activated (i) by analytes; Ratiometric ones (ii) which change 
wavelength of fluorescence emissions on binding. 
 
A variety of methods can be used for importing highly charged fluorescent 
compounds into cells.  These include microinjection,17 scrape loading,18 hypertonic 
lysis,19 and carrier-mediated endocytosis.20 All of these approaches perturb the cell 
resting state physiology.  
Another strategy for import of fluorescent compounds into cells uses concepts 
similar to the “prodrug approach”.21  This strategy involves chemical modification of 
charged, non-cell-permeable dyes outside cells to neutral cell-permeable ones after 
import.  Thus transport of masked forms into the cell allows endogenous cellular 
proteases to liberate the charged fluorescent form of these compounds.  The archetypical 
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example of this is the use of non-fluorescent acetoxylmethyl (AM) or acetate esters of 
fluoresceins as pHi indicators.  These compounds diffuse into cells, and are then 
hydrolyzed by non-selective intracellular esterases to afford the free, charged, 
fluorescent dyes (Figure 2.2).  In fact, conversion of non-fluorescent AM esters into 
fluorescent free dyes has been used for cell viability assays.1   Application of this 
approach is probably less disruptive to the cells than the methods mentioned above, but 
it is not totally innocuous.   Hydrolysis of AM esters yields acetic acid and methanol; 
both these by-products may induce abnormal cellular events.  Moreover, the fluorescent 
dyes can localize in any cellular compartment, and in this approach the fluorescent 
compounds may particularly tend to accumulate in organelles having high 
concentrations of esterases.  The AM ester and the liberated dye also may be cytotoxic to 
some extent.  Nevertheless, these undesirable effects may be tolerable fro many 
applications. 
AM esters are typically synthesized via the same strategy.  This features reaction 
of hydroxyl and/or carboxylic acid groups on the free dye with freshly prepared 
bromomethyl acetate22 in the presence of diisopropylethylamine in anhydrous 
chloroform (Figure 2.2).23,24  
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Figure 2.2  Synthesis and hydrolysis of AM and acetate esters. 
 
Fluorescence intensities of the free pH indicators inside cells are reduced if the 
fluorescent molecules are somehow expelled from the cells.  Rates of dye leakage from 
cells are related to the net charge on the dyes; more highly charged ones are expelled 
slower.  For instance, fluorescein has a higher leakage rate relative to 5-(and 6)-
carboxyfluorescein because the former has one less negative charge.25   Dye-dextran (a 
complex, branched polyglucose with varying lengths from 10 to 150 kilodaltons), -
biomolecule or -nanoparticle conjugates can circumvent the leakage problem because 
passage of the dyes from the inside to the outside of the cells is unfavorable, and the 
concentration decreases only due to cell division.  Cells labled with pH indicator BCECF 
on dextran have been shown to produce much more stable fluorescent signals, reduced 
probe compartmentalization, and 10-fold greater resistance to light-induced damage 
when compared with dye AM–labeled cells.26  Overall, pH indicators that are coupled to 
carrier molecules that do not cross the cell membrane may be particularly useful for 
long-term experiments where retention of the probe in cells is an issue.     
Interactions of probes with biomolecules or organelles in cells can significantly 
change their spectral properties relative to aqueous saline solutions.27,28  Consequently, 
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ex-vivo, calibration is required for more accurate pHi measurements.  Thomas et al in 
1979 introduced the method that is most widely used for pHi calibration.29  In this 
approach, intracellular pH is assumed to be equal to extracellular pH when the cells are 
treated with the K+/H+ ionophore, nigericin (5μL/ml).  Nigericin makes cells permeable 
to K+ and H+, thus equilibrating the intra and extracellular pH.   
This review provides a brief overview of intracellular pH sensors, including 
small fluorescent organic molecules, nanoparticles, and fluorescent proteins e.g. GFP.  It 
focuses on their preparations, photophysical properties, and advantages/disadvantages 
for intracellular pH measurements.  The discussion is limited to fluorescent indicators 
that have been applied to measure intracellular pH values since 1970’s; relatively few 
indictors were used to measure intracellular pH values before that date, and those that 
were are now largely redundant. 30  
 
2. Fluorescein-based pHi Indicators 
2.1 The Most Widely Used pHi Indicator: BCECF 
2’,7’-bis-(2-Carboxyethyl)-5-(and-6-)carboxyfluorescein (BCECF; Figure 2) was 
introduced for measuring cytoplasmic pH by Roger Tsien and his coworkers in 1982.25  
Since then it has been widely used for mammalian or plant cells,5,6 living tissues31 and 
individual organelles, e.g. endoplasmic reticulum.32   
BCECF is synthesized via condensation of ethyl 3-(2,4-dihydroxyphenyl)-
propionate (from hydrogenation of commercially available 7-hydroxycoumarin in 
ethanol containing catalytic amount of trifluoroacetic anhydride) with trimellitic 
  
9
anhydride in the presence of anhydrous ZnCl2 at 180 oC (Scheme 2.1).  The 
commercially available acetoxymethyl ester of BCECF is a mixture of three compounds 
BCECF AM I-III (Figure 2.3).  Three regioisomeric BCECF AM esters could all be 
transformed into the free BCECF by nonselective esterase inside living cells.  
 
Scheme 2.1  Synthesis of BCECF.  TFAA: trifluoroacetic anhydride 
OO OH
H2, 5 mol% Pd/C
TFAA, ethanol OHHO
EtO
O
1 2  95%
(i) 3, ZnCl2, 180 oC
(ii) 3M KOH(aq),100 oC
 
O
O
O
3
OHO O
CO2_
-O2C CO2-
2' 7'
6
5
BCECF  8%
pKa 7.0
φ = 0.84 (0.1M NaOH) 
λmax abs 503 nmλmax emiss 525 nm
CO2HCO2H
 
 
Just like fluorescein, carboxyfluorescein and fluorescein sulfonic acid, the 
absorbance of BCECF is sensitive to the pH.  Absorption of BCECF red-shifts from pH 
3.6 to 9.2, and its molar absorptivity is much larger in the phenolate anion form than in 
the phenolic form.33  However, indicators based on fluorescence are far more sensitive 
than those that use absorption.   
BCECF is often used as a ratiometric excitation (or dual excitation) pH indicator.  
In this approach fluorescence intensity ratios corresponding to excitation at two different 
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wavelengths are measured, and these data are correlated to pH via ex vivo calibration 
using Thomas’s method.29  The physical basis of this method is that the absorption 
profile for the dye changes significantly with pH. 
An alternative to ratiometric excitation for pH measurements is the ratiometric 
emission method.  This strategy involves measuring fluorescence intensities at two 
different wavelengths when the indicator is excited at one wavelength.  BCECF is 
unsuitable for this approach since its relative emissions at any two different wavelengths 
are not significantly dependant on pH.  An example of a dye that can be used in this 
mode is carboxy.SNARF, i.e. C.SNARF-1 (See below). 
BCECF is widely applied in cell biology because of several attributes.  First, the 
free dye is retained well inside cells because it posses 4-5 negative charges at 
physiological pH values (~7.4).   Second, the pKa of BCECF (7.0 ) is ideal for sensing 
cytosolic pHs, which are normally in the range of 6.8 - 7.4.   Third, BCECF AM esters 
are cell membrane permeable and this facilitates non-invasive loading of the dye into 
cells.  Conversion of non-fluorescent BCECF AM esters into fluorescent BCECF acid 
forms is efficient, so much so that this transformation has been used for cell viability 
assays.1  Fourth, ionic strengths of solutions surrounding BCECF do not have much 
influence on the spectral properties of the dye.25   
There are also some problems associated with BCECF in measurements of pHi 
values.  For instance, even though the rate of leakage of this dye form cells is relatively 
slow, it can still be ca 10% over 10 - 20 min at 25 °C, and more at 37 °C.25  To 
circumvent this issue, the BCECF-dextran conjugate might be used; this exhibits 
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excellent intracellular retention and much lower cytotoxicity effects, but it is not cell 
membrane permeable and has to be delivered into cells via relatively destructive 
techniques, e.g. microjection.  Another disadvantage of BCECF is that it, like most 
fluorescein-based dyes, photobleaches relatively quickly hence erroneous pHi 
measurements can result.31  Simultaneously, such photobleaching reactions can damage 
cells.  Free BCECF inside cells does not usually accumulate in any particular cellular 
compartment. 
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Figure 2.3.  Structures of BCECF/BCPCF AM esters 
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2.2 BCPCF 
BCPCF (structure in Scheme 2), 2’,7’-bis-(2-carboxypropyl)-5-(and-6-)-
carboxyfluorescein, is a homolog of BCECF.  BCPCF has 2-carboxypropyl substituents 
at 2’- and 7’-xanthene positions whereas BCECF has 2-carboxyethyl groups there.  The 
original synthesis of BCPCF is shown in Scheme 2.  In this, 1,3-dimethoxybenzene is 
subjected to Friedel-Crafts acylation with succinic anhydride, followed by in situ 
demethylation and Fisher esterification to yield the ketone ester 4 in 40 % yield.  The 
ketone group of the 4 was reduced to 6 which has a chain of three methylene groups.  
Condensation of this resorcinol derivative 6 with trimetallic acid anhydride 3 in 
methanesulfonic acid eventually gives BCPCF as a mixture of two regioisomers.  In fact, 
the intermediate acid is esterified solely to facilitate chromatographic separation, then 
this ester is converted back to the carboxylic acid form.    
 
Scheme 2.2.  Synthesis of BCPCF. 
OHHO
MeO
O
OMe
OMe
O
2
(i) succinic anhydride
AlCl3, ClCH2CH2Cl
reflux
(ii) MeOH, H+, reflux
4  40 %
H2, 10 mol% Pd/C
AcOH, 90 oC
 
OHHO
MeO
3
O
5  90 %
(i) 3, MeSO3H, 80 oC
(ii) MeOH, H+(cat),reflux
(iii) NaOH, MeOH/H2O
O-O O
CO2-
CO2--O2C
3 3
BCPCF  54 %
pKa 7.0
φ = 0.83 (0.1M NaOH)
λmax abs 505 nmλmax emiss 527 nm
6
5 CO2-
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Commercial available BCPCF AM esters predominantly exists in a form shown 
in Figure 2.3.   BCECF and BCPCF have very similar pKa values, absorption and 
emission maximum wavelengths, and quantum yields, just as expected for such 
structurally similar compounds.  The previous section notes that ratiometric excitation 
pHi measurements featuring BCECF are usually achieved by determination fluorescence 
intensity ratios at 535 nm corresponding to excitation at 503 nm and at 439 nm.  The 
absorbance of BCECF at 439 nm corresponds to its isobestic point; this is generally ideal 
for ratiometric methods except that in this case the absorptivity of BCECF at 439 nm is 
quite weak.   Application of BCPCF overcomes this disadvantage of BCECF.  The 
isosbestic point of BCPCF is red-shifted to 454 nm compared with BCECF; this 
corresponds to a stronger absorbance hence BCPCF tends to be a better ratiometric 
excitation probe.    
BCECF and BCPCF share a common disadvantage for pHi measurements.  Their 
fluorescence emission intensities are dependant on the concentration of the probes.  Thus 
if the dyes accumulate in certain regions of the cell then they can indicate different pHi 
values indicative of dye, not proton, concentration differences.33,34 
 
2.3 Fluorescein, Carboxyfluorescein and Fluorescein Sulfonic Acid 
BCECF and BCPCF are preferred for intracellular pH measurements, but 
fluorescein, fluorescein sulfonic acid, and, especially, carboxyfluorescein are still widely 
used for pHi determination presumably because easy and cheap to prepare via standard 
condensation methods.35  Condensation of  resorcinol with trimetallic acid anhydride 3 
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and 4-sulfophthalic acid produced a mixture of 5(6)-carboxyfluorescein and 5(6)-
sulfofluorescein respectively.36,37  The two isomers exhibit essentially identical pH-
dependent spectral properties with pKa of ~6.5, therefore the mixture is sufficiently good 
for pHi determination.  Fluorescein sulfonic acid moves through the paracellular space 
inside live cells since it is water-soluble and is cell membrane impermeant, it can be 
used for the denermination of barrier permeability.38 
On rare occasions it may be desirable to use regioisomerically pure substituted-
fluorescein probes.  Fortunately, methods for the preparation of single isomers are 
available.39,40  For instance, 5- and 6-carboxyfluorescein begins by condensation of 
trigllic anhydride 3 with resorcinol in the presence of methane sulfonic acid at 85 ºC.  
The reaction affords a 1:1 mixture of isomeric compounds 7 and 7’.  An insoluble salt of 
the 6-isomer (7’) is selectively precipitated with an isomeric purity over 98% when this 
mixture is recrysalized in methanol/hexane two times.  The compounds left in the filtrate 
are recrystallized from ethanol/hexane two times to give the 5-isomer (7) also in greater 
than 98% purity. Hydrolysis of the isomerically pure pivalate esters 7 and 7’ under basic 
conditions affords 5-carboxyfluorescein and 6-carboxyfluorescein (Scheme 2.3a).  
Preparation of isomerically pure 5-sulfofluorescein and 6-sulfofluorescein can be 
achieved via a similar approach.  The 5- and 6-isomers 8 and 8’ were produced as 
dipivaloyl esters, and their di-isopropylethylamine salts were separated via 
crystallization from dichloromethane and diethylether solution (Scheme 2.3b).  Basic 
hydrolysis of these pivaloyl esters 8 and 8’ yields the isomerically pure 5-
sulfofluorescein and 6-sulfofluorescein respectively.    
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Scheme 2.3.  Synthesis of: a carboxyfluorescein; and, b sulfonofluorescein, regioisomers. 
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Fluorescein diacetate is occasionally used for measuring pHi values;41 the main 
disadvantage of this is that once fluorescein is liberated via intracellular hydrolysis it can 
rapidly leak out of cells, hence it is not easy to discern if fluorescence intensity decreases 
were induced by leakage or pH changes.  The more charged derivatives, 5- and 6-
carboxyfluorescein applied as cell-permeable carboxyfluorescein AM esters, is more 
often used for pHi measurements because it can be better retained in living cells.   Even 
so, at 37 oC, intracellular concentrations of 5- and 6-carboxyfluorescein have been 
observed to diminish by 30 – 40 % in the first 10 min after washing.25  5- and 6-
Sulfonofluoresceins are more water soluble and even better retained inside cells or 
organelles when compared with carboxy-fluorescein.  However, these sulfonic acid 
derivatives are not commonly used as pHi indicators because their diacetate forms 
cannot easily diffuse into cells.  Some other fluorescein derivatives (e.g. 
dimethylcarboxyfluorescein)34 can be used as pHi indicators, but many of these are not 
particularly photostable or well retained in living cells.   
One approach to the problem of leakage of fluorescein derivatives from cells is to 
import some activated form that will non-specifically conjugate to intracellular 
biomolecules.  For instance, fluorescein isothiocyanate32,42 and 5-(6-)carboxyfluorescein 
diacetate succinimidyl ester,43 have both been used in this way.  
 The xanthene parts of the pHi indicators discussed above have very similar pKa values 
to fluorescein, ~ 6.4.44  The detailed spectral properties of fluorescein, carboxy-
fluorescein and fluorescein sulfonic acid can be obtained on the website of Invitrogen.45  
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2.4 Miscellaneous Fluorescein Derivatives 
Some of fluorescein derivatives with longwave absorption and fluorescence are 
possible for pHi measurements.46  For instance, 5 (and 6)-carboxynaphthofluorecein is a 
dual emission ratiometric near neutral pH probe with a pKa of ~7.6.47  The compound in 
acidic form absorbs and emits at 509 nm and 572 nm respectively.  Its base form has a 
bathchromic shift in absorption and emission with maximum peak at 598 and 668 nm. 
The pH-sensitive long-wavelength dual emission spectra have been applied for 
determination of physiological pHi.47 
 
O
CO2-
5 (and 6)-carboxynaphthofluorescein 
pKa 7.6
φ = NA
λmax abs 509/598 nmλmax emiss 572/668 nm
6
5 CO2-
HO O
 
 
Fluorescein derivatives with different pKa values can be applied in similar ways 
to observe changes of proton concentrations that are centered around other pH values.48  
Electron withdrawing groups on xanthenes  lower their pKa values.  For instance, the 
halogenated fluoresceins Oregon green 488/514,49 and carboxy-DCF50 all have pKa’s of 
~ 4.7.  Otherwise, the pH-dependent absorbance and fluorescence spectral characteristics 
of these dyes are similar to fluorescein, hence dual-excitation ratiometric measurements 
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of pHi are possible.  Detailed information about applications of these dyes can be 
obtained through the Invitrogen website.51  
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Fluorescent rhodols, which is the hybrid of a rhodamine and a fluorescein 
molecules, have the same backbone as rhodamine and rosamine dyes with one of the 
NR2 groups replaced by oxygen.52-54  These fluorophores have high molar absorptivities 
in the visible region, high quantum yields in the range of 520-580 nm with appropriate 
N-substituents.  The dyes are much more photostable comparing to fluorescein 
detivatives.  The probes usually exhibit significant shift in absorbance spectra with 
variation of pH values, and are suitable for dual excitation ratiometric pH measurement.  
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Some of these compounds have lower pKa values between 4.5 - 6.5 and suitable for pH 
measurement in acidic environments.49,54  For instance, the conjugate of rhodol 9 with 
ethylenediamino-ouabain has been used for probing the pH values in the 
microenvironment in the cardiac glycoside-binding site of Na+/K+-ATPase.55 
 
OH2N O
CO2H
CO2H
9
pKa 5.59
φ = 0.89
λmax abs = 494 nmλmax emiss = 520 nm  
 
3. SNAFLs, SNAFRs, and SNARFs 
There are three possible isomers of benzoxanthene dyes that differ via their 
orientation of annulation (Figure 2.4a). Representatives of all three compounds types 
have been prepared, and their spectral and photophysical properties have been studied.  
Benzo[c]xanthenes were introduced by Molecular Probes in the early 1990s.24  These 
dyes include the seminaphthofluorones (SNAFRs), seminaphthofluoresceins (SNAFLs), 
and seminaphthorhodafluors (SNARFs); all these dyes have one benzene and a 
naphthalene component in the fluorophore (Figure 2.4b).  SNAFLs and SNAFRs, and 
SNARFs are long-wavelength fluorescent pHi indicators with oxygen and nitrogen 10-
substitutuents, respectively.24,56 
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The pnemonics for these compounds are so similar that it is bewildering to use 
them.  The following are generalities that may make these abbreviations more user-
friendly.  Throughout, “SNA” stands for “SemiNAphtho-“.  SNAFRs and SNAFLs share 
similar molecular structures except that SNAFRs do not possess a carboxyl substituent at 
the 3’ position (they are FluoRones), whereas SNAFLs are FLuorescein derivatives, and 
SNARFs are derived from RhodaFluors.    Figure 2.4c delineates how these dyes are 
related to fluorescein and rhodamines.  Consideration of this graphic also makes it 
evident that there are other permutations of the annulation structure and O/N-substitution 
patterns that correspond to compounds that are not used as pH indicators, and may even 
not have been prepared. 
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OH
 
OO
R
benzo[c]xanthene
OH
 
Figure 2.4.  (a) Three types of benzoxanthenes; (b), three types of benzo[c]xanthenes that have 
different heterocyclic substituents; and (c), evolution of benzoxanthenes from fluorescein and 
rhodamine. 
 
 
  
21
b 
OO
OH
CO2H
9
10 11
3
OO
OH
9
10 11
3
SNAFR SNAFL
3' 3'
 
OR2N
O
CO2H
9
10 11
3
type B SNARF
ORN
OH
CO2H
9
10 11
3
type A SNARF
R is H or alkyl R is alkyl
 
c 
OO OH
CO2H
fluorescein
OO NH2
CO2H
Rhodol  
OO
CO2H
OH
OO
OH
SNAFR-1SNAFL-1
"L" indicates
3' -carboxylic acid
3'
"R" indicates no
3' -carboxylic acid  
Figure 2.4.  Continued. 
  
22
OO OH
SNAFR-6
OO
CO2H
NMe2
SNARF-1  
OR2+N
CO2H
NR'2
OR2+N NR2
CO2H
rhodamine  
Figure 2.4.  Continued. 
 
Semiempirical computer calculations (AM1) have been used to predict that 
bathochromic shifts should be observed in the absorption and fluorescence spectra of the 
type [a] and [b] benzoxanthene isomers.57  Some compounds in that series have recently 
been prepared, and they do indeed have red-shifted absorbance and emission maxima, 
but they have not yet been used for pHi measurements.56,58 
Scheme 2.5a shows syntheses of benzo[c]xanthene dyes, ie SNARFs and 
SNAFLs, via condensation of 1,6-dihydroxynaphthalenes with the appropriately 
substituted benzophenone derivatives 10; these in turn were made via coupling of 
resorcinol or 3-aminophenol with phthalic anhydride in toluene.  For instance, 
carboxySNARF-4F was synthesized via acid catalyzed condensation of 5-fluoro-1,6-
dihydroxynaphthalene with 2,4- (and 2,5)-dicarboxy-3’-dimethylamino-2’-
hydroxybenzophenone.59  Syntheses of benzo[a] and [c]xanthene dyes was only recently 
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achieved.56,58 For instance, lithiated 1,6-dimethothynaphthelene was coupled with 2,4-
dimethoxybenzophenone to produce compounds 11 and 12.  SNAFR-1 and SNAFR-6 
were isolated in 55% and 15% yield after treatment with BBr3.58 
Molar absorptivities of SNARFs and SNAFLs are highest under basic conditions 
and their absorbance maxima shift to the red; this is true of most fluorescein derivatives.  
However, unlike most fluorescein-based pH indicators, their fluorescent emission 
spectra also show significant pH-dependent shifts.  The protonated form emits in the 
yellow-orange region (540 ~ 580 nm), whereas deep red emissions (620 ~ 640 nm) are 
observed for the basic form.  Both the absorbance and fluorescence spectra of SNARFs 
and SNAFLs show sharp, pH-independent, isosbestic points at ~530 nm and ~585 nm, 
respectively; these are desirable properties for dual-absorbance and dual-emission 
ratiometric measurements.  SNARFs and SNAFLs have been used as dual-emission pH 
indicators60 for determination of intracellular pH values via flow cytometry61 and 
confocal spectroscopy.60  N,N-Dialkyl SNARFs (ie type B SNARFs in Figure 2.4b) are 
more fluorescent in basic solutions where they exist predominantly as their anionic 
forms (quantum yields 0.05-0.20) than in their neutral forms (quantum yields of 0.02-
0.07).  Conversely, SNAFLs and type A SNARFs (Figure 2.4b) have higher quantum 
yields (up to 0.5) in the neutral form (ie under acidic conditions; Figure 2.5).  
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Scheme 2.4.  (a) Original syntheses of SNARFs and SNAFLs; and (b), One example of syntheses of a 
benzo[a]xanthene and a benzo[b]xanthene. 
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Figure 2.5.  Spectral and photophysical properties of some commercially available benzo[c]xanthenes 
that have been used as pH indicators. (a) SNARF; and (b), SNAFL-1 derivatives. 
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Carboxy-SNARF-1 (or “C.SNARF-1”)62 is probably the second most widely 
used pHi indicator behind BCECF (see above).  It has been applied to determine absolute 
cytosolic, mitocontrial60 and nuclear63 pH values in living cells using flow cytometry,61 
microplate readers,20 confocal imaging60 or microspectrofluorometry.27   
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Dyes like C.SNARF-1 have several attributes that may explain why they are so 
widely used.  First, C.SNARF-1 can be temporarily shielded as an AM ester, facilitating 
import into living cells.  Furthermore, the cell permeable chloromethyl SNARF-1 acetate 
slowly reacts with intracellular thiols forming conjugates that are retained inside cells 
and facilitate long-term pH studies.  Second, the ratiometric properties of C.SNARF-1 
are not significantly dependant on its concentration or on the ionic strength of the 
surrounding aqueous media; these are desirable properties for general-use pHi 
indicators.33  When C.SNARF-1 was irradiated to photobleach the compound, the ratio 
of the fluorescence intensities at 580 and 640 nm was shown to be essentially invariant; 
this makes the dye more suitable for extended experiments than it would otherwise be.60  
Furthermore, the fluorescence spectrum of C.SNARF-1 has been shown to be 
sufficiently different to the Ca2+ sensor fura-264 and to the Na+ sensor SBFI,65 
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facilitating simultaneous measurement of H+, Ca2+ and Na+ concentrations in cells.  
Finally, C.SNARF-1 can be excited at longer wavelengths (514 nm or 536 nm) than 
some other probes, reducing cell damage due to irradiation and circumventing some 
effects of intracellular autofluorescence.   
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There are also some drawbacks to using C.SNARF-1 as a pH indicator.  It has a 
low quantum yield, especially under acidic conditions (neutral form; ⎞ = 0.03).  
Intracellular pH values under 7.0 cannot be measured accurately using this dye because 
its pKa is too high (7.5).  Moreover, the spectral properties of C.SNARF-1 are 
significantly influenced by temperatures and environments in living cells.27   The 
quantum yield of the probe decreases by 25% when the temperature increases from 25 
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°C to 37 °C.  Further, the brightness of the dye inside living cells is diminished probably 
because of its interaction with intracellular proteins.  C.SNARF-4F59 and C.SNARF-5F 
have lower pKa values, 6.4 and 7.2 respectively, and are recommended by Invitrogen 
(formerly Molecular Probes) as replacements for C.SNARF-1 to measure acidic or 
cytosolic pHi.66,67  Some other C.SNAFLs, e.g. C.SNAFL-1 and SNAFL-calcein have 
been used for measuring pHi too, but their pKas are usually bigger than 7.6.    Finally, 
the fast photobleaching rate of these dyes, especially at 37 oC, restricts the application of 
SNAFLs for the measurement of pHi in the living systems.68  
 
4. Miscellaneous Small Molecule pHi Indicators 
This section covers small molecule pHi indicators that cannot be grouped into the 
categories discussed above.  The first four considered in this subsection (europium 
complexes, a fluorene derivative 14, 1,4-DHPN, and HPST) are indicators for near 
neutral environments.  The rest of the dyes in this section are useful under more acidic 
conditions; they are based on anthracene, BODIPY, or cyanine structures to give 
emission maxima that occur at longer wavelengths. 
4.1 Various Indicators for Near Neutral pH Values 
Europium Complexes  
Emissive europium(3+)69 complexes such as 13 may be applied for measurement 
of pHi.70  In these molecular, the sensitizing group azathiaxanthone allows excitation in 
the range 360 to 405 nm.  Fluorescence of this complex between 680 - 710 nm is 
hypersensitive to N-ligation of the sulfonamide which, unlike the sensitizing group, 
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dissociates from the metal as the pH is lowered.  Thus the fluorescence intensity at 680 
nm is quite strong in basic aqueous solutions (pH ~8) and diminished in acidic media 
(pH 4-5).  This characteristic makes the complex suitable for ratiometric pH 
measurement based on fluorescence intensity ratios at 587 and 680 nmas a function of 
pH.  The complex possesses a large Stoke shift ~200 nm and fluoresces in the near-IR 
region where cell autofluorescence is less problematic.  Moreover, complex 13 is cell-
permeable and non-toxic.  When the dyes is used to stain cells, confocal fluorescence 
microscopy indicates that both the europium emission (ca 570 nm) and the 
azathiaxanthone fluorescence (450 nm) eminate mainly from the nucleus implying that 
the intact complex is localized there.  A disadvantage of 13 is that, like most lanthanide 
complexes, it has a low quantum yield (0.06). 
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The donor-π-acceptor fluorene derivative 1471 is a near-neutral pHi indicator with 
pKa of ~ 7.  It is water-soluble, cell permeable, and diffuses into the cytosol.  Also it has 
low cytotoxicity (in the 0.1 – 100 μM concentration range)71 as indicated by the Alamar 
Blue (AB) reduction analysis (a method to test cell viability).72  Sharp isobestic points 
are observed in the absorbance and emission spectra of this dye (at 355 and 492 nm 
respectively); as we have already commented, isobestic points are highly desirable for 
ratiometric measurements because they are indicative of well proportioned spectral 
transformations between two {pH} states.  Furthermore, this probe has been applied for 
imaging of with two-photon excitation with a relatively large 2PA cross section (100 
GM at ~800 nm) in its neutral form 14’.  
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1,4-Dihydroxyphthalonitrile (1,4-DHPN) 
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1,4-DHPN73,74 was a commonly used pHi indicator before it was largely 
superceded by BCECF and C.SNARF-1 in the early 1980s.  The spectral properties of 
this compound are more desirable for intracellular pHi measurements than fluorescein 
derivatives; this is because the fluorescence emission maximum for 1,4-DHPN shifts 
with pH whereas fluoresceins tend not to have this properties hence they are used to give 
a change of fluorescence intensity at one single wavelength.29  The maximum 
fluorescence wavelengths in the emission spectra of 1,4-DHPN shift from 450 to 476 nm 
as pH is increased from 3 to 10, and this permits the dual emission ratiometric 
measurement.  The ratio of the fluorescence intensities at 512 and 455 nm do not 
significantly change with dye concentration and the ionic strength of the medium.  
Further, the dye is also not toxic to cells (at least as assessed by monitoring oxygen 
consumption, an older method to test cell viability).74  The parent dye is not especially 
cell permeable but the corresponding diacetate, 1,4-diacetoxyphthalonitrile (1,4-
DAPN),75 is and it can be hydrolyzed into 1,4-DHPN by the enzyme esterase.  1,4-
DHPN has been used to sense the pHi regulatory responses when A6 cells are incubated 
with acid and with base.74    
There are, however, several drawbacks associated with applications of 1,4-
DHPN in pHi measurements.  First the dye is rapidly cleared from living cells because it 
only has 1-2 negative charges at physiological pH values.76  Second the low UV 
excitation wavelengths typically used for this dye (350-365 nm) might perturb the cells.  
Third, the emission spectrum does not have a well-behaved isobestic point hence this 
dyes is not ideal for ratiometric methods based on differences in emission wavelenghts.  
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Overall, dyes like the BCECF and SNARFs are more favorable with respect to these 
parameters hence they tend to be preferred over 1,4-DHPN for pHi measurements. 
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8-Hydroxypyrene-1,3,6-trisulfonic Acid (HPTS) 
HPTS is a highly water-soluble dye compound77 with low toxicity,78 and it is also 
very cheap compared with most other indicators.  It has been used for measurement of 
cytoplasmic pH79  or acidic organelle pH80 in many cell types.  Excitation ratio imaging 
is possible using HPTS since it has absorbance maxima at 405 and 465 nm that increases 
and decreases, respectively, when the solution pH is varied from 5 to 8.  Furthermore, 
this tri- or tetra-anionic dye is retained well inside living cells at physiological pH 
values.  The main limitation to the use of HPTS as an intracellular indicator is its lack of 
cell permeability, and there is no convenient pro-drug like form to facilitate transport of 
this dye into cells.  This accentuates the general need for sulfonic acid protecting groups 
that are cleaved by esterases.  At present HPTS is only useful for pHi measurements 
when loaded inside living cells via microinjection, electroporation,81 and scrape-
loading79 which might damage the cells.   
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Cyanine-based pH Indicators 
Near IR pH stains based on cyanine dyes tend to emit in the near IR region, 
hence minimizing cell damage on excitation and undesirable effects from cell 
autofluorescence.82  A new near-infrared neutral pH fluorescent probe 1583 was recently 
introduced for measurement of near neutral pHi values.  This pH indicator consists of a 
near IR fluorescent tricarbocynine (Cy) fluorophore with high molar absorptivity and a 
4’-(aminomethylphenyl)-2,2’:6’,2”-terpyridine(Tpy) receptor.  In pH 10, the 
fluorescence of 15 was quenched (⎞ = 0.008) by the lone pair electrons of Tpy via PeT.  
Conversely, the protonation of N atoms stops PeT process and the dye fluoresces 
brightly (φ = 0.13) with a peak at 750 nm.  Fluorimetric titration showed that the pKa of 
the probe in aqueous buffered solution is about 7.1.  Compound 15 was applied to living 
HepG2 cells for observing pH-dependent changes of fluorescence brightness.83  
Confocal spectra revealed that dye 15 was more fluorescent at pH 7.0 than at pH 7.8, and 
it could monitor minor pH changes within the range of 6.7 – 7.9.  Extensive studies 
showed that this probe has low toxicity, cell membrane permeability and good 
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photostability.  All these advantages suggest that this probe could be widely used for 
monitoring minor pH changes in biological systems.  
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4.2 Various pH Indicators for Acidic Environments  
Commercialized Lysosensors 
Many probes are available from Life Technologies (former name Invitrogen) for 
measurement of acidic pHi values.  A pyridyl Oxazol probe Yellow/Blue DND-160 
PDMPO84, the anthrathene-based sensor DND-16785 and DND-153, and DND-189 
(Figure 2.6) are dyes that work on the principle of that electronic excited states can be 
quenched before they fluoresce by electron transfer form amines; this is photoinduced 
electron transfer (PeT).86,87  Dyes of this type become more emissive in acidic 
environments when proximal amine is protonated.  Of all the Lysosensors shown in 
Figure 4, DND-160 is unique because it is brightly fluorescent at protonated and 
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deprotonated forms (⎞ < 0.3 for both forms) and its absorbance and fluorescence spectra 
are significantly blue shifted with isosbestic points at 365 and 470 nm as the pH values 
are increased.  Furthermore, it showed pH-dependent lifetime responses indicating a 
good probe for lifetime imaging to determine lysosomal pH.87  The acidic form DND-
160 fluoresces brightly in yellow light with a peak at 540 nm.  The basic form emits 
strongly blue light with a maximum at 440 nm.  The pKa of DND-160 is about 5.1.  
DND-160 has been applied for dual emission imaging for lysosomal pH.  Advantages of 
the DND dyes, and of anthracene derivatives in particular, are that they tend to be very 
photostable, and cell permeable.  Conversely, a disadvantage associated with that 
particular dye type is that that anthracene is a dye that absorbs and emits at relative short 
wavelengths (377 and 430 nm),85 leading to cell damage and undesirable artifacts from 
autofluorescence.  LysoSensor DND-189 is exceptional insofar as it remains fluorescent 
even when the pendant amine is not protonated, ie at pH values from 5.4 to 7.0.88  DND-
153 with a pKa of 7.5 is sensitive to neutral pH, but still has strongly emission in green 
light at pH 8.87  We conclude that PeT does not quench the fluorescence of these dyes so 
effectively because the oxidation/reduction potentials of the fluorophore and the amine 
are not well matched for this.   
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Figure 2.6.  Commercialized Lysosensors for acidic environments. 
 
A group of macrocyclic peptidomimetics FG-H503, FG-H504, FG-H506 and 
FG-H508 derived from 9,10-dimethylanthracene moiety were reported in 2005.88  All of 
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these probes have very similar absorbance (at 377 nm) and fluorescence maxima (ca 430 
nm) in aqueous solution but have tunable pH properties for the fluorescence imaging of 
acidic organelles in live cells.  The peptidic parts differ only in the size of the cyclic 
systems they form around the anthracene (n changes from 3 to 8): this structural change 
modifies the pKa values of the amine parts from 5.06 to 5.43.  Thus these 
peptidomimetics are useful in a pH region that is not covered effectively by lysosensors 
DND-167 and DND-189 (pKa of 5.1 and 5.2).   It was concluded that FG-H503 localizes 
in acidic organelles after being taken up by macrophage Raw 264.3 cells, because it co-
localized with lysosomal probes DND-189 and DND-26.     
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Acridine Dyes 
One of the most commonly method to study the changing of pH in acidic 
organelle in live cell is based on the use of lipophilic weak bases, such as monoamine, 9-
amino-6-chloro-2-methoxyacridine (ACMA), and diamine acridine orange (AO).  These 
dyes are cell permeable in neutral form and much less permeable in protonated form.  
The alteration of absorbance and fluorescence spectra of AO is dependent upon its 
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concentration.89  The monomeric form of AO absorbs at ~ 492 nm and emits green light 
at 530 nm.  A red emission at 655 nm has been attributed to the dimmer or oligomers of 
AO, which has a blue shift absorbance at 465 nm.90,91  The ratio in the green/red 
(530/655 nm) is dependent on the concentration in acidic compartments in living cells, 
which is harnessed by the pH gradient through membrane vesicles.  Therefore, the 
relative acidity of acidic vesicles in sensitive or in muiltidrug-resistant living cancer cells 
has been appraised by determination of the red/green ratio of accumulated AO.90  
Limitations of using AO as a probe for measuring pH across membrane is that its 
spectral properties are significantly affected by temperature and the presence of 
anions.91,92  For instance, NO3- anion can induce aggregation of AO.  Therefore, AO can 
not be used for quantitatively determination of pHi. 
ACMA,93 the nucleic acid stain, mainly exists in monocation form (pKa of 8.6) 
in physiological environments.  This dye, unlike AO, does not dimerize in solution at 
concentration as high as 200 μM.94  Its fluorescence is quenched by pH or potential 
gradients across cell membranes.94,95 
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BODIPY-based  
Cell permeable LysoTracker Green DND-26, a BODIPY derivative (Figure 2.6), 
could also be used for imaging acidic compartments in live cells.  This dye tends to 
absorb and emit at longer wavelengths than the anthracene derivatives, and it is a 
brighter probe because its molar absorptivity is higher. 
A series of pH probes based on BODIPYs (ie NH2BDP, DiMeNBDP, 
EtMeNBDP and DiEtNBDP) were recently reported for imaging acidic endosomes in 
cancer cells.96  These compounds are almost non-fluorescent in basic media (⎞ <0.002) 
due to PeT quenching by the meso-aminophenol substituent.  However, these 
compounds are highly fluorescent in acidic environments (⎞ 0.55 – 0.60) when the 
aniline amine is protonated.  The pKa values of these BODIPY dyes range from 3.8 to 
6.0; this range is possible by changing the alkyl group on the nitrogen.  Monoclonal 
antibody trastuzumab labeled with these acidic pH-sensitive dyes selectively target the 
human epidermal growth factor type 2 (HER2) receptor, and are then internalized.  
Confocal spectroscopy revealed that the antibody-probe conjugates are not fluorescent 
outside cells at neutral pH values.  However, 2 h after they are combined with 
appropriate cells, the pH probe-antibody conjugates fluoresce in endosomes.  Only 
viable cells are visualized under these conditions because the acidic pH in lysosomes is 
maintained by energy-consuming proton pump; this factor can be an advantage for some 
analyses.  
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A Cyanine-based pH Indicator  
The cyanine derivative 15 is cell permeable, and has an optimal pH response 
around ~5.1.97  The aminophenol part is the modulator; when protonated, the dye has a 
maximum absorbance at 558 nm, and fluoresces at 615 nm.  The fluorescence intensity 
increases about 10 times when the pH is decreased from 6.5 to 4.0.  Indicator 15 has 
been applied for monitoring intracellular H+ within HepG2 cells.   One general 
disadvantage cyanine-based dyes is that they tend to photobleach faster than ones based 
on anthracene and BODIPY systems. 
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5. An Energy Transfer Cassette 
Compound 16 based on through-bond energy transfer cassettes98-101 has been 
used for probing pHi in cos-7 cells.20  Probe 16 consists of two xanthene donors, one 
BODIPY acceptor, and a triethylene glycol carboxylic acid linker.  The linker part is 
designed to increase the water solubility of the compound in aqueous solution, and to 
allow attachment to biomolecules.  Energy transfer efficiency from the donors to the 
acceptor is modulated by the oxidative potentials of the xanthene part, which in turn 
depend on its protonation state.  Thus when the system is excited at wavelengths that 
correspond to the donor then the fluorescence of the whole system is sensitive to the pH 
of the medium.  At pH 5.5 or less, the xanthene donors exists the phenolic state, the 
oxidation potential of this is ideal for energy transfer, and the probe fluoresces via the 
acceptor, ie red, around 600 nm.102  Conversely, the xanthene donors exists 
predominantly in the phenolate form under basic conditions pH > 7.  In that state the 
donor and acceptor oxidation potentials are not well matched for energy transfer, and the 
sensor fluoresces almost exclusively from the donors parts (green, ie around 520 nm).  If 
the pH is between 5.5 and 6.5, the cassette emits from donors as well as the acceptor.  
Overall, the cassette remains fluorescent as the pH is changed. 
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A recent discovery from our laboratories shows that Pep-1 mediated import into 
COS-7 cells tends to deposit the dye-labeled protein cargoes into the cytosol and 
ensosome when the experiment is performed at 4 and 37 °C respectively.103  Thus, BSA-
16 under these conditions would be expected to fluoresce with different red-to-green 
ratios when BSA-16 is distributed within the cytosol with pH at ~ 7.2, and the endosome 
with pH around 5-6.  An ex-vivo calibration curve was generated for the cassette shown 
above (Figure 2.7); this facilitated its use to determine pH values for the endosomes and 
the cytosol.  The pH values of endosome and cytosol, obtained from the red/green ratio 
  
43
(R/G = 5.03 and 2.03), were 5.4 and 7.4 respectively; these data are consistent with those 
expected for such intracellular regions.   
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Figure 2.7.  ex-vivo calibration curve with pH values corresponding to those observed within 
endosomes (red/green = 5.03; import at 37 °C) and the cytosol (red/green = 2.03; import at 4 °C). 
 
Imaging of protein-16 inside cells was possible using this probe.  We favor 
reserving the word probe for labels that can be conjugated with biomolecules to track 
them within cells.  This distinction is important when differentiating these from stains.  
We reserve the word stains for dyes like C.SNARF-1 that are usually used in solutions to 
bathe the cells and stain their interiors.  Dyes like C.SNARF-1 are usually not attached 
ot biomolecules then imported into cells for several reasons.  These reasons relate to 
their low quantum yields making them hard to visualize at low concentrations, and 
photobleaching effects.  
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6. pH Indicators Based on Nanoparticles, Lipobeads and Microspheres 
Nanoparticles can have unique properties resulting from their large surface-to-
volume ratios and their small sizes; consequently, they have some potential as sensors in 
medicine and biotechnology.  Probes for pH based on a nanoscaffolds can possess 
several advantages over small molecule pH sensors.  Firstly, multiple indicators can be 
attached to single particles, hence the localized brightness of the system is increased.   
Second, particles can simultaneously support pH-sensitive and -insensitive dyes to 
facilitate ratiometric measurements.  Third, nanoparticles may be less vulnerable to 
leakage through cell membranes and to cellular compartmentalization.  Fourth, some 
nanoparticles are more photostable than small organic dyes.  Finally, the physical 
properties of the nanoparticles can be modulated and manipulated by adjusting their core 
structures, e.g. by choosing between bacteriophage, silica, and coated polystyrenes. 
Fluorescein-loaded onto amino-functionalized polystyrene microspheres, ca 2μM 
diameter have been used for real-time detection of H+ concentrations inside living 
cells.104  These microsphere were shown to be cell permeable to varied cell lines, and 
non-toxic to cells at any concentration tested.  These bead have an aminohexanoic acid 
linker between the bead and the fluorescent label {formed from 5(6)-
carboxyfluorescein}.   
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Scheme 2.5.  Synthesis of fluorescein-capped polystyrene microspheres. 
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M13 bacteriophage particles functionalized with cyanine dyes have been used for 
determination of intracellular pH.105  These particles provide a flexible heterofunctional 
platform that is approximately 880 x 6.6 nm in size.  They contain ca 2700 copies of the 
p8 coat protein, hence the surface of the particle displays amine groups that may be used 
for conjugation to other molecules.  In this particular case those amines were coupled 
with the cyanine dyes, HCyC-646 (pH-sensitive) and Cy-7 dyes (pH insensitive, Figure 
2.8).  When protonated, HCyc-646 absorbs at 646 nm and emits at 670 nm with a 
quantum yield of 0.08 in aqueous solution.   In neutral or basic environments, the dye is 
deprotonated, there is an hypsochromic (blue) shift of the absorbance to 506 nm, and the 
near-IR fluorescence is lost.  The pKa of HCyc-646 is 6.2, which is suitable for sensing 
acidic environments in live cells.  The pH insensitive dye Cy-7 emits at 775 nm, and this 
fluorescence provides an in-built control on the nanoparticle that can be used to calibrate 
the fluorescence changes of the other dye.  Typically 400-500 copies of HCyC-646 and 
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Cy-7 combined were attached to the bacteriophage.   In one experiment, incubation of 
the labeled bacteriophage with RAW cells for 1 h gave internalization of the particles 
into acidic organelles where they indicated a pH of 5.0 - 6.5; such values are to be 
expected for intracellular vesicles such as lysosomes, endosomes and phagosomes.   
Imaging through tissue was also achieved using dye-labeled bacteriophage particles.105  
Good correlations were observed between ratiometric pH readings from these particles 
and the values measured via an electrode.   However, a limitation of this system is that 
fluorescence emissions from HCyC-646 and Cy-7 at (670 and 775 nm respectively) 
penetrate tissue with different efficiencies hence a correction factor must be applied for 
accurate measurements of pH.  
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Figure 2.8.  HCyC-646 and Cy-7 loaded onto bacteriophage particles. 
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Figure 2.8.  Continued. 
 
Colloidal luminescent mercaptoacetic acid capped CdSe/ZnSe/ZnS quantum dots 
are pH-sensitive andhave been applied to sensing intracellular pH in human ovarian 
cancer cells.106  The CdSe core emits visible light, and the two ZnSe/ZnS shells stabilize 
the photoluminescence properties of the quantum dots by preventing oxidation of the 
core.  Capping the dots with mercaptoacetic acid also serves to increase their water 
solubilities.  Fluorescence intensities of these quantum dots in cells increases 
monotonically with increasing pH, ie it is quenched in acidic solutions.  In living cells 
these particles are around 10-fold less fluorescent at pH 4 than at pH 10.  Further, their 
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high resistance to photobleaching facilitates long-term cell tracking and monitoring of 
the intracellular pH. 
Fluorescent dyes encapsulated in silica nanoparticles, ”fluorescent core-shell 
silica nanoparticles”, have been produced for quantitative chemical sensing in live cells.  
The fluors encapsulated in these particles tend to be brighter and more photostable than 
the corresponding free dyes in solution.107,108  Dual emission sensor nanoparticles can 
combine a pH-sensitive fluorescein dye and a pH-insensitive dye like 
tetramethylrhodamine.  Such particles have been shown to be endocytosed by RBL mast 
cells upon the addition of the macropinocytosis stimulator, phorbol 12,13-dibutyrate.  
Following uptake, the particles were trapped in endosomes that later matured into 
lysosomes.  The pH values of various intracellular locations indicated by confocal 
fluorescence images varied from 6.5 (endosome) to 5.0 - 5.5 (lysosome).  The rhodamine 
internal standard for the pHi measurements also acts as an indicator of the particle 
location even in acidic pH conditions where the fluorescein component is less emissive.         
 Micrometric phospholipid-coated polystyrene particles, also called “lipobeads”, have 
been used for determination of pHi in murine macrophage cells.109  Again, just as in the 
work described above, pH sensitive fluorescein and pH-insensitive 
tetramethylrhodamine were used for these ratiometric pH measurements; the liposome-
encapsulated dyes display sensing properties similar to those observed in aqueous 
solution.  In this case those fluors were covalently attached to the phospholipids coats on 
the polystyrene particles thus preventing leakage of dye molecules into the 
microenvironment.  The lipobeads were shown to be non-invasively ingested by 
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macrophage cells and delivered into lysosomes.  However, we note that use of 
macrophage cells is not a stringent test of the ability of particles to permeate cell walls or 
of their cytotoxic effects; this is because macrophage cells easily ingest foreign material, 
and they are relatively robust.  Bright field images of the particles in these cells indicated 
they were not significantly aggregated.   Lysosome pH values deduced using these 
lipobeads were 5.7 ± 0.1; this is a reasonable value. 
    
7. Fluorescent Proteins 
Green fluorescent protein (GFP) from the jellyfish Aequorea Victoria is a widely 
used as the reporter for gene expression110 and as a marker for biomolecules.111 GFP has 
a cylindrical 11-strand β-barrel structure encapsulating the chromophore p-
hydroxybenzylideneimidazolidinone 17.  This fluorescent part is formed by autocatalytic 
condensation, cyclization and oxidation of three consecutive amino acids Ser-Tye-Gly 
from the 65-67 parent protein.  The β-barrel forms a relatively rigid, hydrophobic 
environment which enhances the quantum yield of the chromophore.112     
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Photophysical properties of GFP and similar fluorescent proteins can be modified 
by mutagenesis.113-115  For instance, the replacement of S66 tyrosine residue in GFP with 
histidine gives the blue fluorescent protein BFP that contains the chromophore 18.  The 
spectral properties of both native GFP and its mutants are strongly pH dependent in 
aqueous solutions,116 suggesting a pH sensing roles and applications in cell 
compartments.  The S65T-GFP chromophore has a pKa of 6.0 and has absorbance 
maxima at ~382 and 490 nm.  The intensities of these peaks change with solution pH; in 
acidic environments, absorbance at 382 nm predominates, but in basic media, the 490 
nm peak predominates.   
Two type GFP mutants S65T and F64L/S65T, also termed GFPmul1, have been 
used for measurement of cell compartments in living cells.117,118  Similar pHi values 
were deduced using GFPmul1 and pHi indicator BCECF.  Another pH sensitive GFP 
mutant, called enhanced yellow fluorescent protein (EYFP), has a pKa of 7.1, suggesting 
that this protein is suitable for pHi measurements in pH range of 6.5 -7.5.   
One advantage of fluorescent proteins is that they can be targeted to specific 
organelles (e.g. cytosol, nucleus, mitochondria, trans-Golgi and endoplasmic reticulum) 
by expressing them in conjugation with appropriate targeting peptides or proteins.119,120  
The fact that they are expressed in cells, rather than imported into them, can also be an 
advantage in some situations. 
 
8. Conclusions 
Probes for pHi measurements can be used to study pH-dependent biological and 
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pathological processes, e.g. cell death, cancers, and cell proliferation.  BCECF and 
carboxy-SNARF-1 are the two most widely used pHi indicators since they have desirable 
photophysical properties for the determination of near neutral intracellular H+ 
concentrations.  Fluorescein and fluorescein derivatives, e.g. carboxyfluorescein, are 
common pHi indicators; however, they rapidly leak from the cytosol through cell 
membranes and this can lead to erroneous pH measurements.  HPTS, another widely 
used intracellular pH probe, tends to be retained inside living cells because it has three 
sulfonate groups, and it can be applied for measurements of acidic and near neutral pH 
values.  However, HPTS is not cell permeable and must be injected into cells if it is to be 
observed there.  Other organic fluors that have been used as stains in pH measurements 
have sub-optimal properties in terms of photostabilities or quantum yields.  Figure 2.9 
gives a “pH spectrum” for the most widely used cellular pH sensitive stains.  
Most pHi measurements are ratiometric.  They can be dual excitation (changes at one 
fluorescent wavelength are observed) or dual emission.  Methods based on a single 
excitation wavelength (dual emission) have a significant advantage insofar as they are 
most easily used on different equipment (e.g. confocal microscopes, plate readers, and 
flow cytometers) where only one or limited excitation wavelengths are available. 
Fluorescent proteins can be used to measure the pHi of specific cell organelles 
(e.g. the mitochondria, ER and Golgi) after fusing them to targeting entities.  This is a 
big advantage when probing the pH of specific organelles, but it is a significant amount 
of work to construct suitably genetically encoded cells.   
Other methods for pHi determination are more futuristic.  Nanoparticles, e.g. 
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CdSe quantum dots, dye-dopped silica nanoparticles, and dye-labeled bacteriophage can 
be more photostable and brilliant than small fluorescent organic dyes.  However, they 
tend to be endocytosed into cells and thus they can be trapped in acidic vesicles or 
endosomes.  Moreover, there are more convenient ways to stain cells, and the 
disadvantage of using these indicators as probes bioconjugated to proteins is that they 
tend to be as big or bigger than the protein itself.    
In fact, most of the molecules used for measurements of intracellular pHi values 
are stains, ie entities that color the whole cell.  The xanthene-BODIPY cassette 16 has 
the potential to be used as a probe, ie it can be attached to proteins then imported into 
cells to track that protein.  This is possible because 16 has a higher quantum yield than 
C.SNARF-1 both in acidic and basic environments, and because it has a functional group 
to allow bioconjugation.  There is clearly an opportunity to devise other pHi probes for 
tracking spatial and temporal protein function inside live cells and the way pH changes 
around them. 
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Figure 2.9.  pH sensitive ranges of most widely used cellular pH sensitive stains. 
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B. AN RATIOMETRIC pH REPORTER FOR IMAGING PROTEIN-DYE 
CONJUGATE IN LIVING CELLS 
Of the numerous fluorescent small molecule pH probes that have been reported, 
only a small number are practical for intracellular imaging of protein-dye conjugates.  
This is unfortunate because pH changes within cells are indicative of many cellular 
processes.9-11,121,122  The most useful probes are the ratiometric ones that absorb UV 
excitation at a fixed wavelength, and emit at two different fluorescence wavelengths in a 
pH dependent manner.  These probes do not give dark regions in the cell at extreme pH 
environments, and simply areas where the dye did not permeate are clear.  A widely 
used, commercially available pH-sensitive probe of this type is C.SNARF-1 (Invitrogen 
Inc.). This communication focuses on the pH probe 16 based on a through-bond energy 
transfer cassette.98-100  Data are presented to demonstrate that probe 16 tends to fluoresce 
with higher quantum yields than SNARF over a physiologically relevant pH range.  The 
ideal pH ranges of operation for 16 and for C.SNARF-1 are complementary (4.0 – 6.5 
and 7.0 – 8.0, respectively).  
Xanthene (the fluorescent core of fluorescein) is highly emissive at pH values 
above 7 (φ = 0.9); under those conditions it exists predominantly in the phenolate form.  
As the pH is lowered to around 6, it transforms into the phenolic state that is somewhat 
less emissive (φ = 0.4).51,102,123  The pH probe 16, which has two xanthene donors and 
one BODIPY acceptor, was designed to harness changes in the oxidation potentials 
associated with these protonation states.  We hypothesized that the efficiency of the 
energy transfer from the xanthene donors to the BODIPY core would be governed by 
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oxidation potentials which in turn depend on the protonation state of the xanthenes, 
making the whole cassette sensitive to pH changes in the range of cellular physiological 
processes.  Perfect energy transfer, when the probe is excited near the fluorescein 
absorption maxima (ca 495 nm), would give red fluorescence (600 nm).  Conversely, if 
the energy transfer was completely eliminated at certain pH values then the cassette 
would fluoresces from the xanthene core (ie around 520 nm).  In either case, the cassette 
would remain fluorescent as the cellular pH changes. 
 
1. Design and Synthesis of the pH Probe 
Cassette 16 was prepared via Sonogashira coupling of two 5’-alkynyl fluorescein 
diacetate molecules C98 with an appropriate diiodo-BODIPY 20, followed by 
deprotection of t-butyl ester and acetate esters by pyrolysis and hydrolysis respectively. 
Compound 16 was designed to have a triethylene glycol linker that would somewhat 
separate the dye from the protein as well as increase solubility in polar solvents. 
Iodination of BODIPY 19, which is synthesized by the Sonogashira coupling reaction of 
two known fragments BODIPY B124 and terminal alkyne A125, gave diiodo-BODIPY 20 
in quantitative yield using conditions developed in Nagano’s group.[Yogo, 2005 #10599  
The final cassette is slightly water soluble at neutral pH, and more so at pH 8.  
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Scheme 2.6.  Syntheses of pH indicator 16 
OAcO OAc
O
O
C
O
O3
OtBu
O
A  
 
N
B
N
F F
O
O
19  77 %
N
B
N
F F
I
3
OtBu
O
A, 10 mol% PdCl2(PPh3)2
20 mol% CuI, Et3N 
THF, 55 oC, 5 h
I2, HIO3, EtOH
60 oC, 20 min
B  
 
N
B
N
F F
O
O
20  99 %
3
OtBu
O
I I
C, 10 mol% Pd(PPh3)4
 20 mol% CuI, Et3N
THF, 45 oC, 16 h
 
 
N
B
N
F F
21  72%
O O
OAc
OAcAcO
AcO
O
O
O
O
(i) neat, 200 oC, 15 h
(ii) 5 eq K2CO3 , MeOH
20 oC, 4 h
O
O3
OtBu
O
16
95 %
 
  
57
2. Results and Discussion   
Absorbance spectra for the conjugate of this probe with bovine serum albumin, ie 
BSA-16 were measured as a function of pH in aqueous media.  The absorption maxima 
for the acceptor BODIPY part is around 576 nm, and is impervious to pH changes 
between 4.1 and 7.9.  However, the extinction coefficient for the fluorescein part at 
around 495 nm diminishes markedly from pH 7.9 to 4.1. (Figure 2.10a)  
Fluorescence spectra for BSA-16 as a function of pH are shown in Figure 2.10b.  
Under neutral and basic conditions, pH 7.0 and 7.9, the probe emits almost exclusively 
at around 520 nm, ie green fluorescence.  Conversely, at the acidic extreme, pH 4.1 and 
5.0, the cassette fluoresces almost completely red, ie from the BODIPY acceptor.  The 
inset of Figure 2.10b shows that the ratio of red-to-green fluorescence for BSA-16 is 
highly sensitive to pH in the 4.0 – 6.5 range.  A crossover occurs around pH 6.0 where 
significant red and green fluorescence are observed.  If the measurement at pH 7.9 is 
excluded from consideration in Figure 2.10b (this is justifiable because we do not claim 
that the probe is sensitive above pH 7), then an isobestic point is apparent.  Quantum 
yield measurements for BSA-16 at the pH extremes of 4.1 and 8.8 were 0.18 and 0.14.  
By comparison, literature quantum yields for SNARF are 0.03 (pH 5 – 6) and 0.09 (pH 
10 – 12).[Brasselet, 2000 #13204]  The fluorescence response of 16 as the pH is cycled 
between acidic (3.4) and  basic media (8.0) demonstrated that the probe is stable to this 
treatment as shown in Figure 2.11. 
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Figure 2.10.  Spectroscopy and pH titration of BSA-16 (0.75 x 10-6 M) in aqueous solutions containing 
125 mM KCl, 20 mM NaCl, 0.5 mM CaCl2, 0.5 mM MgCl2, and 25 mM of one of the buffers, 
including acetate (4.1, 5.0), Mes (6.0), Mops (7.0) and HEPES (7.9).  (a) Absorbance spectra; (b) 
emission spectra with excitation at 488 nm.  Inset: Ratio of fluorescence integral for the red channel 
(575-625 nm) relative to the green channel (503–553 nm) at different pH values.  
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Figure 2.11.  Fluorescence responses of 16 (8.0 x 10-7 M) to acid/base cycles in 1:1 water-ethanol 
solutions.  The pH values used were 3.8 to 7.2, 6.0 to 8.0, 3.5 to 7.5, and 3.4 to 7.6, corresponding to 
cycles 1 to 4 respectively. The fluorescence intensities of the donor at 525 nm and acceptor at 600 nm 
were monitored with excitation at 488 and 565 nm respectively. 
 
Endosomes within cells (pH 5.0 – 5.5) are markedly more acidic than the 
cytosol.126  We have observed that when the non-covalently bound carrier peptide “Pep-
1”127 imports dye labeled proteins into COS-7 cells the protein-dye conjugates tend to be 
encapsulated in endosomes.103  Consequently, we anticipated that when BSA-16 was 
imported into cells using Pep-1, it would localize in endosomes and, in that acidic 
environment the probe would emit around 600 nm.  When BSA-16 was imported into 
COS-7 cells using Pep-1 (1 mM protein; 1:20 mol ratio protein:carrier, 37 ºC, 1h), 
irradiation at 488 nm resulted predominantly in red fluorescence localized in punctuate 
vesicular structures (Figure 2.12a). 
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Figure 2.12.  Pep-1 mediated cellular uptake of BSA-16 (1 μM) into COS-7 cells after 1h incubation 
at (a) 37 °C and (b) 4 °C.  The cells were irradiated at 488 nm and fluorescence from donor (503-553 
nm) and acceptor (575-625 nm) was detected respectively. 
 
A recent discovery from our laboratories shows that Pep-1 mediated import into 
COS-7 cells tends to deposit the dye-labeled protein cargoes into the cytosol when the 
experiment is performed at 4 °C.103  Thus, BSA-16 under these conditions would be 
expected to fluoresce with diminished red-to-green ratios.  The fluorescence intensity for 
BSA-16 is distributed within the cytosol, hence the images in Figure 2.12 appear to be 
deceptively weak relative to situations (e.g. Figure 2.12a) where the probe is 
concentrated in punctates.  A better impression of the relative intensities in the red and 
green channels for both experiments (37 and 4 °C) after correction for autofluorescence 
and donor bleed through is shown in the Figure 2.13a. 
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Quantitative data for pH measurements in cells were obtained via a calibration 
experiment.  Details of this are provided in the supporting information, but the salient 
feature is that the ionophore nigericin was used to produce “leaky cells” that were then 
bathed in buffers.  This is a standard approach that has been used for the same purpose to 
calibrate other pH measurements ex-vivo.27,29,61,119  A curve generated with the 
calibration experiment (Figure 2.13b) was used to determine pH values for the 
endosomes and the cytosol for the experiments shown in Figure 22.  The pH values, 
obtained from the red/green ratio (R/G = 5.03 and 2.03 at 37 and 4 °C, respectively), 
were 5.4 and 7.4 and were in good agreement with those expected for such intracellular 
regions.  When C.SNARF-1 AM (not protein conjugated) was imported into COS-7 cells 
(at 37 and 4 °C) as a lipophilic, hydrolysable form, a pH value of 7.1 was determined 
(see Figure 2.13c); this is very close to the value cited above for probe 16 (ie 7.4).  
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Figure 2.13.  (a) Corrected relative intensities observed in the green and red channels for BSA-16 
imported into COS-7 cells at 37 and 4 °C; (b) Ex-vivo calibration curve of BSA-16 with pH values 
corresponding to those observed within endosomes (red/green = 5.03; import at 37 °C) and the cytosol 
(red/green = 2.03; import at 4 °C). (c) Ex-vivo calibration curve of C.SNARF-1with pH values 
corresponding to that observed within the cytosol (red/green = 2.03; import at 4 °C).  Emission spectra 
were obtained upon excitation at 530 nm. 
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Figure 2.13.  Continued. 
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3. Conclusions 
Our interpretation of the C.SNARF-1 literature indicates that this probe is usually 
used as a non-conjugated form (i.e. not attached to proteins); presumably this is because 
it has a low quantum yield and cannot easily be visualized when present at low 
concentrations.128  By contrast, the data presented in this study show that visualization of 
proteins conjugated to 16 is possible.   This is highly significant because the new probe 
should facilitate observation of processes within the cell. Further, the energy transfer 
approach to pH probes for intracellular imaging has considerable potential for 
modifications with other pH sensitive donors to give a spectrum of probes with 
systematically varied pH response transitions.  Design of probes of this type requires an 
understanding of the parameters underlying the fluorescence energy transfer processes.  
These parameters although not simple, have been elucidated in a parallel study that 
focuses on the redox behavior of the cassette components; this is to be reported in the 
following chapter in detail. 
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C. “STOP-GO” FLUORESCENT PROTON SENSORS BASED ON THROUGH-
BOND ENERGY TRANSFER 
Intracellular sensing of protons is a non-trivial task; it is often achieved via 
oblique methods that do not allow direct observation of sensors that fluoresce at different 
wavelengths according to pH.  Such sensors would be preferred relative to ones that 
switch off completely at certain pH values, because probes of the latter type are not easy 
to locate inside cells in their “off-state”.  The former chapter that precedes this work 
described how a through-bond energy transfer cassette 16, a derivative of compound 22 
in this paper, could be used for intracellular imaging of pH.  This probe does have a 
desirable pH-fluorescence profile and it is always in the “on-state”.  Described here are 
syntheses of three other cassettes; another one containing two xanthene donors 23, and 
two more that each have two BODIPY-based donors, 24 and 25.  Remarkably, both the 
cassettes with xanthene-based donors, 22 and 23, fluoresce red under slightly acidic 
conditions (pH < ca 6), and green when the medium is more basic (> ca 7), whereas the 
corresponding cassettes with BODIPY donors, 24 and 25, give almost complete energy 
transfer regardless of pH.  Further, the quantum yield of the xanthene donor parts in 
cassettes 22 and 23 were much less (< 0.1) than the unsubstituted reference compound F 
(0.7 – 0.9).  Cassettes 24 and 25, by contrast, show no significant fluorescence from the 
donor parts, but the overall quantum yields of the cassettes when excited at the donor 
(observation of acceptor fluorescence) are high (ca 0.6 and 0.9).  Electrochemical 
measurements were performed to help explain the marked differences between the pH-
fluorescence profiles of cassettes 22 and 23 relative to 24 and 25.  Relative energies of 
  
66
the HOMO and LUMOs for the donor and acceptor parts were deduced from the 
oxidation and reduction potentials of reference compounds representing the donor and 
acceptor fragments in the BODIPY-donor cassette 24 and the xanthene donor cassette 22 
in different protonation states.  This led to a unifying hypothesis to explain the pH-
fluorescence profiles of these cassettes (Figures 1.17 – 1.19).  It is suggested that the 
concept of designing through-bond energy transfer cassettes wherein orbital levels can 
be perturbed by analytes, is a relatively new, and potentially useful, approach to sensors 
for biomedical applications. 
 
1. Introduction 
Fluorescent sensors are widely used for detection of protons and metals in 
several applications, especially intracellular imaging.129 Types of indicators may be 
divided into three: (i) ones that are insignificantly fluorescent in the absence of analyte, 
but are much more emissive when it is present; (ii) the inverse, where fluorescence of 
the probe is quenched by the analyte; and, (iii) sensors which have observable 
spectroscopic differences when the analyte is present compared to when it is absent.  The 
third type of sensor is “always on” and this is a significant advantage because it is clear 
that the probe is present even if the analyte is not (Figure 2.14).   
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Figure 2.14.  Fluorescent sensors may be activated (i) or quenched (ii) by analytes; ones that are 
“always on” (iii) but change wavelength of fluorescence emissions on binding. 
 
When imaging inside cells, it is hard, and in some cases impossible, to gauge if a 
probe that is invisible in cells until it is activated [ie a type (i) probe as defined above] 
has permeated to the relevant place.  Conversely, probes that are always fluorescent 
inside cells until they bind an analyte [type (ii)] are of little value because the absence of 
signal tends not to be observable over background.  Probes of the third type outlined 
above tend to be more useful than the others if they fluoresce at different wavelengths in 
the presence and in the absence of analyte.130  To detect protons, however, there are very 
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few probes of this kind.115,131-136 Consequently, researchers are forced to rely on much 
less conspicuous changes in sensors that are “always on”.  Typical fluorescence based 
methods to detect intracellular proton concentrations (pH),29,60,70,82,88,97,104,106,137 for 
instance, gauge emission intensities as a function of excitation wavelength that change as 
pH varies.104 Fluorescein-based probes, for example, can be used in this way. 138-
140However, these sensors do not change emission wavelength maxima as the pH is 
varied; if they did, they would be far easier to use.  A simple analogy is that traffic lights 
based on only a green or a red light would be less effective than ones that switch 
between the colors. 
This paper focuses on how red-green, “stop-go” sensors can be produced using 
through-bond energy transfer (TBET) cassettes arranged to exploit photoinduced 
electron transfer (PeT).  The background on “TBET cassettes” and “PeT” is as follows.  
Rapid and efficient through-bond energy transfer may be possible when a fluorescent 
donor fragment is joined to a fluorescent acceptor part in such a way that the two 
fragments would be electronically conjugated if they became planar, but they are 
sterically prevented from doing so.98-100,141,142 The fact that they cannot easily achieve 
planarity means that the absorption spectra of the complete system, the “cassette”, 
resembles that of the sum of the donor and acceptor parts.  However, the donor part will 
not fluoresce when it is excited in an efficient TBET cassette; instead the energy will be 
rapidly transferred to the acceptor fragment that will then fluoresce (Figure 2.15a).  
Through space energy transfer may occur simultaneously, but the through-bonds routes 
tends to be faster.143-145  
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Figure 2.15. The concepts of: (a) through-bond energy transfer cassettes; (b) fluorescent probes not 
effected by PeT; (c) reductive PeT for a meso-substituted BODIPY; and, (d) oxidative PeT for a meso-
substituted BODIPY. 
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Photoinduced electron transfer (PeT) generally quenches fluorescence via the 
two ways that are illustrated for the hypothetical fluorescent 8-aryl (or meso-aryl) 
BODIPY system in Figure 2.15b.146 8-Aryl substituents that raise the HOMO of this 
aromatic part facilitate reduction of the BODIPY core in the excited state; fluorescence 
of this fragment then becomes impossible (Figure 2.15c).   Conversely, 8-aryl 
substituents that lower its LUMO facilitate oxidation of the BODIPY excited state, and 
fluorescence of this is also impossible (Figure 2.15d). 
Nagano and co-workers recently described PeT in the context of both 
fluorescein-147,148 and BODIPY-149 based dyes.  This led them to demonstrate some 
elegant ways in which PeT could be exploited.  Some examples of the application of this 
strategy include development of probes to sense: singlet oxygen when it undergoes a 
cycloaddition to a fluorescein meso-substituent,150 nitric oxide,151,152 nitrite,153 nitronium 
ions that nitrate BODIPY meso-aryl substituents,154 and thiols when they add to a 2’-N-
maleimide on an 8-aryl BODIPY.155 More recently, Dan Yang and co-workers have 
devised a hypochlorous acid probe that responds by oxidizing a 8-(4’-
methoxyphenol)BODIPY substituent to a quinone.156 Most of this work features 
oxidation by analytes causing  “on-off” responses in sensors of type (i) and (ii) as 
defined above.  A possible exception is the thiol probe that probably functions by 
changing the electron donating properties of the substituents near a BODIPY core. 
An application of probe 16 to monitoring intracellular pH has already been 
demonstrated in the last chapter. That work shows this to be a “stop-go” probe that 
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fluoresces red at pH values less than about 6.5, and green at pH values above about 7.0 
and, significantly, it is always on. 
Data shown in this paper features the four TBET cassettes 22 – 25.  The research 
described here includes: (i) syntheses of these four TBET cassettes; (ii) the observation 
that the change of the meso-substituent on the central BODIPY [acceptor] fragment 
represented by the difference between cassettes 22 and 23 and between 24 and 25 is 
largely inconsequential to their fluorescence vs pH profiles indicating that PeT between 
the acceptors and meso-substituents does not play a significant role in the photophysical 
properties of the cassettes; (iii) the observation that the change of donor fragment from 
xanthene to BODIPY represented by the structural differences between 22 or 23, and 24 
or 25 have profound differences on the fluorescence characteristics of these cassettes; 
and, (iv) electrochemical data that can be interpreted to comprehensively explain these 
differences.  We feel this work is significant because it highlights the underlying 
electronic properties of TBET cassettes 22 and 23 that make them type (iii) stop-go, pH 
sensors.  One may conclude that it is reasonable this same strategy could be used to 
prepare “always on”, stop-go sensors for other analytes, and this would be particularly 
important in intracellular imaging.  
 
  
72
N
B
F2
N
O
O
O
OtBu
O
HO
O
O
OH
O
HO2C
CO2H
22
donor acceptor
2
O
 
 
N
B
F2
N
O
HO
O
O
OH
O
HO2C
CO2H
CO2H
23  
 
N
B
F2
N
N
F2B
N N
BF2
N
24
O
O
O
OtBu2
O
 
 
N
B
F2
N
N
F2B
N N
BF2
N
CO2H
25  
  
73
2. Syntheses of the Cassettes 22 - 25   
Two key diiodinated BODIPY intermediates, 20 and 27, were prepared to make 
the cassettes featured in this paper.  Synthesis of the first compound 20 is shown in 
Scheme 2.6. The second, compound 25 (Scheme 2.7), was formed via a route that is 
analogous to one used for a homolog formed from glutaric anhydride.157  Synthons 20 
and 27 lead to cassettes with different meso substituents: aryl and alkyl functionalities.   
A minor objective of this study was to determine if these differences would have any 
significant effects on the electronic spectra of these cassettes as explained above; in fact, 
they did not (see below). 
 
Scheme 2.7.  Syntheses of pivotal diiodinated synthons BODIPY 27. 
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Sonogashira reactions158,159 were used to assemble the cassettes from the 
acceptor components 20 and 27, and the fluorescein-based and BODIPY-based donor 
components C100,160,161  and D56 (Scheme 2.8).  The diacetate intermediate 21 is of some 
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importance because this compound has been shown to be cell permeable, and hydrolyzes 
in the cytosol to give green fluorescence. (Data are not shown here) The fluorescein-
based cassettes 22 and 23 are soluble in lower alcohol solvents giving pink solutions. 
 
Scheme 2.8.  Syntheses of cassettes: a, 22; and, b, 24. 
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Scheme 2.8.  Continued. 
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Cassette 23 (Scheme 2.9) was difficult to purify.  Flash chromatography did not 
give pure material, but the compound was isolated via preparative reverse phase HPLC 
in 4 % yield.  Both cassettes 24 and 25 are soluble in lipophilic solvents like CH2Cl2, and 
give strongly colored pink or red solutions. 
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Scheme 2.9. Syntheses of cassettes: a, 23; and, b, 25. 
a 
O
O
O
OAc
OAc
(i) 0.5 equiv. 27
cat. PdCl2(PPh3)4, cat. CuI
Et3N, DMF, 40 ºC, 4 h
(ii) Na2CO3, MeOH
25 ºC 12 h
C  
N
B
F2
N
O
HO
O
O
OH
O
HO2C
CO2H
CO2H
23  4 %  
 
 
b 
0.5 equiv. 27
cat. Pd(PPh3)4, cat. CuI
Et3N, DMF, 25 ºC, 3 d
D
N
BF2
N
 
N
B
F2
N
N
F2B
N N
BF2
N
CO2H
25  53 %  
 
During the course of these studies the methyl ester of cassette 29 was also 
generated, and crystallized for single crystal X-ray diffraction studies.  The solid state 
structure of this molecule (Figure 2.16) demonstrates how the BODIPY donor fragments 
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can rest in conformations that are perpendicular to the acceptor part.  In part, it is this 
molecular twist that differentiates cassettes from planar dyes consisting of a single 
conjugated chromophore.   Interestingly, the molecule appears to “sag” around the 
central BODIPY fragment; this is because the alkyne parts are not exactly in the same 
plane.  In the solid state this degree of sagging can be quantitated from the angle formed 
between two lines that connect the two carbons of each alkyne.  An ideally linear 
arrangement would give a 180° angle; in fact, the observed angle was 168.2 degrees.  
This parameter may have some relevance because if the angle were 180° and rigid then 
the transition dipoles of the BODIPY acceptor and the two donor fragments (which are 
aligned with their long axes)144 would be exactly perpendicular in any conformation 
about the alkyne.  In that orientation there can be no dipole-dipole coupling hence 
fluorescence resonance energy transfer (FRET) could not occur.  The fact that the 
molecule is not perfectly linear means that FRET cannot be completely excluded 
because rotation about the alkyne bond could place the BODIPY donors in 
conformations in which weak dipole-dipole coupling could occur.  However, the “sag-
angle” is small, and conformations that allow dipole-dipole coupling also take the phenyl 
group out of conjugation with the rest of the acceptor; consequently, energy transfer via 
this mechanism162 is unfavorable. 
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N
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CO2Me
 
 
Figure 2.16.  Single crystal X-ray structure of 29. 
 
An important set of new acceptor fragments 30 - 33 and known BODIPY E and 
xanthene F reference compounds were also generated for this study.  Photophysical and 
electrochemical properties in cassettes tend to be accurately represented by the 
individual donor and acceptor fragments.163 Consequently, electrochemical studies were 
performed on these constituents, thus avoiding the need for destructive experiments 
(electrochemistry) on the valuable cassette samples.  All these acceptors 30 - 33 were 
synthesized by Sonogashira coupling reactions of 20 and 27 with the corresponding 
phenyl alkynes.  Detailed syntheses of the new materials are outlined in the supporting 
material. 
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3. Results and Discussion 
3.1. Photophysical Properties.   
Salient photophysical properties of the cassettes are shown in Table 2.1.  The key 
feature of these is that the acceptor fragment is formed by the 2,6-(alkyne-aryl) 
substituents because these impose a dramatic red-shift on the absorbance and 
fluorescence properties of that BODIPY core; Ziessel and co-workers have also 
observed this.159  The fluorescein and BODIPY donor parts exhibit characteristically 
large extinction coefficients, and absorb/fluoresce at wavelengths that are characteristic 
of the free dye fragments (see Table 2.2 below). 
Through-bond energy transfer cassettes are usually designed to absorb light at the 
donor excitation wavelength, relay it to the acceptor part, then emit fluorescence from 
there.  The term “energy transfer efficiency” (ETE %) quantifies this, and we define it as 
follows: 
quantum yield of the acceptor fragment in the cassette
excited at the donorETE % = x 100
quantum yield of the acceptor fragment in the cassette
excited at the acceptor  
 
ETE % is a measure of the quantum yield of the cassette when irradiated at the 
donor.  It reflects the extent of energy transfer including the negative effects of non-
radiative loss in the transfer process.  The product of the extinction coefficient of the 
  
81
donor in the cassette and the ETE give a measure of the brightness of the acceptor in the 
system.  
Values of the ETE % for the cassettes 22 – 25 are shown in Table 2.1.  Several 
important observations are clear.  First, the fluorescein-based cassettes 22 and 23 have 
moderate ETE values in the absence of base, but not when Bu4NOH is added.   Second, 
the BODIPY-based cassettes 24 and 25 have excellent ETE values, and these are not 
influenced by added base.   This contrast between the cassettes with fluorescein- and 
BODIPY-based donors is the key observation presented in this paper. 
 
Table 2.1.  Photophysical properties of 22 - 25 in 1:1 ethanol:CH2Cl2.  
absorptionb fluorescencec
cmpd basea 
λmax D(nm) / 
log ε 
λmax A(nm) 
/ log ε 
 
λmax D
(nm)
λmax A
(nm) 
φA 
excited 
at Ad 
φA 
excited 
at De,j 
ETE 
(%)f φdonorg
22 - 505 / 4.73 575 / 4.55 521 600 0.30i 0.15 51 0.05 
22 + 505 / 5.06 578 / 4.48 529 - 0.01i - < 5 0.09 
23 - 506 / 4.57 560 / 4.29 528 579 0.24j 0.09 38 0.07 
23 + 505 / 5.13 561 / 4.45 529 - 0.01j - < 5 0.08 
24 - 502 / 5.14 566 / 4.82 513 606 0.62i 0.58 93 -h 
24 + 502 / 5.13 566 / 4.82 516 604 0.66i 0.60 92 -h 
25 - 502 / 5.03 561 / 4.67 521 588 0.84j 0.79 94 -h 
25 + 502 / 5.06 560 / 4.72 515 588 0.93j 0.85 91 -h 
a with nBu4NOH at a concentration of 8 x 10-5 M. b At 1 x 10-5 M. A acceptor, D donor c At 1 x 10-6 M.  
d Quantum yield of acceptor when excited at the acceptor.  e Quantum yield of acceptor while excited at the 
donor.  f Energy transfer efficiency calculated with the quantum yield of the acceptor with excitation at 
donor divided by that with excitation at the acceptor.  g Fluorescein (φ = 0.92 in 0.1 M NaOH)164 was used 
as a standard.  h Donors in these cassettes show no significant fluorescence emission.  i Rhodamine 101 (φ 
= 1.00 in EtOH)165 was used as a standard.  j Rhodamine B (φ = 0.97 in EtOH)164 was used as a standard. 
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Effects of base on the cassettes are probably best visualized by considering their 
absorbance and fluorescence spectra (Figures 1.17 and 1.18).  Addition of nBu4NOH to 
cassettes 22 and 23 increases the absorption corresponding to the fluorescein component 
relative to that from the BODIPY acceptor part.   This is logical because addition of base 
forces the fluorescein donor into its ring-opened phenolate carboxylate form.  
Absorbance spectra of cassettes 24 and 25 are almost completely insensitive to base, as 
would be predicted since the electronic spectra of BODIPY dyes are not significantly 
affected by pH. 
 
a  cassette 22 (fluorescein donor) 
0.0
0.2
0.4
0.6
0.8
1.0
400 450 500 550 600 650 700
wavelength (nm)
without base
with base
 
 
Figure 2.17.  (a – d) Normalized absorption spectra of cassettes 22 - 25  (at 1 x 10-5 M conc in 1:1 
ethanol/CH2Cl2); throughout, spectra recorded without added bases are shown in blue, and with 
nBu4NOH (concentration of 1 x 10-4 M) are shown in red. 
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b  cassette 23  (fluorescein donor) 
0.0
0.2
0.4
0.6
0.8
1.0
400 450 500 550 600 650 700
wavelength (nm)  
 
c  cassette 24  (BODIPY donor) 
 
0.0
0.2
0.4
0.6
0.8
1.0
400 500 600 700
wavelength (nm)  
 
d  cassette 25  (BODIPY donor) 
0.0
0.2
0.4
0.6
0.8
1.0
400 450 500 550 600 650 700
wavelength (nm)  
Figure 2.17.  Continued. 
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In the absence of base, excitation of the fluorescein donor of cassettes 22 and 23 
leads to significant fluorescence from the BODIPY acceptor.  However, no significant 
fluorescence is observed from the BODIPY part when base is added to the same 
solutions (Figure 2.18a and b).  Conversely, addition of base has no significant effect on 
the extent of energy transfer for the cassettes 24 and 25 that have BODIPY donors.  The 
conclusion from these experiments is that in 1:1 ethanol/CH2Cl2 the fluorescein donor 
parts of cassettes 22 and 23 are, at least partially, protonated, and energy transfer to the 
BODIPY acceptor is possible in this form.  This energy transfer is quenched when the 
fluorescein donors are completely deprotonated.  Cassettes 24 and 25 have BODIPY, not 
fluorescein, donor parts, but they are otherwise identical to 22 and 23.  These systems 
are not affected by base indicating that the pH sensitivity at the fluorescein donor makes 
these cassettes sensitive to treatment with acids or bases. 
 
a  cassette 22 (fluorescein donor)  
0.0
0.2
0.4
0.6
0.8
1.0
500 550 600 650 700
wavelength (nm)
without base
with base
 
Figure 2.18.  (a – d) Fluorescence spectra of cassettes 22 - 25 (1 x 10-6 M in 1:1 ethanol/CH2Cl2); 
throughout, spectra recorded without added base are shown in blue, and with nBu4NOH (concentration 
of 1 x 10-4 M) are shown in red. 
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b  cassette 23  (fluorescein donor) 
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wavelength (nm)  
 
c  cassette 24  (BODIPY donor) 
0.0
0.2
0.4
0.6
0.8
1.0
500 550 600 650 700
wavelength (nm)  
 
d  cassette 25  (BODIPY donor) 
0.0
0.2
0.4
0.6
0.8
1.0
500 550 600 650 700
wavelength (nm)  
Figure 2.18.  Continued. 
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Table 2.3 shows photophysical properties for the reference compounds 30 – 33, 
E and F.  A striking observation from this data is that none of the building blocks that 
were assembled to give cassettes 22 – 25 have fluorescence characteristics that are 
significantly changed by added base.  The largest change in quantum yield is seen for 
the dicarboxylate 31 and xanthene F: for these compounds a 25 % increase in the 
presence of base.  There are no appreciable shifts in λabs, λem, or even the peak width 
values when these fragments are compared without and with base. 
 
Table 2.2.  Photophysical properties of reference compounds in 1:1 ethanol/CH2Cl2.  Absorption spectra 
taken at 1 x 10-5 M.  Emission spectra taken at 1 x 10-6 M.  
cmpd baseb λabs (nm) / log ε 
λem 
(nm) 
fwhm 
(nm) φa 
30 _ 560 / 4.41 587 41 0.72 
30 + 559 / 4.42 587 41 0.71 
31 _ 565 / 3.94 593 46 0.46 
31 + 563 / 4.00 592 43 0.61 
32 _ 574 / 4.50 606 44 0.52 
32 + 574 / 4.50 605 53 0.54 
33 _ 573 / 4.36 612 53 0.42 
33 + 578 / 4.40 613 52 0.44 
E _ 506 / 4.94 511 16 0.98 
E + 506 / 4.94 511 17 0.90 
F _ 508 / 4.87 517 26 0.76 
F + 508 / 5.04 517 25 0.95 
a Rhodamine 101 (φ = 1.0 in ethanol)165 was the standard for 30 - 33 and fluorescein (φ = 0.92 in 0.1 
M NaOH)164 for E and F.  b with Bu4NOH at a concentration of 8 x 10-5 M. 
 
None of the reference compounds can undergo changes like that shown in 
equilibrium 1, but this has been comprehensively studied for fluorescein in aqueous 
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media.123  These data show that the quantum yield of fluorescein is highest in its dianion 
state.   However, Table 2.2 shows that the quantum yield of the donor part in the 
fluorescein-based cassettes 22 and 23 are less than 0.1, with or without base.  Without 
base there is significant energy transfer to the acceptor, so some quantum yield reduction 
is anticipated.  With base, however, less of the energy transferred between the donor and 
acceptor is emitted as acceptor fluorescence.  Further, the xanthene quantum yields in 
the cassettes are much less than for fluorescein in any of the accessible protonation 
states, or for the xanthene F.  Integration of the fluorescein donors in cassettes 22 and 
23 reduces their quantum yields relative to the parent fragments. 
 
O
O
O
OHHO O OHO
CO2H
neutral forms
φ 0.29
log(ε490)  3.43
pKa 4.3
 
O O-O
CO2-
ring opened phenolate
φ 0.93
log(ε490) 4.90
pKa 6.4
O OHO
CO2-
ring opened phenol
φ 0.36
log(ε490)  4.23  
equilibrium 1 
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3.2. Electrochemical Studies  
Oxidation and reduction potentials were measured for the reference fragments E, 
F, 32 – 33, and for cassette 24 relative to the ferrocene/ferrocinium couple.  BODIPY 32 
shows a reversible reduction wave, while for 33 and E the wave is quasi-reversible for 
the first reduction events.  For F and FNa the first reduction wave is irreversible.  The 
oxidation events for all compounds are irreversible.  In a method similar to the one used 
by Reynolds et al.166 the ferrocene/ferrocenium couple in Volts is estimated to an orbital 
level of 5.15 eV and 5.16 eV relative to vacuum in DMF and CH2Cl2, respectively.167,168 
Thus energy levels of HOMO and LUMOs can be pegged relative to this reference point.  
The same data was acquired for compounds 30 and 31 (see supporting information). 
 
Table 2.3.  Electrochemical data for reference compounds E, F, 32 – 33, and cassette 24.  Cyclic 
voltammograms were recorded using a glassy carbon working electrode (A = 0.071 cm2) referenced to 
Fc/Fc+ and a Pt counter electrode at a scan rate of 200 mV/s.  All potentials are reported vs. Fc/Fc+ and 
all HOMO and LUMO energies are derived from electrochemical results based on Fc/Fc+ = 5.15 eV 
(DMF) and 5.16 eV (CH2Cl2) vs vacuum.  All solvents were flushed with Ar(g) before use.  
Cmpd Eonset,ox (V)
HOMO 
(eV) Eonset,red (V)
LUMO 
(eV) Eg (eV) 
      
Ea +1.22 6.38 -1.43 3.73 2.65 
Fb +0.72 5.87 -1.25 3.90 1.97 
FNab, d +0.25 5.40 -1.89 3.26 2.14 
32a +1.21 6.37 -1.12 4.04 2.33 
33b +0.79 5.94 -1.09 4.06 1.88 
33c +0.80 5.95 -1.12 4.03 1.92 
24a +1.27 6.43 -1.10 
-1.36
4.06 
3.80
2.37 
2.63 
(a) In CH2Cl2.  (b) In DMF.  (c) In DMF and 0.1 M pyridine.  (d) Xanthene was first reacted with 
NaOH to obtain the sodium salt. 
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Figure 2.19a plots HOMO and LUMO energy levels for the reference BODIPY 
E and the acceptor mimic 32 that represent cassette 24 (BODIPY donor and acceptor).  
The HOMO level of the acceptor part is marginally higher than that of the donor, and the 
energy transfer efficiency observed (ETE) is high (93 %).  This could be due to two 
single electron transfer processes as shown in Figure 2.19b that are both favorable 
because they move electrons from higher to lower orbital levels.  The net effect is that 
the compound fluoresces strongly from the acceptor, and the donor fluorescence is 
almost completely quenched. 
 
a 
HOMO
LUMO 3.73 eV
6.38 eV 6.37 eV
4.04 eV
ETE = 93 %
donors acceptors
E 32
corresponds to cassette 24  
 
 
 
 
 
b 
donor
HOMO
LUMO
acceptor
HOMO
LUMO
hv
hv
good energy
transfer
donor acceptor
ΔG = -0.01eV
electron transfer fast
excitation
good
energy
transfer
 
Figure 2.19.  (a) HOMO and LUMO levels of the reference compounds representing cassette 24; and, 
(b) rationale for the good energy transfer and strong fluorescence of the acceptor. 
 
Fragments of cassette 22 under neutral conditions are represented by the 
reference compounds F (protonated on xanthene) and 33 (Figure 2.20).  Here we suggest 
the situation is similar to that depicted in Figure 2.19, but with one key difference: the 
HOMO energy level for the acceptor is marginally below that of the donor.  Electron 
transfer from the acceptor to the donor becomes slow while that in the reverse direction 
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is fast.  This would explain the attenuated energy transfer efficiency (51 %) and the fact 
that the donor also fluoresces, but with a low efficiency because it is quenched by 
oxidative PeT.  
 
a 
HOMO
LUMO 3.90 eV
5.87 eV 5.94 eV
4.06 eV
ETE = 51 %
F 33
corresponds to cassette 22 protonated on xanthene
donor acceptor
 
 
 
 
 
 
 
b 
HOMO
LUMO
HOMO
LUMO
hv
 donor and acceptor 
fluorescese
donor acceptor
excitation
partial 
energy
transfer
hv
ΔG = 0.07 eV
electron transfer slow
 
Figure 2.20.  (a) HOMO and LUMO levels of the reference compounds representing cassette 22 under 
neutral conditions; and, (b) rationale for the partial energy transfer. 
 
Figure 2.21 depicts the situation for cassette 22 under basic conditions.  
Deprotonation of the xanthene fragment (represented by F-Na) would be expected to 
elevate the HOMO/LUMO orbital levels for the donor, and, in actuality, this is 
supported by the electrochemical data.  Electrons cannot be transferred from the highest 
filled (2e) orbital of the acceptor to the donor hence fluorescence emission is observed 
only from the donor part.  The quantum yield of the donor is diminished (from 0.95 to 
0.09) because of electron transfer from the donor excited state to the acceptor (Figure 
2.21b).    
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a 
HOMO
LUMO
ETE < 5 %
corresponds to cassette 22 under basic conditions
donor acceptor
3.26 eV
5.40 eV
5.95 eV
4.03 eV
33F-Na
 
 
 
 
 
 
b 
no energy
transfer
HOMO
LUMO
HOMO
LUMO
hv
no acceptor fluorescence 
donor fluorescence 
quenched
donor acceptor
excitation ΔG = 0.54 eV
electron transfer 
unlikely
 
Figure 2.21.  (a) HOMO and LUMO levels of the reference compounds representing cassette 22 under 
basic conditions; and, (b) rationale for the poor energy transfer. 
 
4. Conclusions 
Previous studies from these laboratories in collaboration with Topp, 
Hochstrauser and co-workers measured energy transfer rates between donor and 
acceptor fragments for TBETs based on BODIPY and fluorescein components.144,145,169 
The rates were faster than would be expected from a FRET mechanism, and for some 
systems the orientations of the transition dipoles are suboptimal for this mechanism 
anyway, just as outlined here.  Dependence on HOMO and LUMO energy levels for the 
donors and acceptor parts is consistent with electron transfer.163,170-172  
Probably the majority of fluorescent sensors tends to feature ligands that quench 
fluorescence in the absence of analyte, usually via electron transfer, but which are 
switched on when a metal or proton binds to prevent this.  Ratiometric dyes that are 
“always on” can be formed by combining FRET coupled dyes in a single molecule.173,174 
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To the best of our knowledge, the data reported here, and in our communication on 16 in 
intracellular imaging, is the first that describes how TBET cassettes can be used as 
proton probes.  The closest work in the literature is from Akkaya’s group who have 
made two metal-sensing cassettes functionalized with coordinating groups that allow 
them to detect Ag(+1)175 and Hg(+2)176, ie compounds G and H respectively.  In our 
cassettes 22 and 23 the analyte modulates the electronic properties of the donor part, but 
in G and H they effect the acceptor.   In fact, in TBETs the donor, acceptor, and linker 
fragments177 could all be modified to give sensors.  The work described here may 
represent the beginning of a new paradigm in which electronically coupled dye pairs can 
be used to sense analytes in biomedical applications. 
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CHAPTER III  
SYNTHESIS OF WATER SOLUBLE THROUGH-BOND ENERGY TRANSFER 
CASSETTES FOR PROTEIN LABELING 
 
A. SYNTHESIS OF WATER-SOLUBLE FUNCTIONALIZED BODIPYS 
1. Introduction 
Behind fluorescein, rhodamine, and possibly cyanine derivatives, 4,4-difluoro-4-
bora-3a,4a-diaza-s-indacene, or BODIPY®51,146,178,179 (hereafter abbreviated to BODIPY) 
dyes are probably the most useful fluorescent probes in biotechnology.  This is because 
they tend to absorb UV radiation efficiently, and emit relatively sharp fluorescence 
peaks at useful wavelengths (typically 520 – 650 nm) with high quantum yields.  
The core of BODIPY dyes is hydrophobic, and does not contain any functionality 
to attach the probes to proteins.  Both these obstacles can be surmounted via synthetic 
modifications.  For instance, there are many BODIPY dyes with carboxylic acid 
functional groups154,157,180,181 that can be activated then linked to amino groups on 
proteins or DNA-derivatives.  Further, such carboxylic acids can be activated using 
sulfonated succinimide reagents;182  this makes the hydrophobic dyes more water-
soluble enabling them to be dissolved in aqueous media for coupling to various water-
soluble biomolecules.  Once hydrophobic BODIPY dyes are conjugated to biomolecules 
then they tend to embed into hydrophobic pockets, or even create micellular-like 
environments via aggregation effects.  This is not always disadvantageous; indeed, 
variations of BODIPY fluorescence with the polarity of their immediate environment 
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can be useful.183-188  However, in other cases it is definitely advantageous to have water-
soluble BODIPY dyes that can be conjugated easily, and that will tend to exist in the 
aqueous environment that surrounds a biomolecule without perturbing it. 
Despite the obvious practical value of water-soluble BODIPY dyes, very few 
have been reported in the open literature.  This is even more surprising in view of the 
fact that BODIPY dyes were first reported in 1969,189 and have been investigated with 
increasing vigor since then.146,179 Indeed, the sum total of synthetic procedures to obtain 
BODIPY dyes includes only the four sulfonated derivatives I – L190,191 and several 
closely related oligoethylene-glycol-containing systems, of which M192 is illustrative 
(Figure 3.1a).  The fact that water-soluble BODIPYs are relatively under-represented in 
the literature is unsurprising to anyone who has attempted to sulfonate these dyes.  
Sulfonation reagents tend to be highly reactive whereas the BODIPY core is relatively 
fragile.  Further, many sulfonated products are not isolated via flash chromatography.  
Consequently, reaction conditions for sulfonation of BODIPY dyes must be controlled 
carefully, and some optimization is required to isolate pure materials from these 
transformations.  
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Figure 3.1  (a) Previously known water-soluble BODIPY systems; and, (b) compounds prepared in 
this work. 
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Figure 3.1  Continued. 
 
This paper describes several procedures for the preparation of several sulfonated, 
water-soluble BODIPY systems (Figure 3.1b).  Mono (a) and di-substituted (b) 
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tetramethyl-BODIPYs 34 have a 4-iodo-benzene substituent at the meso-position to 
enable further functionalization via organometallic cross coupling reactions.  The bromo 
compounds 35 can be similarly derivatized, but they are also potentially reactive towards 
nucleophiles in SNAr reactions.193-195  Compounds 36 are valuable since they can be 
coupled to active carbonyl groups, the azides 37 are amenable to copper-mediated 
cycloadditions to alkynes,196,197 and the disulfonate 38 can be activated and coupled to 
amino groups on biomolecules.  Thus the end-products of this work have potential uses 
in many different scenarios for labeling biological molecules. 
 
2. Results and Discussion 
The following sections describe the preparation of the unusual BODIPY starting 
materials, the pivotal sulfonation reactions, and reactions of the sulfonated products to 
further transform them into useful probes.  Finally, the spectral properties of the target 
molecules are discussed. 
2.1. BODIPY Starting Materials  
The lipophilic starting materials used in this project were generally known 
compounds,143,153,198 with the exception of compounds 39 shown in Scheme 3.1.  
Condensation of 4-substituted benzaldehydes with pyrrole is a known reaction for 
formation of the dipyrromethane N;199 this was repeated here, and an analogous 
procedure was used to prepare the bromoderivative 37.  Chlorination of compounds 
similar to 37 has been reported by Boens and co-workers.200  Slight modifications of 
their procedures enabled us to obtain gram amounts of the dipyrromethenes 38 after a 
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“one-pot” chlorination oxidation sequence and a flash chromatographic separation.  
Incorporation of the difluoroboron groups was achieved via the standard procedure, 
though we found that the products 39 could be isolated via recrystallizations rather than 
column chromatography.  
 
Scheme 3.1. Synthesis of 41 
X
CHO
H
N
NH HN
X
TFA
25 oC, 1 h
+
39 X = Br  34 %
N X = NO2  84 %  
N HN
Cl Cl
X
40a X = Br  53 %
40b X = NO2  42 %
(i) NCS
THF, - 78 oC, 1.5 h
then 25 oC, 3 h
(ii) DDQ
CH2Cl2, 25 oC, 1 h
 
BF3•OEt2, NEt3
CH2Cl2, 25 oC, 24 h N B
F2
N
Cl Cl
X
41a X = Br  98 %
41b X = NO2  71 %  
 
 
 
  
100
2.2. Sulfonation of Various BODIPY Derivatives 
Scheme 3.2 shows the key sulfonation reactions featured in this paper.  After 
considerable experimentation it was discovered that monosulfonations (Scheme 3.2a) of 
BODIPYs tend to proceed efficiently using 1.2 eq of fresh chlorosulfonic acid in 
CH2Cl2.  The sulfonating agent in CH2Cl2 was added dropwise over a few minutes to a 
solution of the BODIPY starting material at – 40 °C.  After the addition was complete, 
the cooling bath was removed and the reaction was allowed to warm to 25 °C and stirred 
for 20 min.  For syntheses of compounds 34a, 35a, and 42a the reactions were quenched 
with NaHCO3(aq), and (after an extraction procedure) the crude products were purified 
via flash chromatography on silica.   A critical observation in this work was the need for 
the bicarbonate quench; it appears that the protic forms of these sulfonic acids tend to be 
unstable (though this is not always the case, see below).  
Disulfonations of the same starting materials to give products 34b, 35b, and 42b 
are shown in Scheme 3.1.2b.  Two equivalents of the chlorosulfonic acid were used to 
achieve the second sulfonation.  Separation in this case is relatively easy because the 
disulfonic acids precipitate from the dichloromethane solution after 20 min at room 
temperature.  The products were collected by filtration, dissolved in a small amount of 
aqueous NaHCO3, evaporated to dryness, then reprecipitated from brine to give 
essentially pure products.  No chromatography is involved, so the procedure is 
convenient and amenable to scale up. 
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Scheme 3.2. Sulfonation Reactions 
a 
X R1 R2 %
34a I CH3 CH3 60
35a Br H Cl 92
42a NO2 CH3 CH3 63
N
B
F2
N
R1
R2
R1
R2
X
(i) 1.2 eq ClSO3H
CH2Cl2
-40 oC to 25 oC
20 min
(ii) 1.2 eq NaHCO3 N B
F2
N
R1
R2
R1
R2
X
SO3Na
 
b 
X R1 R2 %
34b I CH3 CH3 88
35b Br H Cl 85
42b NO2 CH3 CH3 100
N
B
F2
N
R1
R2
R1
R2
X
(i) 2 eq ClSO3H
CH2Cl2
-40 oC to 25 oC
20 min
(ii) 2 eq NaHCO3
N
B
F2
N
R1
R2
R1
R2
X
SO3NaNaO3S
 
 
One exception to the preferred sulfonation conditions was for the alkyne-
functionalized BODIPY;143,160 as shown in reaction 1.  Here the disulfonate 43 
precipitated out of the CH2Cl2 solution in near pure form.  This is very fortunate because 
compound 43 is unstable in aqueous media, undergoing relatively rapid hydrolysis at the 
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alkyne group.  For that reason, this is not a particularly useful building block unless the 
sulfonic acid was neutralized with a base, e.g. Et3N. 
 
N
B
F2
N
2 eq ClSO3H
CH2Cl2
-40 oC to 25 oC
20 min
N
B
F2
N
SO3HHO3S
43  60 %O  
reaction 1 
 
 
Reaction 2 shows a sulfonation of the relatively electron-poor BODIPY system 
41b with varying equivalents of chlorosulfonic acid.  A mixture of mono- 44a and 
disulfonation 44b products formed if less than 3.5 equivalents of the sulfonating agents 
were used, and neither of these materials precipitated from the solution; it was, however, 
possible to obtain the yields indicated via flash chromatography.   Clean disulfonation 
was obtained when 3.5 equivalents of chlorosulfonic acid were used and, under those 
conditions, the product 44b precipitated in a relatively pure form and the sample could 
be further purified by re-precipitation from brine as described for compounds 34b and 
35b.  The water-solubility of the monosulfonate 44a was lower than the similar 
tetramethyl-BODIPY monosulfonates 34a, 36a, 37a, and 42a; for instance, it was 
impossible to obtain a clear 13C NMR spectrum of 44a in D2O. 
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N
B
F2
N
Cl Cl
NO2
(i) ClSO3H
CH2Cl2
-40 oC to 25 oC
20 min
(ii) NaHCO3
41b  
 
 
N
B
F2
N
Cl Cl
NO2
SO3NaNaO3SN
B
F2
N
Cl Cl
NO2
SO3Na +
44b44a  
amount of ClSO3H       yield of 44a       yield of 44b
         (eq)                            (%)                    (%)
         1.2                              90                      0         
         2.0                              68                     21        
         3.0                              22                     74
         3.5                               0                      97  
reaction 2 
 
 
2.3. Derivatization of Some BODIPY Sulfonates 
Nitro functionalities on BODIPYs have few direct applications, but this group 
allows access to more useful derivatives that contain amine or azido “handles”.  
Exploratory work to establish conditions for hydrogenation of the nitro-compounds 42 
was not encouraging. Almost no reduction was observed under 1 atm of hydrogen in 
aqueous media.  In ethanol, the rates were very slow, and the product amine was 
contaminated by N-ethyl impurities (this is a relatively common occurrence).201 
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Reactions featuring SnCl2 in HCl(aq) tended to be complicated, probably by tin 
complexes that did not elute from silica.  Ultimately, hydrazine and catalytic palladium 
on carbon proved to be effective (Scheme 3.3).153  To decrease the risk of an explosion 
during this reaction, the hydrazine was added dropwise to the substrate and reagents in 
refluxing ethanol.  This procedure has been repeated several times on up to 400 mg of 
the nitro compound without any mishaps; however, we advocate use of a blast shield and 
certainly do not recommend that this reaction be performed on a much larger scale.  The 
amino derivatives 36 were isolated via flash chromatography. 
 
Scheme 3.3. Synthesis of 36 and 37. 
N
B
F2
N
NO2
SO3NaR1
NH2NH2•H2O
10 % Pd/C
EtOH, reflux, 30 min
42a-b
N
B
F2
N
NH2
SO3NaR1
36a R1 = H  92 %
36b R1 = SO3Na  70 %  
 
(i) HCl, NaNO2
0 oC, 30 min
(ii) NaN3
H2O, 25 oC, 1 h
N
B
F2
N
N3
SO3NaR1
37a R1 = H  75 %
37b R1 = SO3Na  77 %  
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A diazotization/azide treatment reaction was used to convert the amines 36 into 
the corresponding azides 37.  Visually, this reaction is interesting.  The amine starting 
materials are weakly green fluorescent, it becomes more fluorescent under acidic 
conditions, but this fluorescence disappears when sodium nitrite is added, corresponding 
to formation of the diazocompound.  However, addition of azide gives a solution that is 
more fluorescent than the starting amine.   
Reaction 3 shows how the disulfonate 37b was functionalized via a copper-
mediated azide-alkyne cycloaddition reaction.  Attempts to perform this reaction in the 
absence of tris-(benzyltriazolylmethyl)amine (TBTA)202 gave very little product, but 
addition of this ligand made the reaction viable.  The disulfonate 38 is freely water-
soluble and contains an easily accessible carboxylic acid for activation and conjugation 
to biomolecules. 
 
N
B
F2
N
N3
SO3NaNaO3S +
37b
1 eq Cu, 0.1 eq CuSO4• 5H2O
0.1 eq TBTA
H2O/THF, 25 oC, 12 h
HOOC
 
N
F2B
N
N
SO3Na
SO3Na
NN
COOH
38  42 %
N
N
N
N
3
TBTA  
reaction 3 
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2.4. Spectroscopic Properties of BODIPY Derivatives  
Table 2.1 summarizes the spectroscopic data collected for the target materials 34 
- 38 and some interesting intermediates 42 and 44.  In general, all these compounds are 
sufficiently water-soluble to allow their UV and fluorescence properties to be recorded 
in aqueous media.  All of the disulfonates are freely soluble whereas the monosulfonates 
will not form relatively concentrated solutions. 
All the compounds shown in Table 2.1 have absorption maxima in the range 492 
– 518 nm, and their molar absorption coefficients are high (5.60 – 14.9 x 104 M-1cm-1), 
as is characteristic of BODIPY dyes in general;146 they fluoresce in the 507 – 540 nm 
range.  Throughout, there are small differences between the emission maxima of the 
mono- and disulfonated forms; in fact, the maxima shift bathochromically between 2 and 
4 nm when going from the mono- to disulfonated compound, except for the nitro 
derivatives where the opposite trend is observed.  Longest wavelength fluorescence 
emission maxima in the series are associated with the dichlorinated compounds 35 and 
44; all the other probes emit between 507 and 513 nm.  Sharp emissions, as seen in small 
fwhm (full width at half maximum height) values (904 – 1752 cm-1); for comparison it is 
informative to consider the series of water-soluble Nile Red derivatives recently 
reported;203 these have fwhm values for their fluorescence emission of between 1410 – 
1680 cm-1.  Figure 3.2 shows the spectra obtained. 
Quantum yields for the target compounds 34, 35, 37, and 38 were all reasonably 
high for fluorescent probes (0.15 – 0.49).  Some BODIPY dyes have quantum yields that 
are greater than 0.5; the slightly diminished values for 34, 35, 37, and 38 can be 
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attributed to non-radiative decay mechanisms associated with free rotation of the meso-
substituent.204 Compounds 36 have a 4-aminobenzene meso-substituent; this electron 
rich aromatic ring probably quenches the fluorescence of the BODIPY core via 
photoinduced electron transfer (PeT) in which the excited state of the BODIPY 
fluorophore is reduced by electron transfer from the relatively high-lying HOMO of the 
electron-rich meso-substituent quencher (i.e., reductive electron transfer).  Such effects 
have been elegantly described as a-PeT by Nagano et al.148,149,162,205,206 The “a” denotes 
that the fluorescent chromophore acts as an acceptor.  The low quantum yield observed 
for compounds 36 is not a concern if the amine group is transformed into an amide in the 
bioconjugation process, because that will adjust the oxidation potential of the meso-
substituent, bringing down its HOMO level, and restoring the fluorescence. 
 
Table 3.1.  Spectroscopic properties of the BODIPY Derivatives.  
dye 
λmax abs a 
(nm) 
log(εmax) a,b λmax emiss
a
 
(nm) 
Fwhm a 
(cm-1) 
Φ a 
34a c 494 5.18 ± 0.01 507 1021 0.47 ± 0.02 d 
34b c 498 5.00 ± 0.01 509 994 0.34 ± 0.02 d 
35a c 509 4.86 ± 0.01 523 997 0.27 ± 0.01 e 
35b c 512 4.89 ± 0.01 524 904 0.41 ± 0.01 e 
36a f 492 4.93 ± 0.01 507 1050 0.001 d 
36b f 496 5.06 ± 0.01 511 945 0.001 d 
37a f 494 4.84 ± 0.01 507 1062 0.34 ± 0.01 d 
37b f 498 4.89 ± 0.01 509 1053 0.15 ± 0.001 d 
38 g 498 4.90 ± 0.01 511 1027 0.49 ± 0.01 d 
42a c 497 4.76 ± 0.01 513 1752 0.001 d 
42b c 501 4.96 ± 0.01 511 1409 0.002 d 
44a h 514 4.82 ± 0.01 540 1440 0.002 e 
44b h 518 4.76 ± 0.01 538 1177 0.008 e 
a In H2O. b εmax were estimated by linear fit of absorbance A vs dye concentration c at four dye 
concentrations (one dye concentration was at zero). c Scheme 3.1.2. d Fluorescein was used as a standard 
(Φ = 0.92  in 0.1 M NaOH(aq)).207 e Rhodamine 6G was used as a standard (Φ = 0.95 in EtOH)208. f Scheme 
3.1.3.  g Reaction 2.1.3.  h Reaction 2.1.2 
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Compounds 42 and 44 are intermediates rather than target materials.  They both 
have relatively low quantum yields, and these can be rationalized via PeT effects.  For 
these materials, the LUMO of the meso-substituent is relatively low-lying due to the 
influence of the 4-nitro group.  This means that the excited state of the BODIPY 
chromophore can act as an electron donor to the electron-poor meso-substituent 
quencher (i.e., oxidative electron transfer). 
 
a
0
0.2
0.4
0.6
0.8
1
400 450 500 550 600
Wavelength (nm)
32a
33a
34a
35a
40a
42a
 
Figure 3.2.  (a) UV absorption, and (b) fluorescence: spectra for the mono-sulfonated BODIPYs.  (c) UV 
absorption, and (d) fluorescence: spectra for the bis-sulfonated BODIPYs.  All these spectra were recorded 
in deionized water at concentrations of approximately 10-6 M for the UV spectra and 10-7 to 10 -6 M for the 
fluorescence, then normalized. 
 
 
 
 
 
 
 
 
  
109
109
b 
0
0.2
0.4
0.6
0.8
1
450 500 550 600 650 700
Wavelength (nm)
32a
33a
34a
35a
40a
42a
 
c
 
0
0.2
0.4
0.6
0.8
1
400 450 500 550 600
Wavelength (nm)
32b
33b
34b
35b
36
40b
42b
 
Figure 3.2.  Continued. 
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Figure 3.2.  Continued. 
 
3. Conclusions 
Sulfonation reactions of BODIPY derivatives are hard to develop into useful 
synthetic procedures for two reasons: (i) inappropriate conditions give mixtures of 
products; and (ii) sulfonic acid derivatives of BODIPYs can be hard to purify.  The 
sulfonation reactions shown in Scheme 3.2 tend to give predominantly one product, and 
reactions 1 and 2 give essentially binary mixtures that are easily separated by flash 
chromatography.  Conjugation of the target materials to biomolecules could be achieved 
via amide bond formation to amines or acids, or “click” chemistry.  Further, some of the 
dyes presented here can be derivatized via organometallic couplings to the organic 
halide functionalities, and, in the case of the chlorinated derivatives 35 and 44, via SNAr 
reaction.
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B. 3- and 5-FUNCTIONALIZED BODIPYs VIA THE LIEBESKIND-SROGL 
REACTION 
1. Introduction 
Organometallic cross coupling reactions are useful for extending the conjugation 
of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, or BODIPY® (here abbreviated BODIPY) 
dyes to give probes that fluoresce at longer wavelengths.  Usually this is achieved via 
inherently basic processes (Suzuki209 and Sonogashira210) that tend to cause partial 
decomposition of BODIPY dyes.  Furthermore, chemoselective reactions involving 
different halides in the same molecule are sometimes desirable, but hard to achieve via 
these transformations.  For instance, the C-Cl sites of systems like 41a211 are reactive for 
Sonogashira and Suzuki reactions, but competitive reactions of the aryl bromide site 
would be expected.  This paper describes how Liebeskind-Srogl reactions can be used to 
achieve chemoselective couplings to BODIPY dyes under neutral conditions; further, 
this transformation was used to give a water-soluble two dye cassette system. 
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Scheme 3.4. Synthesis of 3-,5- functionalized BODIPY via Liebeskind-Srogl reaction.   
N
B
F2
N
ArSnBu3, 
cat. Pd(PPh3)4
 
4 eq CuMeSal
THF, 55 oC
Br
SBuBuS
N
B
F2
N
Br
ClCl
BuSH, Et3N
 CH3CN, 85 oC
41a 45   99 %
3 5
8
 
a
b
c
MeO2C
MeO
N
B
F2
N
Br
SBuAr
N
B
F2
N
Br
ArAr
+
46 47
Ar 46 47
isolated yields
(%)
a 0 85
b 26 62
c 0 75
Ar
 
CuMeSal = copper (I) 3-methylsalicylate 
 
2. Results and Discussion 
It has been demonstrated that Liebeskind-Srögl couplings can be used to 
substitute thioalkyl groups at the C8 position of the BODIPY core.212 Chemoselective 
Liebeskind-Srögl couplings at thioalkyl groups over aryl bromides have also been 
demonstrated.213  Consequently we felt that selective  substitution at the 3,5-positions as 
in compound 45 would be possible.  In actuality, phenyltin (a) and electron-rich aryl-tin 
(c) reagents cleanly gave the disubsituted products 47, some monosubstituted 
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intermediate was isolated for the electron-deficient aryl group tested (b), but in no case 
was the aryl-bromide affected.  The synthesis of electron-deficient tin compound 49, 
methyl 4-(tributylstannyl)benzoate, is outtined in the supporting information. 
 
a 
0.0
0.2
0.4
0.6
0.8
1.0
400 450 500 550 600 650 700
Wavelength (nm)
45
46b
47a
47b
47c
absorbance
 
b 
0.0
0.2
0.4
0.6
0.8
1.0
500 550 600 650 700 750
Wavelength (nm)
45
46b
47a
47b
47c
fluorescence
 
Figure 3.3.  (a) Normalized absorbance spectra of compounds 45 - 47 (1 x 10-6 M) in EtOAc; and,  (b) 
normalized fluorescence spectra of compounds 45 - 47 (1 x 10-7 M) in EtOAc with excitation at 540 
nm. 
  
114
Figure 3.3 shows normalized absorbance (a) and fluorescence (b) spectra for 
compounds 45 - 47.  The newly installed aryl groups shift both maxima to the red, as 
previously described for 3,5-diaryl-BODIPY dyes.214  More extensive spectroscopic data 
for these products is shown in Table 2.2. Both para-electron withdrawing (CO2Me) and 
donating (OMe) groups shifted the maximum fluorescence wavelength to red (8 nm and 
33 nm respectively, compare 47a, 47b and 47c). 
 
Table 2.2.  Photophysical properties of compounds 45 - 47 in EtOAc.   
compd 
λabs max 
(nm) 
εmax 
(L·mol-1·cm-1) 
λfl max 
(nm) 
fwhm 
(nm) a 
Φf b 
45 577 46700 595 47 0.40 ± 0.04 
46b 571 50600 597 59 0.58 ± 0.01 
47a 555 52400 588 49 0.14 ± 0.01 
47b 559 44000 596 48 0.36 ± 0.03 
47c 581 51900 621 41 0.38± 0.01 
a Full width at half maximum height of fluorescence (fwhm).  b Rhodamine 101 (Φ = 1.0 in ethanol) as 
standard 
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C. SYNTHESIS OF WATER-SOLUBLE CASSETTE FOR PROTEIN 
LABELING 
1. Synthesis of Two-dye Cassette 55 
Meso-(4-bromoaryl)BODIPY substituents like those in compounds 46 and 47 can 
be further elaborated via Sonogashira reactions.  However, recent unpublished data from 
our laboratories have shown that there are advantages to using copper-mediated alkyne-
azide coupling reactions196,197 to join two BODIPY fragments together to form two-dye 
cassette systems. Azido-functionalized dyes are required to achieve this.  Thus the 
sequence outlined in Scheme 3.4a was performed to generate the azidodicarboxylic acid 
system 53.  Coupling of the dithioether 48, which is synthesized from 41b,211 to the 
appropriate 4 eq stannane gave 17 % of the corresponding monosubstituted material 50a, 
and 66 % the desired disubstituted product 50b (data not shown here).  However, using 
4eq 4-methoxycarbonylphenylboronic acid afforded 50b in quantitative yield. We think 
the boronic acid is much more stable than the tin compound under the reaction condition.  
A mild ester hydrolysis215 of this material, and reduction of the nitro group gave the 
amine 53 which was then converted to the azide 53.   
The sulfonated BODIPY alkyne 54 was formed from the known starting material 
Q160 via sulfonation conditions recently reported by us (Scheme 3.4b).211  Finally, the 
appropriately functionalized BODIPYs, azide 53 and alkyne 54, were joined via the 
click reaction shown in Scheme 3.4c.  The final product 55 is highly water soluble.  It 
was isolated via preparative reverse phase HPLC. 
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Scheme 3.5. Synthesis of energy transfer cassette 55.  
a 
N
B
F2
N
cat. Pd(PPh3)4
 
4 eq Cu(I)MeSal
THF, 55 oC
NO2
SBuBuS
N
B
F2
N
NO2
ClCl
BuSH, Et3N
 CH3CN, 85 oC
41b 48  99%
B(OH)2
CO2Me
 
N
B
F2
N
NO2
Ar1Ar1
Ar1  = MeO2C
50b  99 %
N
B
F2
N
X
Ar2Ar2
X = NO2 51 95 %
X = NH2 52 95 %
(i) KOTMS, THF, 25 oC
(ii) NH2NH2•H2O
 Pd/C, EtOH, 80 oC
Ar2  = HO2C
(ii)
 
(i) NaNO2, 0.1 M HCl(aq) 
THF, H2O
(ii) NaN3, H2O, THF N B
F2
N
N3
Ar2Ar2
53  75 %  
b 
N
B
F2
N
SO3--O3SN
B
F2
N
ClSO3H, CH2Cl2
-40 to 20 oC
then Et3N
O 54  75%
2Et3NH
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Scheme 3.5. Continued.  
c 
(i) 0.1 eq CuSO4, Cuo, 1:1 THF/H2O, 25 ºC
(ii) NaHCO3, H2O, 25 ºC, then HPLC
53    +    54
 
 
N
BF2
N
N
N N
N
F2B
N
SO3Na
NaO3S
CO2H
CO2H
55  30 %  
 
2. Spectral Properties of 55 and BSA-55 
Cassette 55 is designed to function as a “through-bond energy transfer” (TBET) 
system.  These feature two dye components that are prevented from becoming 
completely planar because of steric issues.  Thus the UV-visible absorption spectrum of 
55 and BSA-55 has two maxima corresponding to the donor fragment and the acceptor 
part (Figure 3.4a).  
Motivation for making TBET cassettes is derived from the fact that they can be 
excited at a much shorter wavelength (donor absorbance) than their fluorescence 
emission (from acceptor part).  This leads to enhanced spectral resolution of emission 
peaks if several dyes are used together.  However, three major obstacles have emerged 
from our research efforts: (i) making the cassettes in water soluble form; (ii) obtaining 
good energy transfer from the donor to the acceptor in an aqueous medium (cassettes 
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that work well in less polar solvents can be poor in water); and, (iii) maintaining good 
energy transfer when the cassette is conjugated to a protein.  Cassette 55 is quite water 
soluble, so that parameter is satisfied.  To quantitate the function of the cassettes we 
measure their overall quantum yields for the acceptor fluorescence emission when 
excited at the donor.   
The overall quantum yield of 55, and its ETE % for 55 in pH 7.4 phosphate 
buffer were determined as 0.23 and 85%. Qualitatively, the undesirable “leakage” of 
fluorescence from the donor is seen at about 520 nm in Figure 3.4b. 
Cassette 55 was activated by forming an ester of N-hydroxysuccinimide (see 
supporting information) and conjugated to bovine serum albumin (BSA).  This caused 
the absorbance maxima to be red-shifted by about 8 mm, but had little impact on the 
fluorescence maxima (Figure 3.4).  The overall quantum yield of the BSA-55 conjugate, 
and its ETE % for pH 7.4 phosphate buffer were determined as 0.10 and 75 %.  Again 
these data are comparable to the best TBET-conjugates prepared so far. 
In summary, the work described here indicates that Liebeskind-Srogl couplings 
provide another dimension for chemoselectivity in construction of BODIPY dye 
derivatives.   
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Figure 3.4.  (a) Normalized absorption of 55 and BSA-55 in pH = 7.4 PBS buffer; and, (b) Normalized 
fluorescence spectra of 55 and BSA-55 in pH = 7.4 PBS buffer. 
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CHAPTER IV  
CHEMILUMINESCENT ENERGY TRANSFER CASSETTES BASED ON 
FLUORESCEIN AND NILE-RED 
 
A. Introduction 
The two most common ways to induce chemiluminescence in purely organic, 
non-biological, systems are to treat either oxalate esters or luminol derivatives with basic 
hydrogen peroxide.216,217 Both these types of mixtures give light of relatively short 
wavelengths that are not ideal for applications in biotechnology.  Luminol, for instance, 
emits in the range 420 - 450 nm, depending on the solvent media.218  Intimate mixtures 
of oxalate esters or luminol,219 an oxidant, and an acceptor dye give longer wavelength 
emissions via intermolecular energy transfer.  This results in the mesmerizing, long-lived 
emissions seen in “light stick toys”.  However, the options for forming discrete probes 
for biotechnology that emit at longer, and generally more useful, wavelengths are 
limited.124,220-224  
An ongoing project in our group features twisted, but otherwise conjugated, 
donor and acceptor cassettes for labelling biomolecules.98,99,124 The motivation for this is 
that energy transfer can occur through-bonds as well as through space, hence it can be 
relatively fast and efficient.  All our published research to date features cassettes based 
on UV-absorbing donors, like compound P.  We thought it would be intriguing to make 
cassettes where the donor might be activated chemically instead.  Oxalate esters are not 
useful donors for through-bond energy transfer cassettes because it is impossible to 
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conjugate an acceptor to the oxalate fragment.  Consequently, luminol-based systems 
were selected.  Described here are the syntheses and spectroscopic properties of the 
fluorescein- and Nile Red-based, chemically activated, cassettes 56 and 57. 
 
UV-activated cassette
NH
NH
O
ONH2
luminol
NN+ O
OHO O
O
O
-O2C
P
UV-donor
acceptor
(fluoresces)
 
OHO O
CO2H
NH
H
NO
O
O
N
NH
H
NO
O
N O
56 57
chemiluminescent donors
activated via oxidation
acceptors
(fluoresces)
oxidatively activated cassettes
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B. Synthesis of Cassettes 56, 57, 63 and 64 
Nearly all luminol derivatives are almost insoluble in most organic media, and 
this makes them extremely difficult to manipulate.  After considerable experimentation, 
one solution to this problem emerged: bis(N-protection) of compounds like 58 with 4-
methoxybenzyl (PMB) groups.  This approach gave organic-soluble, easily 
chromatographed, intermediates, and the PMB group is removed in the closing stages of 
the synthesis via treatment with TFA.   Thus, Scheme 4.1 shows the syntheses that 
evolved for compounds 56 and 57.  In both routes, the cyclic hydrazide 58 was bis-N-
protected, then elaborated via Sonogashira reactions.210 These featured derivatives of 5-
bromofluorescein35 and  2-hydroxy Nile Red.225 The route to the cassettes would have 
been more convergent if an alkyne derivative of luminol could have been coupled with 
halogenated/triflated acceptors, but that approach was ineffective.  The approach to the 
control fluorescein and Nile Red compounds 66 and 68 are similar to luminol cassettes 
56 and 57.  Sonogashira coupling reaction of fluorescein alkyne C and 2-hydroxy Nile 
Red alkyne S with dimethyl 4-bromophthalate, followed by hydrolysis afforded the 
water soluble dyes 66 and 68.  
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Scheme 4 .1.  Preparation of: (a) the fluorescein cassette 56; (b) the Nile Red based cassette 57; (c) the 
fluorescein control 66; and, (d) the Nile Red control 68. 
a 
NH
NH
O
O
Br
O
O
O
Br
NH2NH2•H2O
AcOH, reflux, 30 min
58  95%  
 
OAcO OAc
O
O
PMBCl, NaH
DMF, 20 oC, 1 h NPMB
NPMB
O
O
Br
5 mol% PdCl2(PPh3)2
10 mol% CuI, Et3N
THF, MW, 120 oC, 20 min
(sealed tube)
59  41%
C
 
 
OAcO OAc
O
O
NPMB
PMB
NO
O
neat TFA
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OHO O
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H
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Scheme 4.1.  Continued. 
b 
O
N
Et2N
OH
O
Tf2NPh
Et3N, THF
23 oC, 24 h
O
N
Et2N
OTf
O
61  75%Q  
 
TMS    
      10 mol% Pd(PPh3)4
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Scheme 4.1.  Continued. 
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C. Results and Discussion 
It is hard to describe the spectacular chemiluminescence of these compounds 
without moving pictures of the experiments to support the words (Figure 4.1).  For 
cassette 56, a 100 μl aliquots of the compound (10-5 M, in pH = 10 aqueous 
Na2CO3/NaHCO3 buffer) was added to a sample cell containing CuSO4 (1.5 x 10-3 M) 
and H2O2 (2.0 x 10-3 M) with stirring.  Cassette 57 is not very soluble in aqueous media 
and, in any case, the quantum yield for Nile Red emission is less than 0.1 in water.  
Consequently, for 57, potassium tert-butoxide in THF (10-2 M) was added to the 
compound dissolved in dry DMF (10-5 M).  This experiment is done open to the air and 
oxygen is presumed to be the oxidant.   Luminol under the conditions used for cassette 
56 gives a bright blue emission. If efficient energy transfer occurred for compounds 56 
and 57 then we were expecting them to emit yellow/green and red chemiluminescence 
instead, characteristic of fluorescein and Nile Red, respectively.  This is exactly what we 
saw.  Cassette 56 gave a bright yellow/green emission, while 57 glowed with a less 
intense red colour.  No trace of blue in the emission was seen in either case. 
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Figure 4.1.  Pictures of (a) luminol, (b) cassette 56, and (c) cassette 57 when activated with an oxidant. 
 
Compounds 63 and 64 were prepared as controls (see Scheme 4.1c) since it is 
thought that the excited species from luminol derivatives involves the corresponding 
phthalate dianions.  Indeed, ESI-MS analysis of cassettes 56 and 57 after the oxidative 
activation revealed the presence of 63 and 64, respectively.  This was confirmed via 
HPLC analyses in the case of 56.  
Figure 4.2a shows normalized UV absorption and fluorescence spectra for 66, 
and 68.  The extent of overlap between the chemiluminescence output of the phthalate 
derived from luminol and the UV absorption of the acceptor part of cassettes 66 and 68 
is shown in Figure 4.2b.  Normalized chemiluminescence emissions for 56 and 57 are 
shown in Figure 4.2c.  The emissions of 56 and 57 are sharp and characteristic of the 
acceptors only; no chemiluminescence from the donor was detected. 
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Figure 4.2. Normalized: (a) UV/visible and fluorescence spectra of 66 in pH = 10 aqueous sodium 
carbonate/bicarbonate buffer solution, and of 68 in dry DMF; (b) chemiluminescence spectrum of 
luminol (blue), UV/vis absorption bands of compound 66 (green) and compound 68 (red); (c) 
chemiluminescence spectra of luminol (blue), cassette 56 (green), and cassette 57 (red). 
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Figure 4.2.  Continued. 
 
Sometimes, the eyes can play tricks on the brain, and that is partially true in this 
case.  The chemiluminescence from cassette 57 appears to be weaker than that for 56, 
but the quantitative data collected in Table 4.1 indicates this is not the case.  
Chemiluminescent quantum yields measured relative to luminol indicate 57 actually 
emits more strongly.  Probably, chemiluminescence from 57 appears to be weaker than 
that from 56 because the human eye is about five times more sensitive to light near the 
emission maximum of fluorescein than it is to light emitted from the Nile Red 
acceptors.226  
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Table 4.1. Selected spectroscopic properties of luminol, 56, 66, 57, 68 and R. 
UV Fluorescence Chemiluminesence 
Compds λabs max 
(nm) 
λfluor max 
(nm)b] 
λchemi max 
(nm)b] 
Relative Φchemi 
luminola - - 442 100a 
56a 494 518 524 61b 
66a 493 519 - - 
57b 558 628 634 >100b 
68b 558 628 - - 
R - - 412 0.02d 
                           a In carbonate/bicarbonate buffer.  b In dry DMF.  c From ref. 221. 
 
The relative quantum yields for chemiluminescence that are presented in Table 
4.1 use luminol as a standard.  However, the donor fragments of cassettes 56 and 57 do 
not have the amino substituent of luminol.  Small changes to the luminol structure tend 
to reduce its chemiluminescence dramatically.218 If the emissions from cassettes 56 and 
57 were compared with the hydrazide R (which has a much lower absolute quantum 
yield for chemiluminescence) then the data for cassettes 56 and 57 would appear to be 
even more impressive.   
 
NH
NH
O
O
R  
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Experimentally, it is extremely challenging to determine the extent of energy 
transfer through-bonds and through space in twisted but otherwise conjugated cassettes.  
For the UV-activated system P we asserted that through-bond energy transfer must be 
fast and efficient by considering rates of energy transfer.144 However, direct observation 
of rates is hard in chemically activated systems where excitation of the donor occurs 
continuously.  Further, we have so far been unable to prepare the logical control 
compounds for comparison: those in which the alkyne linker of cassettes 56 or 57 are 
replaced by an ethylene fragment.   In any case, through-space energy transfer for those 
controls might differ considerably from that occurring in 56 or 57 because the 
orientation of the donor and acceptor fragments would be dynamic in the reduced 
compounds.  However, the through-space energy transfer cassette S, based on luminol, 
was prepared approximately four decades ago and does provide an interesting 
comparison.227-229 The reported relative chemiluminescence quantum yield for this 
compound (luminol standard) is significantly less than that measured here for cassettes 
56 and 57.  It may be that, just as in our UV-activated cassettes like P, rapid and efficient 
energy transfer can occur for the systems that facilitate the possibility of through-bond 
energy transfer.   
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Calculations of Förster energy transfer for systems that have donor and acceptor 
fragments arranged within a few Ångstroms are not correct because the theory implies a 
point dipole approximation which fails when the distance becomes less than the special 
size of the donor and acceptor charge distributions.  Nevertheless, these calculations 
were performed; the dipole-dipole energy transfer efficiency was smaller (39 and 42% 
for 56 and 57, respectively) than actually observed. 
Chemiluminescence provides detection methods that approach the sensitivity of 
ones based on radioactivity.230 In the context of intracellular imaging, it has the 
advantage that no excitation irradiation is required.  Simple in vitro experiments show 
that cassettes 56 and 57 can be activated via treatment with peroxidase under 
physiological conditions, and they emit in longer wavelength regions that are more 
transparent to cellular tissues than the 420 - 450 nm range where luminol 
chemiluminesces.  Consequently, there is a possibility that probes based on chemically-
activated energy transfer can be applied in biotechnology. 
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CHAPTER V  
NON-COVALENT DELIVERY OF PROTEINS INTO MAMMALIAN CELLS 
 
A. Introduction 
Import of proteins into cells is an important problem that is frequently 
encountered in many aspects of biological chemistry.  One of the best-studied 
approaches is to covalently attach a peptide carrier, either chemically or genetically, to 
the protein of interest. Perhaps the most commonly used carriers of this type are the 
short peptide segments derived from HIV-1 Tat and Drosophila Antennapedia 
homeodomain proteins.231,232 Use of the HIV-1 Tat carrier, in particular, has motivated 
researchers to look for simpler peptides for more efficient intracellular233 cellular uptake. 
In living cells, both R8 and R16 have been reported to facilitate significant cellular 
uptake, while R4 gave relatively little internalization.234,235 A major drawback to the use 
of these peptide delivery agents, however, is that cargo proteins imported into the cells 
tend to be concentrated in vesicular structures.236,237 These vesicles are widely assumed 
to correspond to endosomes, hence the cargo proteins are not released in the cytoplasm.  
This has inspired many groups to investigate the mechanism of import, and to look for 
ways of liberating the cargo proteins from the endosomes.  For instance, Wender and co-
workers have suggested that the oligo-guanidine moieties can form an ideal hydrogen 
bonding networks with the cell surface phosphates, and this facilitates the import on a 
molecular level.233,238,239 Meanwhile, an elegant series of experiments by Dowdy 
indicates the macromolecular mechanism of import involves macropinocytosis,240 and 
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liberation of protein cargo-Tat conjugates from endosomes could be achieved by adding 
the N-terminal 20 amino acids of the influenza virus hemagglutinin protein, HA-2,241 to 
the carrier sequence.236  
Genetic or chemical methods for covalently attaching carrier peptide sequences 
to cargo proteins are experimentally inconvenient, time consuming, and restrictive with 
respect to the scope of the experiments that can be performed.  Conversely, carrier 
vehicles that can import proteins without being covalently attached have the potential to 
circumvent all these disadvantages.  “Non-covalent carriers” include “Pep-1” (also 
known as Chariot®),127 the cationic pyridinium amphiphile and a helper lipid, SAINT-
PhD,242 BPQ24 BioPORTER® QuikEaseTM (a protein delivery kit of unspecified 
composition),243 and a few used systems like the peptide K16SP244 and the somewhat 
cytotoxic polymer, polyethyleneimine (PEI) (Figure 5.1).245,246 However, the issue of 
whether or not the imported cargo proteins are trapped in endosomes blurs the true 
utility of these systems.  It is clear from some reports in the literature that fluorescently 
labeled proteins imported using these systems become concentrated in cytoplasmic 
vesicles; this was our experience in previous studies.99,247 However, some papers claim 
imported fluorescently labeled proteins appear to be free in the cytoplasm, and there 
have been papers wherein import of proteins using these systems is thought to give a 
predictable functional response.248  
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Figure 5.1.  Structures of the “Non-covalent Carriers” (a) Pep-1 (also known as ChariotTM), (b) 
polyethyleneimine (PEI) and (c) K16SP. 
 
There were no reports of simple Arg-oligomers being useful for non-covalent 
import until recent work by Lee et al.249,250 They described experiments in which high 
concentrations (600 mM) of R9 mediated import of various fluorescent proteins (eg 
GFP) and b-galactosidase into plant (onion root tip) and animal (MCF7) cells.  It was 
claimed that this produced diffuse fluorescence in the cytosol and in the nucleus, 
however, only low resolution images were shown, and in these cells, the fluorescence 
appears as small green aggregates.  Furthermore, the b-galactosidase was imaged after 
fixing the cells, and this is known to give different results relative to live cells.249,250  
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Data presented in this paper deal with import of four proteins labeled with Alexa Fluor® 
488 (F*):51 specifically, avidin, bovine serum albumin (BSA), b-galactosidase (b-gal), 
and a recombinant streptavidin.  These cargoes were chosen to represent proteins with 
different pI values and sizes (Table 5.1).  The potential carriers examined were Pep-1, 
R8, and a novel system that was synthesized “in house”, azo-R8, all of which were not 
covalently attached to the protein.  The key observations are that: (i) at 37°C, avidin was 
imported by all three carriers (Pep-1, R8, and azo-R8) but in each case the labeled protein 
primarily accumulated in vesicles that co-localized with the endosomal marker FM 4-64; 
however, (ii) at 4°C weak, diffuse fluorescence was observed within the cytoplasm with 
little evidence of punctate vesicle formation for all four proteins.  These observations 
indicate a temperature dependence of carrier-mediated protein delivery that was similar 
for three chemically different carriers. 
 
Table 5.1.  Proteins Studied For the (Arg)8 Mediated Cellular Uptake 
Protein Molecular Weight (kDa) Size (a.a.) pI (unlabeled protein)
Avidin 66-68 512 10 – 10.5 
BSA 66 583 4.7 
Streptavidin, rec. 52 560 7.4 – 7.7 
β-Galactosidase 540 1171 4.8 
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B. Results and Discussion 
1. R8 and Azo-R8: Design and Synthesis 
At the onset of this project, we had hypothesized that mimics of Pep-1 could be 
made by fusing well-known “promiscuous binders” (molecules that seem to bind many 
proteins in high throughput screens for drug leads)251,252  to a cell-penetrating warhead. 
The idea was that the promiscuous binder parts of several pep-1 analogs might non-
covalently attach to the protein, coating it with entities that promote cell penetration.   
Thus, an azo-compound was chosen for the promiscuous binder part, and R8 for the cell-
penetrating unit; these were synthetically joined to give azo-R8.  However, azo-R8 was 
found to behave in much the same way as R8, but with some minor differences as 
indicated below. 
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Figure 5.2.  Structure of azo-R8. 
 
Starting from commercially available bis-N protected amino acid, R8 was 
synthesized in 10 steps according to the literature procedure.253 The coupling reagent 
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EDC was used to replace isobutyoxycarbonyl chloride because the reaction is clean, and 
the working up and purification procedure for the reaction are easy.  The coupling 
products can be easily isolated in > 95% pure using extraction by simply washing away 
the byproduct from organic phase with aqueous acid and base solutions.  
 
Scheme 5.1. Synthesis of azo-R8 
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Scheme 5.1.  Continued. 
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The azo-R8 synthesis starts from a known nasty compound azo-phenol T, which 
is synthesized from the coupling reaction of phenol and 4-iodophenyldiazonium salts. 
The submission of the azo-phenol to Sonogashira coupling reaction with trimethylsilyl 
acetylene afforded trimethylsilyl alkyne 72 in moderate yield, which might result from 
decomposition of the s.m. under the reaction conditions. Terminal alkyne 73 was 
achieved by deprotection of the TMS group with K2CO3 in methanol.  The key 
promiscuous binder intermidiate triazole 73 was synthesized by copper I catalyzed cyclo 
addition of terminal alkyne 70 and azide 71, followed by deprotection of Boc group of 
72.  Azide 71 was synthesized from U by simple SN2 reaction as shown in Scheme 5.1b.  
The standard EDC mediated coupling of the known acid W with 73 produced the key 
intermediate 74 in 80% yield in 95% purity after washing away the by products from 
CH2Cl2 phase with 5% NaHSO4 and 5% NaHCO3 aqueous solution.  Removal of the 
trifluoroacetyl protection group, followed perguanidilation afforded the desired products 
75 as a light yellow solid after prep HPLC.  The final azo-R8 was transformed from 75 
by Boc deprotection, followed by RP HPLC purification and counter anion exchange 
with Cl- resin.  The azo-R8 was 95% pure as indicated by analytical HPLC; also it has   
the correct MS peak. 
 
 2. Formation of Carrier: Cargo Complexes 
Pep-1 and azo-R8 are amphipathic peptides, while R8 is cationic.  Pep-1 is known 
to associate with protein cargoes through non-covalent electrostatic or hydrophobic 
interactions and form stable complexes. 127,254-256   The formation of the carrier:cargo 
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complex for azo-R8 was easily monitored by fluorescence spectroscopy.  The azo 
compound can act as quencher of the label on the protein, proving that the two are in 
close contact.  Figure 5.3 shows the intense fluorescecne of BSA-F* (2 μM in DMEM) 
was greatly quenced when azo-R8 was added (1.0:10 mol ratio protein:carrier).  In a 
control experiment, a solution of fluorescein (0.1 μM) was mixed with 1 μM azo-R8 
under almost identical conditions and no quenching was observed. 
0
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Figure 5.3.  Azo-R8 forms a non-covalent complex with BSA-F*.  The fluorescence of BSA-F* upon 
excitation at 488 nm is compared to the one of a 1:10 molar ratio protein:carrier mixture. 
 
3. Delivery at 37ºC: Uptake into Punctuate Vesicular Structures 
Cellular uptake of avidin-F* into COS-7 at 37°C was studied in the first phase of 
this work.  All three carriers, pep-1, R8, and azo-R8, were used at 10:1 carrier:cargo 
mol:mol ratio, and similar results were observed in all cases.  Figure 5.4 for avidin 
uptake is illustrative.  After 1 h of incubation, followed by a 15 min incubation period 
with FM 4-64, the Alexa Fluor 488-labeled protein accumulated as green, punctate 
cytoplasmic vesicles.  These green vesicles were localized in endosomes as suggested by 
co-loading with the endosomal marker FM 4-64 (Figure 5.4C). 257   When the cells were 
  
142
co-incubated with avidin-F* and FM 4-64 for 1h at 37 °C, little to no co-localization was 
observed with the endosomes, as the mitochondria were labeled under those conditions 
and not the endosomes (see supplementary).  The perinuclear distribution of these 
vesicles suggests potential sorting and transport to Golgi and lysosomes.  This was 
confirmed by co-loading the cells with the Golgi marker BODIPY TR ceramide 
complexed to BSA (Figure 5.4D). 51   After extended incubation times (up to 24 h) the 
vesicles persisted, and no significant dispersed fluorescence was observed in the cytosol.  
These observations are consistent with the imported protein being trapped in endosomes, 
even after long periods of time. 
 
 
Figure 5.4.  Delivery of avidin-F* in COS-7 cells at 37 ºC.  (A) Non-covalent protein delivery 
mediated by R8;  (B) Non-covalent protein delivery mediated by azo-R8;  (C)  Endosomal 
colocalization of avidin-F* and FM 4-64 (fluorescent general endosomal marker);  (D)  Golgi 
colocalization of avidin-F* and BODIPY TR ceramide complexed to BSA (fluorescent marker for 
Golgi); (E) Cell autofluorescence; (F) Non-mediated protein delivery.  Throughout the carrier (5.0 
μM), avidin-F* (0.5 μM) and the COS-7 cells were incubated at 37 ºC for 1 h; the cells were then 
washed with PBS and analyzed by fluorescence microscopy.  For endosomal colocalization, the cells 
were incubated with FM 4-64 at 37 ºC for 15 min, then washed with PBS before imaging.  For Golgi 
colocalization, the cells were incubated for 30 min at 4 ºC in DMEM containing 5 μM BODIPY TR 
ceramide complexed to BSA, washed several times with ice-cold medium and incubated in fresh 
medium for 30 min at 37 ºC.  (a) Overlaid images of the avidin-F* (green) and the nuclei (blue, 
Hoechst 33342 marker).  (b) Differential interference contrast (DIC) images. 
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Figure 5.4.  Continued. 
 
Consideration of the images from import mediated by azo-R8 shows this 
consistently directs more of the labeled protein into the cellular membrane compared 
with R8 and pep-1.  This observation implies some protein/azo-R8 complex may be 
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trapped in the membrane in these experiments.  It was also observed that when confluent 
cell cultures were used, more membrane staining was observed for all three carriers, but 
more so for azo-R8. 
 
4. Delivery at 4ºC: Diffuse Cytosolic Fluorescence 
Punctate vesicle formation was largely suppressed when the experiments 
described in the previous section were repeated at 4°C.  As an added precaution against 
surface binding,240  the cells were treated with heparin (3 x 5 min, 1 mg/mL of PBS)  
after the PBS washes.  Nevertheless, a weak, diffuse fluorescence signal was observed 
(see supplementary).  Further, fluorescence deconvolution imaging of the cells showed 
the same diffuse fluorescence pattern.  These observations indicate that at 4°C, the 
protein is indeed being imported inside the cytoplasm by all the carriers. 
Experiments were performed to increase the fluorescence signal in the cytosol by 
increasing the concentration of the protein from 2 mM and to 5 mM (carrier:protein = 
10:1 mol:mol, as before).  At 2 μM, the fluorescence intensity in the cytosol was 
increased but some additional binding to the cell membrane was observed.  At 5 mM, the 
intensity of membrane labeling was considerably brighter, however, the cytoplasmic 
signal was retained (Figure 5.5). 
Similar experiments on BSA-F*, β-gal-F*, and recombinant Streptavidin-F* also 
gave diffuse cytoplasmic fluorescence (see supplementary).  Uptake of β-gal-F* was 
significantly lower than for the avidin and BSA dye-conjugates, even when a higher 
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ratio of carrier:protein (20:1) ratio was used.  This difference was confirmed in the flow 
cytometry experiments described in the next section. 
 
a a
b b
 
 
c c
 
Figure 5.5.  Delivery of avidin-F* in COS-7 cells at 4 ºC mediated by R8.  (a) 0.5 μM of avidin–F*..  (b) 2 
μM avidin–F*.  (c) 5 μM avidin–F*.  (d) No carrier used  Throughout COS-7 cells were incubated for 1 h 
at 4°C with R8 and avidin-F* (10:1.0 mol:mol), then washed 4x with PBS buffer.  Images shown are after 
deconvolution; left images are fluorescence images of avidin-F* and Hoechst 33342, right images are 
DIC. 
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Figure 5.5.  Continued. 
 
5. Comparison of Uptake Levels For Different Carriers via Flow Cytometry 
Flow cytometry was used to analyze and compare the non-covalent protein 
transduction (Figure 5.6).  Before the analyses, the cells were washed with PBS, treated 
with trypsin, then washed with heparin (3 x 5 min, 0.5 mg/mL PBS) to minimize the 
possibilities for surface binding.  In each case, the uptake measured by flow cytometry 
was greater when the carrier molecule was included (0.5 mM protein; carrier:protein 
10:1.0 for avidin-F* and BSA-F*, and 20:1.0 for b-gal-F*).  Import of avidin-F* was 
significant, with pep-1 and R8 being more effective than azo-R8 at 4 oC (Figure 5.6A).  
However, for BSA-F* the reverse was true: azo-R8 was far more effective than the other 
two carriers.  The largest protein-dye conjugate, b-gal-F*, was the least well imported of 
the three proteins that were tested, with pep-1 and azo-R8 being the most effective 
carriers. 
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Figure 5.6.  (a) Flow cytometric analysis of the uptake of the Alexa Fluor 488 labeled proteins, avidin-
F*, BSA-F* and b-gal-F* at 4°C relative to FITC Quantum Bead standards (shaded histograms). Each 
histogram for avidin-F* and BSA-F* represents 20,000 to 24,000 cells and 20,000 beads.  For b-gal-
F*,each histogram represents 10,000 cells and 20,000 beads.  The FITC Quantum Beads peaks 
represent 8534, 25857, 79264, and 214887 MESF units each.  The scale for the X-axis is MESF units.  
(b) Summary of the flow cytometric data for each protein with the carriers tested.  Results are 
presented as the median MESF units for each protein-carrier combination. 
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Figure 5.6.  Continued. 
 
6. Evaluation of the Cytotoxicity of the Carriers 
Cell viability during the non-covalent protein internalization mediated by R8 and 
azo-R8 was accessed using ethidium homodimer.  Thus COS 7 cells were treated with a 
l.0:10 mol ratio protein:carrier (2 μM protein) for 1 h at 4°C, washed with PBS and 
treated with ethidium homodimer  (2 μg/mL). Figure 7A illustrates that cells treated with 
R8 and azo-R8 peptides for 1 h at 4°C did not result in any cytotoxicity.  Incubation at 
37°C for another 16 h gave no cytotoxicity (the fluorescence was now mostly 
concentrated into vesicles, probably lysosomes, Figure 5.7B).  After a further incubation 
period of 24 h at 37°C however, all the cells were dead (Figure 5.7C). 
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Figure 5.7.  Viability Assay.  Delivery of avidin-F* (2 μM) in COS-7 cells at 4 ºC mediated by (a) R8 
and (b) azo-R8.  (A) COS-7 cells were incubated for 1 h at 4°C with R8 or azo-R8 and avidin-F* (10:1.0 
mol:mol), then washed 4x with PBS buffer and treated with ethidium homodimer for 30 min.  (B) The 
same cells were incubated at 37°C for 16 h.  (C) The medium was removed, fresh PBS was added and 
the same cells were incubated at 37°C for another 24 h.  Before imaging, 2 μL of ethidium homodimer 
were added. 
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C. Conclusions 
Import into cells at 37°C could be regulated via energy-dependent or independent 
pathways, but at 4°C it is generally accepted that only energy independent pathways are 
operative.  The data accumulated here indicate that at 37°C import into endosomes is 
prevalent and significant diffuse fluorescence in the cytosol was not observed.  
However, the relative brightness of the vesicular staining may obscure low level 
cytoplasmic fluorescence.  Thus, at least two different pathways appear to be operative 
for three different carrier molecules, and the desired one, diffuse import into the cytosol, 
prevails at 4°C.  This observation is parallel and consistent with work reported by Futaki 
et al.237  They studied the mechanism of translocation of R8-Texas Red at 37 and 4°C, 
without cargo proteins and observed vesicular staining at 37°C and diffuse fluorescence 
in the cytosol at 4°C.  The simplest explanation for the reduced efficiency for import of 
b-gal-F* relative to the other proteins is that it is approximately eight times larger.  
Similarly, the simplest explanation for the observation that three chemically different 
carriers facilitate import of three different proteins at 4°C via an energy independent 
pathway is that they form pores in the cells membrane that allow leakage into the cells, 
even at 4°C.  This would explain the fact that the levels of diffuse fluorescence observed 
are weak, and that the larger protein was the one least effectively imported.  At 37°C, 
other mechanisms, perhaps involving macropinocytosis (an energy dependant process), 
become dominant. 
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CHAPTER VI  
SUMMARY AND CONCLUSIONS 
 
In summary that we have demonstrated that TBET cassettes with specific 
characteristics are useful in three different biological areas.  TBET cassettes have desired 
spectral properties for studying proteins' interactions.  The well-resolved muitiple 
fluorescence emission spectra for multiplexing could be obtained.  I have synthesized a 
water-soluble cassette 55 based on bissulfonated BODIPYs, it has been demonstrated to 
be a good protein labeling dye.  A series of this kind of cassettes will be ideal for 
studying multi-protein interactions in vivo.  A ratiometric fluorescent pHi indicator 16 
based on energy transfer has been shown to image protein-dye conjugates in living cells.  
It has better quantum yields than a widely used pH probe C.SNARF-1.  The pH sensitive 
range of this cassette is also complementary to the C.SNARF-1.  Also we have 
demonstrated that the descrete long-wavelength chemiluminescence probe could be 
obtained via TBET cassettes. Described in chapter IV are the syntheses and 
spectroscopic properties of the fluorescein- and Nile Red-based, chemically activated, 
cassettes, 56 and 57.  The chemiluminescence spectra and figure indicate that the energy 
transfer efficiency is very efficient (>90%).  These two cassettes could be activated by 
H2O2 at physiological pH, therefore it might be a potential indicator for reactive oxegen 
species in living cells. 
Importing proteins into cytosol is a challenged problem in biology.  The data 
accumulated in chapter V indicate that at 4 °C import into cytosol is prevalent and 
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significant accumulation of fluorescence in the endosome was not observed. This 
observation is parallel and consistent with work reported by Futaki et al.237  The simplest 
explanation for the observation that three chemically different carriers facilitate import 
of three different proteins at 4°C via an energy independent pathway is that they form 
pores in the cells membrane that allow leakage into the cells, even at 4°C.  This would 
explain the fact that the levels of diffuse fluorescence observed are weak, and that the 
larger protein was the one least effectively imported.   
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APPENDIX A 
EXPERIMENTAL DATA FOR CHAPTER II 
 
General Experimental Procedure 
Bovine serum albumin (BSA) was purchased from Calbiochem.  SephadexTM G-
25 (PD-10) was bought from GE healthcare.  Pep-1 (Chariot) was purchased from 
Active Motif.  Et3N were distilled from CaH2.  Unless otherwise mentioned, other 
solvents and reagents were used as received. NMR spectra were recorded on a VXP-300 
MHz and Inova-500 MHz spectrometers (1H at 300 MHz or 500 MHz, 13C at 75 or 125 
MHz) at room temperature unless otherwise mentioned.  Chemical shifts of 1H NMR 
spectra were recorded and reported in ppm from the solvent resonance (CDCl3 7.26 ppm, 
CD3OD 3.30 ppm).  Data are reported as follows: chemical shift, multiplicity (s = 
singlet, bs = broad singlet. d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), 
coupling constants, and number of protons.  Proton decoupled 13C NMR spectra were 
also recorded in ppm from solvents resonance (CDCl3 77.0, CD3OD 49.1ppm). 
Analytical thin layer chromatography (TLC) was performed on EM Reagents 0.25 mm 
silica-gel 60-F plates, and visualized with UV light.  Flash chromatography was 
performed using silica gel (230–600 mesh).  UV/Visible and fluorescence spectra were 
taken in pH 7.4 PBS buffer unless otherwise mentioned.  MS were measured under ESI 
or MALDI conditions.  
Determination of Quantum Yields and Extinction Coefficients 
UV/Vis absorbance spectra were recorded on a Cary 100 Bio spectrophotometer.  
Steady-state fluorescence spectroscopic studies were performed on a Cary Eclipse 
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fluorometer.  The slit width was 5 nm for both excitation and emission.  The excitation 
wavelength for the test sample and the standard is the same.  Fluorescence spectra were 
corrected for detector sensitivity.  The relative quantum yields of the samples were 
obtained by comparing the area under the corrected emission spectrum of the test sample 
with that of a solution of standard.  The quantum efficiencies of fluorescence were 
average of two measurements with the following equation: 
Φx = Φst (Ix/Ist) (Ast/Ax) (ηx2/ηst2) 
Where Φst is the reported quantum yield of the standard, I is the area under the 
emission spectra, A is the absorbance at the excitation wavelength and η is the refractive 
index of the solvent used, measured on a pocket refractometer from ATAGO.  X 
subscript denotes unknown, and st means standard.  
Fluorescein (φ =  0.92 in 0.1M NaOH)1 and Rhodamine 6G (φ =  0.95 in EtOH)2 
were used as the standards for measurements of quantum yields of BSA-18 in pH 4.1 
and 8.8 buffers respectively, and the excitation wavelength was 488 nm.  
 
Cell Culture 
COS-7 cells (American Type Culture Collection) were cultured as subconfluent 
monolayers on 75 cm2 culture flask with vent caps in DMEM supplemented with 10 % 
fetal bovine serum (FBS) in a humidified incubator at 37 ºC with 5 % CO2.  Cells grown 
to subconfluence were enzymatically dissociated from the surface with trypsin and 
plated 2-3 days prior to the experiments in Lab-Tek two well chambered coverglass 
slides (Nunc).  
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Fluorescence Microscopy 
Cells were washed several times with PBS buffer and then put on the stage of the 
Bio-Rad 2000MP system (Bio-Rad Laboratories, Hercules, CA) equipped with a Nikon 
T300 inverted microscope with a 60x (NA1.2) water immersion objective lens and an 
Argon laser tuned to 488 nm wavelength.  Through-bond Energy Transfer data in COS-7 
cells loaded with 5-bromo-fluorescein diacetate (D, control donor) alone (2 min at 37 
ºC), BODIPY derivative (A, control acceptor) (30 min at 37 ºC) alone or with BSA-1 
(1:20 mol ratio of BSA-1:pep-1 for 1h at 37 ºC; the complex BSA-1:pep-1 was 
preformed by mixing both reagents and incubating them at room temperature for 30 min) 
were collected  using 488 nm excitation wavelength. Both SA and SB were excited at 
488 nm and emission of SA (FITC channel; donor signal) was collected using a 560 
DCLP XR dichroic mirror and a HQ 528/50 –nm emission filter whereas emission of SB 
(FRET channel; acceptor signal) was collected using a HQ 600/50-nm filter. Donor 
bleed through signal to the FRET channel was calculated by measuring the FRET 
channel signal resulting from COS cells loaded only with the donor. Acceptor bleed 
through to the FRET channel was calculated by measuring the FRET channel signal 
resulting from COS cells loaded with SB alone.  Accumulated images (N=6, F=1) at a 
1024 x 1024 resolution were captured. 
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For the experiment done at 4 °C, the cells were pre-incubated at 4 °C for 30 min, before 
the addition of the complex.  After addition of the complex, the cells were incubated for 
another hour at 4 °C.   
 
Measurement of pHi Using BSA-18 
COS-7 cells (American Type Culture Collection) were cultured as subconfluent 
monolayers on 75 cm2 culture flask with vent caps in DMEM supplemented with 10 % 
fetal bovine serum (FBS) in a humidified incubator at 37 ºC with 5 % CO2.  Cells grown 
to subconfluence were enzymatically dissociated from the surface with trypsin and 
plated 2-3 d prior to the experiments in Lab-Tek two well chambered coverglass slides 
(Nunc) in 1 mL DMEM.  To measure pHi with BSA-18, cells were incubated with the 
pre-formed BSA-18:pep-1 complex (1 μM BSA-18:20 μM pep-1) for 60 min at 37 or 4 
°C.  When the experiment was performed at 4 °C, the cells were pre-incubated at 4 °C 
for 30 min before the addition of the complex.  After incubation, the cells were washed 
and analyzed on a Bio-Rad 2000MP system (Bio-Rad Laboratories, Hercules, CA) 
equipped with a Nikon T300 inverted microscope with a 60x (NA1.2) water immersion 
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objective lens and an Argon laser tuned to 488 nm wavelength (as described in the 
section Fluorescence Microscopy above). 
Ex vivo calibration curve was obtained as follows.  Briefly, after incubation with 
BSA-16, the cells were washed in ACAS medium of varying pH values (pH was 
adjusted by adding small amounts of 0.2 N solution of NaOH or 0.1 N solution of HCl). 
1 μg/mL of nigericin (Aldrich) was added to the medium to allow a rapid exchange of 
K+ for H+ which resulted in a rapid equilibration of external and internal pH.  The cells 
were then analyzed by fluorescence microscopy as described above. 
The pHi calibration was fit to a linear regression curve using Excel.  The fitted 
parameters were used to generate an equation that converted ratio channel (red/green) 
number to pHi. 
 
Measurement of pHi Using C.SNARF-1 
COS-7 cells (American Type Culture Collection) were cultured as subconfluent 
monolayers on 75 cm2 culture flask with vent caps in DMEM supplemented with 10 % 
fetal bovine serum (FBS) in a humidified incubator at 37 ºC with 5 % CO2.  Cells grown 
to subconfluence were enzymatically dissociated from the surface with trypsin and 
plated 2-3 d prior to the experiments in a 12 wells tissues culture plate (Falcon) in 1 mL 
DMEM.  To measure pHi with C.SNARF-1, cells were placed in 1 mL ACAS medium 
and 10 μM (2 μL) SNARF-1/AM (Invitrogen) was added from a 5 mM stock solution in 
DMSO and the sample was incubated for 60 min at 37 °C or 30 min at 4 °C.  When the 
experiment was performed at 4 °C, the cells were pre-incubated at 4 °C for 30 min 
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before the addition of C.SNARF-1/AM.  After incubation, the cells were washed and 
analyzed on a BioTek Synergy 4 plate reader.  Emission spectra were obtained upon 
excitation at 530 nm.   
A calibration curve was generated by staining the cells in high K+ buffers of 
varying pH values, and adding 5 μg/mL nigericin (Aldrich) to equilibrate the 
intracellular/extracellular pH.  High K+ buffers contained 125 mM KCl, 20 mM NaCl, 
0.5 mM CaCl2, 0.5 mM MgCl2, and 25 mM of one of the buffers, including acetate 
(4.14, 4.97), Mes (5.97), Mops (6.98) and HEPES (7.93). 
The pHi calibration was fit to a sigmoid.  The fitted parameters were used to 
generate an equation that converted ratio channel (λ645/λ595) number to pHi. 
 
Electrochemistry  
Cyclic voltammograms and differential pulse voltammograms were recorded on 
a BAS-100A electrochemical analyzer using a three-electrode cell.  The working 
electrode was a glassy carbon disk (0.071 cm2) and a coiled platinum wire was used as 
the counter electrode.  The experimental reference electrode used was a Ag/AgCl 
prepared by electroplating method.  Solutions were deaerated by an argon purge for 5-10 
min and a blanket of argon was maintained over the solution while performing the 
measurements.  Experiments were performed in CH2Cl2 or DMF solutions containing 
0.1 M n-Bu4NPF6 at room temperature.  All potentials are reported relative to Ag/AgCl 
electrode using Cp2Fe/Cp2Fe+ as an internal reference (E1/2 = 0.00 V vs Ag/AgCl in 
CH2Cl2 or DMF). 
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Iodophenyl BODIPY (142 mg, 0.316 mmol), A (100 mg, 0.331 mmol), 
PdCl2(PPh3)2 (24 mg, 0.032 mmol, 10 mol %), CuI (12 mg, 0.064 mmol, 20 mol %), 
Et3N (0.44 ml, 3.16 mmol) and 5 ml THF were added into a 50 mL round bottom flask.  
The solvent was degassed three times to remove oxygen, and then the reaction was kept 
at 55 oC for 5 h.   The reaction solvent was removed under reduced pressure. The crude 
product was purified by flash column chromatography eluting with 30 % hexane/ethyl 
acetate to give the desired product as an orange solid (151 mg, 77 %).   1H NMR (300 
MHz, CDCl3), δ7.53 (d, J = 8.1, 2H), 7.20 (d, J = 8.1 Hz, 2H), 5.95 (s, 2H), 4.42 (s, 2H), 
3.98 (s, 2H), 3.72-3.78(m, 2H), 3.63-3.69(m, 10H), 2.51(s, 6H), 1.45(s, 9H), 1.36(s, 6 H) 
13C NMR (125 MHz, CDCl3), δ169.5, 155.6, 142.8, 140.6, 135.0, 132.3, 131.0, 128.0, 
123.4, 121.2, 86.5, 85.4, 81.4, 70.6, 70.5, 70.4, 70.3, 69.2, 68.9,59.0, 27.9, 14.4. MS 
(ESI) calcd for C34H43BF2N2O6 (M+H)+, 624.32, found 624.13. TLC (1:1 
EtOAc/Hexane), Rf = 0.42. 
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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A mixture of 19 (104 mg, 0.165 mmol), I2 (100 mg, 0.412 mmol), HIO3 (58 mg, 
0.33 mol) and 10 mL EtOH  in a 50 mL flask were warmed up to 60 oC for 20 min, and 
then it was cooled to room temperature.  The reaction was quenched by addition of 
Na2SO3 (2 mL 1M).  Water (20 mL) was added to the reaction mixture, and the product 
was extracted from water with CH2Cl2 (25 mL x 3).  The combined organics were 
concentrated under reduced pressure, and the resulting crude product was purified by 
flash chromatography eluting with hexane and ethyl acetate (1:1) to give 20 (145 mg, 
99%) as a red solid that is very soluble in CH2Cl2.  1H NMR (300 MHz, CDCl3), δ 7.60 
(d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 4.47 (s, 2H), 4.02 (s, 2H), 3.78-3.81 (m, 
2H), 3.70-3.75 (m, 10H), 2.64 (s, 6H), 1.47 (s, 9H), 1.40 (s, 6 H).  13C NMR (125 MHz, 
CDCl3), δ 169.9, 157.3, 145.4, 140.6, 135.0, 133.0, 131.3, 128.2, 124.4, 87.3, 86.1, 85.5, 
81.8, 71.0, 70.9, 70.9, 70.8, 70.7, 69.7, 69.3, 59.4, 28.4, 17.4, 14.4.  MS (MALDI) calcd 
for C34H41BF2N2NaO6+ (M+Na)+, 899.10, found 898.91.  TLC (1:1 EtOAc/Hexane), Rf = 
0.45. 
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A mixture of 20 (65 mg, 0.074 mmol), diacetylfluoresceinalkyne C, (82 mg, 
0.186mmol), Et3N (0.11 mL, 0.74 mmol), Pd(PPh3)4 (8 mg, 0.007 mmol), CuI (3 mg, 
0.014 mmol) were dissolved in THF (2 mL).  After the solution was degassed three 
times via the freeze-thawed method, the mixture was heated up to 45 oC for 16 h.  The 
reaction solvent was removed under reduced pressure and the crude product was purified 
by flash column eluting with 50% hexane:ethyl acetate to give the desired product as a 
light yellow solid (80 mg, 72%).  1H NMR (500 MHz, CDCl3), δ 8.08 (m, 2H), 7.73 (dd, 
J =8.0, 1.5 Hz, 2H), 7.65(d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 8.2 
Hz, 2H), 7.10 (d, J = 2.0 Hz, 4H), 6.83 (bs, 4H), 6.83 (d, J = 2.0 Hz, 4H), 4.48 (s, 2H), 
4.02 (s, 2H), 3.80-3.82 (m, 2H), 3.70-3.75 (m, 10H), 2.75 (s, 6H), 2.32 (s, 12H), 1.58 (s, 
6H), 1.47(s, 9H).  13C NMR (125 MHz, CDCl3), δ 169.6, 168.8, 168.2, 159.1, 152.1, 
151.8, 151.5, 144.6, 142.1, 137.9, 134.1, 132.8, 131.1, 128.9, 127.9, 127.7, 126.6, 125.8, 
124.3, 124.2, 117.8, 116.0, 115.6, 110.5, 94.7, 87.2, 85.3, 84.1, 81.8, 81.5, 70.7, 70.6, 
70.6, 70.5, 69.5, 69.0, 59.2, 28.1, 21.1, 13.8, 13.7 MALDI MS calcd for 
C86H71BF2N2NaO20+ (M+Na)+ 1523.46, found 1523.26.  TLC (1:1 EtOAc/Hexane), Rf = 
0.20. 
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Compound 21 (6.1 mg, 0.004 mmol) in 5 mL ground bottom flask was heat up to 
200 oC in a sand bath for 15 h.  Then the crude product was dissolved in 1 mL MeOH, 
followed by addition of K2CO3 (3 mg, 0.022 mmol). The mixture was stirred at room 
temperature for overnight.  Then 10 mL water was added to the mixture and the non-
water-soluble impurity was extracted out of the aqueous solution with CH2Cl2 (5 mL x 
2).  The aqueous solution was carefully neutralized with 0.1M HCl and the product was 
extracted out of the water with 75% CHCl3/iPrOH (10 mL x 3) to afford a dark red solid 
16 (5 mg, 95 %).  1H NMR (500 MHz, 75% CD3OD/CDCl3), δ 8.06 (s, 2H), 7.78 (dd, J 
= 8.5 Hz, 1.3 Hz, 2H), 7.68 (d, J = 8.5Hz, 2H), 7.36 (d, J = 8.5 Hz, 2H), 7.19 (d, J = 8.5 
Hz, 2H), 6.74 (s, 4H), 6.67 (d, J = 7.5 Hz, 4H), 6.58 (d, J = 7.5 Hz, 4H), 4.49 (s, 2H), 
4.13 (s, 2H), 3.81-3.83(m, 2H), 3.69-3.75 (m, 10H), 2.74 (s, 6H), 1.61 (s, 6H).  13C NMR 
(125MHz,75%CD3OD/CDCl3),δ 180.8, 173.4, 169.8, 159.6, 154.1, 154.0, 153.9, 145.3, 
143.0, 138.1, 134.8, 133.4, 131.8, 129.9, 128.7, 128.5, 128.4, 126.1, 125.5, 124.8, 116.4,
 113.8, 111.0, 103.3, 95.6, 87.4, 86.0, 84.3, 71.2, 71.1, 71.0, 70.9, 70.8, 69.8, 68.8, 59.5, 
30.2, 14.0.  19F NMR (300 MHz, CD3OD), 30.6 (q, J = 36.0 Hz).  MS (MALDI) calcd 
for C76H55BF2N2O16- (M-H)- 1275.35, found 1275.31.
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BSA-16.  Cassette 16 (1.5 mg) was dissolved in dry DMF (0.15 mL) and N-
hydroxysuccinimide (0.4 mg), diisopropyl carbodiimide (DIC, 0.7 μL) were added. The 
reaction mixture was stirred at room temperature for 24 h.  The activated cassette 16 
solution (100 μL, 6 eq.) was added to the solution of bovine serum albumin (13 mg, 1 
eq.) in 1.5 mL freshly prepared sodium bicarbonate (0.1 M, pH 8.3). The solution was 
stirred at room temperature in the dark for 1 h. The desired product was purified by 
SephadexTM G-25 (PD-10) desalting column eluting with DI-water.  The UV-vis 
spectra show the absorbance peak of avidin at 280 nm and the two maximum absorbance 
peaks of the cassettes 16 at 490 nm and 570 nm (Figure S1.1).    
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Figure S1.1 UV absorbance spectra of BSA-16 conjugate in DI water. 
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A solution of 2,4-dimethylpyrrole (1.0 mL, 10 mmol), succinic anhydride (400 
mg, 4.0 mmol), and BF3• Et2O (0.50 mL, 4.0 mmol) in 30 mL toluene was heated to 80 
ºC under N2 for 5 h.  The mixture was cooled to 25 ºC and BF3•Et2O (5.0 mL, 40 mmol) 
and Et3N (10 mL, 80 mmol) were then added.  After stirring for 16 h at 25 ºC under N2 
the reaction was quenched with 60 mL of 0.1 M HCl aqueous solution.  Extraction was 
performed and the organic fractions were combined and dried over magnesium sulfate. 
The organic solvent was removed under reduced pressure and the product was purified 
via flash silica column with 85 % ethyl acetate:hexane to afford the desired product as an 
orange solid (203 mg, 18 %).  1H NMR (300 MHz, CDCl3) δ (ppm) 6.07 (s, 2H), 3.29-
3.35 (m, 2H), 2.62-2.68(m, 2H), 2.52 (s, 6H), 2.44 (s, 6H), 13C NMR (75 MHz, CDCl3), 
δ (ppm), 176.6 154.8, 142.8, 140.3, 131.2, 122.0, 35.1, 23.4, 16.4, 14.5. MS (ESI) calcd 
for C16H18BF2N2O2 [M -H]- 319.15, found 319.15. TLC (50 % EtOAc:Hexane) Rf = 
0.50. 
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Tetramethyl-BODIPY acid 26 (600 mg, 1.87 mmol) was suspended in 200 mL of 
MeOH.  I2 (1.24 g, 4.87 mmol) was added followed by iodic acid (660 mg, 3.75 mmol) 
in ~3 mL water was added over 5 min.  The mixture was stirred for 30 min at 25 ºC.  
The MeOH was then removed under reduced pressure and the crude product was 
purified via flash silica column with 50 % ethyl acetate:hexane to afford the desired 
product as a red solid (574 mg, 54 %). 1H NMR (300 MHz, CDCl3) δ (ppm) 3.28-3.32 
(m, 2H), 2.45-2.52 (m, 2H), 2.50 (s, 6H), 2.43 (s, 6H), 13C NMR (75 MHz, CDCl3), 
δ (ppm), 175.1 156.3, 142.5, 142.3, 131.1, 87.0, 34.9, 24.2, 19.3, 16.5. MS (ESI) calcd 
for C16H17BF2I2KN2O2[M + K]+ 610.9, found 611.6. TLC (50 % EtOAc:Hexane) Rf = 
0.55. 
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To 21 (12 mg, 0.01 mmol) in 5 mL 2:1 methanol/THF in was added Na2CO3 (3.5 
mg, 0.03 mmol).  The mixture was stirred for 3 h at 25 ºC under N2.  The reaction was 
quenched by adding aqueous HCl (0.1M, 10 mL) and the product was extracted out of 
the solution with 75% CH2Cl2:iPrOH (5 mL x 3).  The organic layers were washed with 
brine solution (10 mL) and dried with magnesium sulfate. The desired product was 
isolated as a purple solid (10 mg, 99 %).  1H NMR (500 MHz, 75% CD3OD:CDCl3), δ 
8.00 (s, 2H), 7.74 (dd, J = 8.0 Hz, 1.5 Hz, 2H), 7.65 (d, J = 7.5Hz, 2H), 7.33 (d, J = 8.5 
Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 6.67 (d, J = 2.5 Hz 4H), 6.59 (d, J = 8.0 Hz, 4H), 6.51 
(dd, J = 9.0 Hz, 2.5 Hz, 4H), 4.47 (s, 2H), 4.00 (s, 2H), 3.79-3.81(m, 2H), 3.71-3.73(m, 
2H), 3.66-3.69 (m, 8H), 2.71 (s, 6H), 1.58 (s, 6H), 1.44(s, 9H), 13C NMR (125 MHz, 
75% CD3OD:CDCl3), δ 170.9, 170.1, 169.8, 159.5, 153.5, 145.2, 142.9, 138.3, 134.8, 
133.4, 131.7, 131.2, 129.6, 128.7, 128.5, 128.0, 126.1, 125.9, 124.9, 116.3, 110.3, 108.2, 
103.3, 95.6, 87.4, 86.0, 84.1, 82.7, 71.0, 70.9 (2 C), 70.8 (2 C), 69.7, 69.3, 59.5, 30.2, 
28.3, 14.0.    MS (MALDI) calcd for C78H63BF2N2O16+ (M+H)+ 1333.42, found 1333.44. 
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A mixture of 20 (80 mg, 0.09 mmol), D (69 mg, 0.20 mmol), Et3N (0.13 mL, 
0.91 mmol), PdCl2(PPh3)2 (6 mg, 0.01 mmol), CuI (4 mg, 0.01 mmol) were dissolved in 
3.0 mL THF.  The solution was degassed three times via the freeze-thaw method and the 
mixture was heated to 50 ºC for 16 h under N2.  The reaction solvent was removed under 
reduced pressure and the crude product was purified via flash silica column eluting with 
67% hexane:ethyl acetate to give the desired product as a purple solid (89 mg, 74 %).  
1H NMR (500 MHz, CDCl3), δ 7.64 (d, J = 8.0 Hz, 2H), 7.59 (d, J =8.0 Hz, 4H), 7.29 (d, 
J = 8.5 Hz, 2H), 7.27 (d, J = 8.0 Hz, 4H), 5.99 (s, 4H), 4.48 (s, 2H), 4.02 (s, 2H), 3.80-
3.82 (m, 2H), 3.70-3.75 (m, 10H), 2.76 (s, 6H), 2.55 (s, 12H), 1.58 (s, 6H), 1.47(s, 9H), 
1.43 (s, 12H), 13C NMR (125 MHz, CDCl3), δ 169.6, 158.9, 155.7, 144.1, 143.0, 141.7, 
140.7, 134.8, 134.3, 132.8, 131.9, 131.2, 128.2 (2 C), 128.0, 124.1 (2 C), 121.3, 116.0, 
96.0, 87.1, 85.3, 82.9, 81.6, 70.7, 70.6 (3 C), 70.5, 69.5, 69.0, 59.2, 28.1, 14.6 (2 C), 
14.6, 13.7. MALDI MS calcd for C76H77B3F6N6NaO6+ (M+Na)+ 1339.61, found 1339.68. 
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A mixture of 26 (34 mg, 0.11 mmol), phenylacetylene (47 μL, 0.43mmol), Et3N 
(0.15 mL, 1.1 mmol), PdCl2(PPh3)2 (8 mg, 0.01 mmol), and CuI (4 mg, 0.02 mmol) were 
dissolved in 2 mL THF under N2.  The solution was degassed three times via the freeze-
thaw method and then heated to 50 ºC for 16 h under N2.  The solvent was removed 
under reduced pressure and the crude product was purified via flash silica column 
eluting with 20% methanol:CH2Cl2 to give the desired product as a red solid (17 mg, 
55%).  1H NMR (500 MHz, CDCl3), δ 7.44-7.46 (m, 4H), 7.27-7.31 (m, 6H), 3.32-3.36 
(m, 2H), 2.62 (s, 6H), 2.56 (s, 6H), 2.53-2.57 (m, 2H), 13C NMR (125 MHz, 3:1 
CDCl3:CD3OD), δ 174.0, 157.5, 144.9, 141.4, 131.4, 131.2, 128.4, 128.3, 123.2, 116.7, 
96.7, 81.4, 24.2, 15.1, 15.1, 13.6. MALDI MS calcd for C32H27BF2N2O2 (M-H)- 519.21, 
found 519.21.  TLC (50 % EtOAc:Hexane) Rf = 0.20. 
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A mixture of 20 (66 mg, 0.08 mmol), phenylacetylene (42 μL, 0.38 mmol), Et3N 
(0.10 mL, 0.75 mmol), PdCl2(PPh3)2 (6 mg, 0.01 mmol), and CuI (3 mg, 0.01 mmol) 
were dissolved in 5.0 mL THF.   The solution was degassed three times via the freeze-
thaw method and then heated to 45 oC for 16 h under N2.  The reaction solvent was 
removed under reduced pressure and the crude product was purified via flash silica 
column eluting with 50% hexane:ethyl acetate to give the desired product as a purple 
solid (52 mg, 79%).  1H NMR (500 MHz, CDCl3), δ 7.62 (d, J = 8.0 Hz, 2H), 7.45-7.47 
(m, 4H), 7.31-7.34 (m, 6H), 7.27 (d, J = 8.5 Hz, 2H), 4.47 (s, 2H), 4.02 (s, 2H), 3.80-
3.81 (m, 2H), 3.69-3.75 (m, 10H), 2.72 (s, 6H), 1.54 (s, 6H), 1.47(s, 9H), 13C NMR (125 
MHz, CDCl3), δ 169.6, 158.7, 143.7, 141.4, 134.5, 132.7, 131.3, 130.9, 128.3, 128.1, 
128.0, 124.0, 123.2, 116.3, 96.6, 86.9, 85.4, 81.5, 81.4, 70.7, 70.6 (2 C), 70.5, 69.4, 69.0, 
59.1, 28.1, 13.7, 13.6. MALDI MS calcd for C50H51BF2N2NaO6+ (M+Na)+ 847.37, found 
847.12. 
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A mixture of 20 (58 mg, 0.066 mmol), 3-ethynylbenzoic acid (30 mg, 0.20 
mmol), Et3N (0.10 mL, 0.75 mmol), PdCl2(PPh3)2 (5 mg, 0.003 mmol), and CuI (3 mg, 
0.01 mmol) were dissolved in 5.0 mL THF.  The solution was degassed three times via 
the freeze-thaw method and heated to 45 oC for 16 h under N2.  The reaction solvent was 
removed under reduced pressure and the crude product was purified by flash silica 
column eluting with 80% CH2Cl2:MeOH to give the desired product as a purple solid 
(35 mg, 58%).  1H NMR (500 MHz, CD3OD), δ 8.12 (s, 2H), 8.01 (d, J = 8.0 Hz, 2H), 
7.75-7.78 (m, 4H), 7.53-7.58 (m, 6H), 4.49 (s, 2H), 4.00 (s, 2H), 3.76-3.77 (m, 2H), 
3.66-3.69 (m, 4H), 3.61-3.64 (m, 6H), 2.71 (s, 6H), 1.60 (s, 6H), 1.44 (s, 9H), 13C NMR 
(125 MHz, CD3OD), δ 166.9, 159.2, 144.9, 141.4, 136.0, 135.0, 133.5, 132.8, 132.0, 
131.8, 130.2, 129.7, 129.3, 125.1, 124.4, 116.5, 108.8, 96.6, 88.5, 85.6, 82.8, 81.2, 71.2, 
71.1, 70.0, 69.3, 59.2, 32.6, 30.5, 28.2, 23.3, 14.3, 13.8. MALDI MS calcd for 
C52H51BF2N2NaO10+ (M+Na)+ 935.35, found 935.37. 
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4. Complete Electrochemical Data 
 Cyclic Voltammetry (CV)  DPVe 
cmpd Eonset,ox (V) 
HOMO 
(eV) 
Eonset,red 
(V) 
LUMO 
(eV) 
Eg 
(eV) 
Eonset,ox 
(V) 
HOMO 
(eV) 
Eonset,red 
(V) 
LUMO 
(eV) 
Eg 
(eV) 
           
Ea +1.22 6.38 -1.43 3.73 2.65 +1.15 6.31 -1.20 3.96 2.35 
Fb +0.72 5.87 -1.25 3.90 1.97 +0.51 5.66 -1.08 4.07 1.59 
FNab, d +0.25 5.40 -1.89 3.26 2.14 +0.11 5.26 -1.80 3.35 1.91 
30a +1.20 6.36 -1.22 3.94 2.42 - - - - - 
31b +0.80 5.95 -1.14 4.01 1.94 +0.67 5.82 -1.04 4.11 1.71 
32a +1.21 6.37 -1.12 4.07 2.33 +1.14 6.30 -0.94 4.22 2.08 
33b +0.79 5.94 -1.09 4.06 1.88 +0.66 5.81 -1.02 4.13 1.68 
33c +0.80 5.95 -1.12 4.03 1.92 - - - - - 
Table S1.1 Electrochemical data for 30 - 33, E, and F. All experiments were recorded using a glassy 
carbon working electrode (A = 0.071 cm2) referenced to Fc/Fc+ and a Pt counter electrode at a scan 
rate of 200 mV/s.  All potentials are reported vs. Fc/Fc+ and all HOMO and LUMO energies are 
derived form electrochemical results based on Fc/Fc+ = 5.1 eV vs vacuum.  All solvents were dearated 
using Ar(g).  a. CH2Cl2 solution b. DMF solution.  c. DMF solution (0.1 M pyridine).  d. xanthene was 
first reacted with NaOH to obtain the sodium salt.  e. DPV:Differential Pulse Voltammetry. 
Compounds 30 and 33 (base) decomposed during DPV scan.  
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APPENDIX B  
EXPERIMENTAL DATA FOR CHAPTER III 
 
General Experimental Procedures 
All chemicals were obtained from commercial suppliers and used without further 
purification. Chlorosulfonic acid was purchased from Aldrich and can be used within 
two to three months before it decomposed in to sulfuric acid.  Dichloromethane was 
dried with MBRAUN MB-SPS solvent purification system. All organic tin compounds 
were received from commercially available sources unless otherwise mentioned. 
Chromatography on silica gel was performed using a forced flow of the indicated solvent 
on EM reagents silica gel 60 (230-400 mesh). 1H NMR spectra were recorded at room 
temperature and chemical shifts are reports in ppm from the solvent resonance (CDCl3 
7.24 ppm, DMSO-d6 2.50 ppm, CD3OD 3.31 ppm, D2O 4.79 ppm). Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = 
broad, m = multiplet), number of protons, and coupling of constants. Proton decoupled 
13C NMR spectra were also reported at room temperature. Chemical shifts are reported 
in ppm from tetramethylsiliane resonance (CDCl3 77.2 ppm, DMSO-d6 39.5 ppm, 
CD3OD 49.1 ppm). Mass spectra were measured under ESI condition.  Proton decoupled  
19F NMR spectra were also recorded in ppm comparing the standard BF3•Et2O resonance 
(CD3COCD3, 0.00 ppm). Some compounds were purified using preparative HPLC 
(Beckman Coulter, X Terra Prep-MS-C18 Column, 5mm, 19 x 160 mm) eluting with 
solvents A (H2O with 0.1 % TFA) and B (CH3CN with 0.1 % TFA). 
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Determination of Quantum Yields and Extinction Coefficients.  
UV/Vis absorbance spectra were recorded on a Cary 100 Bio spectrophotometer.  
Steady-state fluorescence spectroscopic studies were performed on a Cary Eclipse 
fluorometer.  The slit width was 5 nm for both excitation and emission.  Fluorescence 
spectra were corrected for detector sensitivity.  The quantum efficiencies of fluorescence 
were obtained from the average of three measurements with the following equation: 
Fx = Fst (Ix/Ist) (Ast/Ax) (ηx2/ηst2)   
Where Fst is the reported quantum yield of the standard, I is the area under the emission 
spectra, A is the absorbance at the excitation wavelength and η is the refractive index of 
the used solvent, measured on a pocket refractometer from ATAGO.  X subscript 
denotes unknown, and st denotes standard.  Extinction coefficients (ε) where measured 
from Beer’s Law plots. 
General Procedure for the Preparation of Disulfonated BODIPYs 
A solution of chlorosulfonic acid (2 eq) in dry CH2Cl2 was added dropwise to a 
solution of BODIPY in dry CH2Cl2 over 10 min under N2 at -40 oC.  An orange 
precipitate was formed as the solution mixture warmed slowly to room temperature 
within 20 mins.  The disulfonic acid was isolated by vacuum filtration and treated with 
water.  The aqueous solution was neutralized with NaHCO3 (2 eq), concentrated to 5-10 
ml and treated with brine.  The desired product was reprecipitated afterwards to afford 
an orange solid (85-100% yield).  
 
 
  
218
34b
N
B
F2
N
I
SO3NaNaO3S
 
Disodium 2,6-disulfonate-1,3,5,7-tetramethyl-8-(4’-iodophenyl)-4,4-difluoro-
4-bora-3a, 4a-diaza-s-indacence (34b) 1,3,5,7-Tetramethyl-8-(4’-iodophenyl)-4,4-
difluoro-4-bora-3a, 4a-diaza-s-indacence{Chen, 2000 #11402} (53 mg, 0.118 mmol) and 
chlorosulfonic acid (16 μl, 0.236 mmol) were reacted according to the general procedure 
giving an orange powder (68 mg, 88%).  1H NMR (500 MHz, D2O) d7.84 (d, 2H, J = 8.0 
Hz), 6.97 (d, 2H, J = 8.0 Hz), 2.57 (s, 6H), 1.49 (s, 6H); 13C NMR (75 MHz, D2O) 
d155.5, 145.7, 144.0, 139.2, 133.1, 132.7, 130.6, 129.7, 95.7, 13.7, 13.0; MS (ESI) calcd 
for C19H17BF2IN2O6S2- (M-2Na+H)- 608.96 found 608.98. 
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Disodium 2,6-disulfonate-3,5-dichloro-8-(4’-bromophenyl)-4,4-difluoro-4-
bora-3a,4a-diaza-s-indacence (35b) Compound 41b (500 mg, 0.12 mmol) and 
chlorosulfonic acid (160 μl, 0.24 mmol) were reacted by the general procedure giving an 
orange powder (624 mg, 85%).  1H NMR (500 MHz, D2O) d7.73 (d, 2H, J = 8.4 Hz), 
7.45 (d, 2H, J = 8.4 Hz), 7.27 (s, 2H); 13C NMR (75 MHz, D2O) d147.6, 141.9, 133.7, 
132.6, 132.3, 131.8, 131.5, 130.0, 126.7; MS (ESI) calcd for C15H6BBrCl2F2N2O6S22- 
(M-2Na)2- 285.91 found  285.84; IR (thin film) 2968, 1572, 1382, 1206, 1033, 650 cm-1.  
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42b  
Disodium 2,6-disulfonate-1,3,5,7-tetramethyl-8-(4’-nitrophenyl)-4,4-
difluoro-4-bora-3a,4a-diaza-s-indacence  1,3,5,7-Tetramethyl-8-(4’-nitrophenyl)-4,4-
difluoro-4-bora-3a,4a-diaza-s-indacence{Li, 2004 #11780} (400 mg, 1.08 mmol) and 
chlorosulfonic acid (144 μl, 2.16 mmol) were reacted according to the general procedure 
giving an orange powder (630 mg, quant. yield).  1H NMR (300 MHz, D2O) d8.49 (d, 
2H, J = 8.5 Hz), 7.70 (d, 2H, J = 8.5 Hz), 2.77 (s, 6H), 1.63 (s, 6H); 13C NMR (75 MHz, 
D2O) d156.1, 148.8, 144.0, 143.6, 140.5, 132.9, 130.2, 129.6, 125.3, 13.8, 13.0; MS 
(ESI) calcd for C19H16BF2N3O8S22- (M-2Na)2- 263.52 found 263.45; IR (thin film) 1522, 
1347, 1190, 1004, 853, 669 cm-1. 
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43  
1,3,5,7-Tetramethyl-8-(4’-ethynylphenyl)-4,4-difluoro-4-bora-3a,4a-diaza-s-
indacence 2,6-disulfonic acid  A solution of chlorosulfonic acid (19 μl, 0.276 mmol) in 
CH2Cl2 (2 ml) was added dropwise to a solution of 1,3,5,7-tetramethyl-8-(4’-
ethynylphenyl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacence{Wan, 2003 #11399}2 (48 
mg, 0.138 mmol) in CH2Cl2 (5 ml) over 10 min at -40 oC.  An orange precipitate was 
formed as the solution mixture warmed slowly to room temperature.  The disulfonic acid 
was isolated by vacuum filtration giving the disulfonic acid as an orange powder (42 mg, 
60%).  1H NMR (300 MHz, D2O) d7.66 d, 2H, J = 8.8 Hz), 7.29 (d, 2H, J = 8.5 Hz), 
3.48 (s, 1H), 2.63 (s, 6H), 1.54 (s, 6H); MS (ESI) C21H18BF2N2O6S2- (M-H)- 507.07 
found 507.08. 
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Disodium 2,6-disulfonate-1,3,5,7-tetramethyl-8-(4’-aminophenyl)-4,4-
difluoro-4-bora-3a,4a-diaza-s-indacence   A solution of 42b (200 mg, 0.35 mmol) in 
EtOH (10 ml) was purged with N2 for 10 min. Hydrazine monohydrate (0.2 ml) and 10% 
Pd/C (37.1 mg, 0.1 eq) were added.  The mixture was refluxed under N2 for 30 min. 
Then Pd/C was removed under vacuum filtration.  After evaporation the solvent, the 
residue was dry-loaded onto a silica gel flash column, and eluted using 30% 
MeOH/CH2Cl2 to afford an orange solid (133 mg, 70%). Rf = 0.2 (30% MeOH/CH2Cl2). 
1H NMR (300 MHz, D2O) d7.02-6.94 (m, 4H), 2.70 (s, 6H), 1.70 (s, 6H); 13C NMR (75 
MHz, D2O) d154.7, 148.2, 144.1, 132.3, 131.2, 130.0, 123.9, 117.1, 117.0, 13.0 (2); MS 
(ESI) C19H19BF2N3Na2O6S2+ (M+H)+ 544.0572 found 544.0557; IR (thin film) 3346, 
2854, 1608, 1519,1197, 1032, 655 cm-1.    
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45  
A mixture of 41a (310 mg, 0.75 mmol), n-butane thiol (0.17 mL, 1.55 mmol), 
Et3N (0.22 mL, 1.58 mmol) was dissolved in try acetonitrile (15 mL), and then the 
solution was stirred at 85 oC for 4 h.  The solvent was removed under reduced pressure 
and the residue was purified by flash column eluting with 3:1 Hexane/ethyl acetate to 
afford the desired product (365 mg, 99 %) as a purple solid.  1H NMR (500 MHz, 
CDCl3), δ 7.61 (d, J = 8.8 Hz, 2H), 7.34 (d, J = 8.8 Hz, 2H), 6.68 (d, J = 4.5 Hz, 2H), 
6.39 (d, J = 4.5 Hz, 2H); 3.06 (t, J = 7.5 Hz, 4H), 1.80-1.74 (m, 4H), 1.55-1.47 (m, 4H), 
0.95 (t, 6H). 13C NMR (125 MHz, CDCl3), δ 157.3, 146.8, 135.4, 132.9, 131.8, 131.6, 
128.8, 124.2, 116.5, 32.5, 31.0, 21.9, 13.6. MS (MALDI) calcd for C23H26BBrFN2S2+ 
(M-F), 503.08, found, 503.08.  TLC (1:1 EtOAc-Hexane), Rf = 0.80.  
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48  
A mixture of 41b (257 mg, 0.67 mmol), n-butylthiol (0.17 mL, 1.55 mmol), Et3N 
(0.28 mL, 2.02 mmol) was dissolved in dry acetonitrile (15 mL), and then the solution 
was stirred at 85 oC for 4 h.  The solvent was removed under reduced pressure and the 
residue was purified by flash silica gel column eluting with 3:1 hexane/ethyl acetate to 
afford the desired product (326 mg, 99 %) as a purple solid.  1H NMR (300 MHz, 
CDCl3) δ 8.34 (d, J = 8.7 Hz, 2H), 7.65 (d, J = 8.7 Hz, 2H), 6.62 (d, J = 4.4 Hz, 2H), 
6.41 (d, J = 4.4 Hz, 2H); 3.08 (t, J = 7.4 Hz, 4H), 1.82-1.72 (m, 4H), 1.57-1.45 (m, 4H), 
0.95 (t, J = 7.4 Hz, 6H). 13C NMR (125 MHz, CDCl3), δ 158.3, 148.5, 140.5, 135.1, 
133.3, 131.2, 128.5, 123.5, 116.8, 32.5, 30.8, 21.9, 13.6.  MS (ESI) calcd for 
C23H26BF2N3O2S2- (M-), 489.15, found 489.28.  
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2 eq Bu3SnSnBu3
5 mol% Pd(PPh3)4
toluene, reflux, 5 h
O OMe
SnBu3
49  
Methyl 4-iodobenzoate (300 mg, 1.15 mmol), bistributyltin (1.15 mL, 2.29 
mmol) and Pd(PPh3)4 (70 mg, 0.06 mmol) was degassed by vaccum/nitrogen cycles 
(three times), then  degassed toluene (12mL) was added into the flask. The reaction 
mixture was heated to 120 oC for 5 h.  The solvent was removed under reduced pressure 
and the product was purified by silica gel chromatography eluting with 50:1 
hexane/EtOAc to afford the product as colorless oil (330 mg, 70 %). 1H NMR (500 
MHz, CDCl3), δ 7.96 (d, J = 8.0 Hz, 2H), 7.56 (d, J = 8.0 Hz, 2H), 1.57 - 1.51 (m, 6H), 
1.37 - 1.30 (m, 6H), 1.10 - 1.07 (t, J = 9.0 Hz, 6H), 0.88 (t, J = 7.0 Hz, 9H). 13C NMR 
(75 MHz, CDCl3), δ 167.5, 149.6, 136.4, 129.5, 128.3, 52.0, 29.0, 27.3, 13.6, 9.6.  
HRMS (ESI) calcd for C20H34BO2SnLi+ (M+Li)+, 433.16, found, 433.09.  TLC (1:4 
EtOAc/Hexane), Rf = 0.80.  
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General Procedure for the Liebeskind-Srogl Coupling 
The BODIPY substrate (1 eq), organotin reagent (3-6 eq) or organoboron 
compound (4 eq), CuMeSal (4 eq) and Pd(PPh3)4 (5 mol %) were added to a round 
bottom flask. After 3 vacuum/nitrogen cycles, degassed THF was added into the flask.  
The mixture was stirred for 16 h at 55 oC under nitrogen and the reaction was monitored 
by TLC.  After completion, the solvent was removed under reduced pressure and ethyl 
acetate was added.  The mixture was filtered, and the filtrate was concentrated in vacuo.  
The residue was purified by silica gel flash column eluting with a mixture of hexane and 
ethyl acetate. 
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46b  
Purple solid (26 %).   1H NMR (300 MHz, CDCl3), δ 8.11 (d, J = 8.6 Hz, 2H), 
7.96 (d, J = 8.6 Hz, 2H), 7.66 (d, J = 8.1 Hz, 2H), 7.40 (d, J = 8.1 Hz, 2H), 6.87 (d, J = 
4.7 Hz, 1H), 6.71 (d, J = 4.2 Hz, 1H), 6.61(d, J = 4.2 Hz, 1H), 6.51 (d, J = 4.7 Hz, 1H), 
3.94 (s, 3H), 3.09 (t, J = 7.2 Hz, 2H), 1.82-1.72 (m, 2H), 1.56-1.44 (m, 2H), 0.95 (t, J = 
7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3), d 166.9, 162.5, 154.0, 138.4, 137.2, 136.1, 
135.8 132.9, 131.9, 131.7, 131.4, 130.0, 129.5, 129.2, (t, J = 15.5 Hz), 127.9, 124.6, 
119.3, 118.2, 52.2, 32.4, 30.9, 21.9, 13.5.  MS (ESI) calcd for C27H25BBrF2N2O2S 
(M+H)+ 568.08, found, 569.09, 571.08.  19F NMR (282 MHz, CDCl3), 32.1 (q, J = 33.6 
Hz).  TLC (1:1 EtoAc/Hexane) Rf = 0.50. 
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Red solid (85 % )  1H NMR (500 MHz, CDCl3), δ 7.87 (dd, J = 7.5 Hz, 2.3Hz, 4 
H), 7.69 (d, J = 9.0 Hz, 2H), 7.47 (d, J = 9.0 Hz, 2H), 7.44-7.41 (m, 6H), 6.86 (d, J = 4.3 
Hz, 2H), 6.64 (d, J = 4.3 Hz, 2H),  13C NMR (125 MHz, CDCl3), δ 159.3, 142.3, 136.2, 
133.2, 132.4, 132.0, 131.6, 130.6, 129.6, 129.4 (t, J = 17.0 Hz), 128.2, 124.7, 121.2. 19F 
NMR (282 MHz, CDCl3), 40.5 (q, J = 50.2 Hz), MS (ESI) calcd for C27H18BBrF2N2Li+ 
(M+Li)+, 505.07, found, 505.08, 507.08.  TLC (1:2 EtOAc/Hexane), Rf = 0.80. 
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47b  
Red-purple solid (62%).  1H NMR (500 MHz, CDCl3), δ 8.09 (d, J = 9.0 Hz, 
4H), 7.92 (d, J = 9.0 Hz, 4H), 7.71 (d, J = 8.5 Hz, 2H), 7.47 (d, J = 8.5 Hz, 2H), 6.92 (d, 
J = 4.5 Hz, 2H), 6.70 (d, J = 4.5 Hz, 2H), 3.93 (s, 6H), 13C NMR (125 MHz, CDCl3), 
δ 166.6, 158.1, 143.8, 136.5, 132.8, 132.0, 131.8, 131.1, 130.8, 129.5, 129.4 (t,  J = 15.0 
Hz), 125.1, 121.4, 52.2.    MS (MALDI) calcd for C31H22BBrF2N2O4Na (M + Na)+, 
637.08 found 637.24, 639.24.  TLC (1:3 EtOAc/Hexane), Rf = 0.35. 
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47c  
Purple solid (72 %)  1H NMR (300 MHz, CDCl3), δ 7.88 (d, J = 9.0 Hz, 4 H), 
7.67 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 9.0 Hz, 4 H), 6.81 (d, J = 
4.5 Hz, 2H), 6.62 (d, J = 4.5 Hz, 2H), 3.85 (s, 6H), 13C NMR (125 MHz, CDCl3), δ 
160.8, 158.6, 140.6, 135.9, 133.4, 132.0, 131.5, 131.1 (t, J = 18.0 Hz), 130.1, 125.0, 
124.4, 120.7, 113.8, 55.3.  19F NMR (282 MHz, CDCl3), 20.1 (q, J = 32.5 Hz), MS (ESI) 
calcd for C29H23BBrF2N2O2+ (M+H)+, 559.09, found, 559.15, 561.15.  TLC (1:3 
EtOAc/Hexane), Rf = 0.25. 
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Purple solid (17 %).  1H NMR (500 MHz, CDCl3), δ 8.38 (d, J = 8.5 Hz, 2H), 
8.11 (d, J = 8.5 Hz, 2H), 7.96 (d, J = 8.3 Hz, 2H), 7.71 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 
4.5 Hz, 1H), 6.64 (d, J = 4.5 Hz, 1H), 6.62 (d, J = 4.0 Hz, 1H), 6.55 (d, J = 4.5 Hz, 1H), 
3.94 (s, 3H), 3.11 (t, J = 7.0 Hz, 2H), 1.80-1.74 (m, 2H), 1.54-1.47 (m, 2H), 0.95 (t, J = 
7.5 Hz, 3H). 13C NMR (125 MHz, CDCl3), δ 166.8, 163.9, 154.6, 148.7, 140.4, 136.9, 
136.3, 136.1, 135.4, 131.3, 131.0, 130.2, 129.5, 129.2 (t, J = 16.0 Hz), 127.6, 123.6, 
119.7, 118.7, 52.2, 32.5, 30.9, 21.9, 13.5.  MS (ESI) calcd for C27H24BF2N3O4SLi+ 
(M+Li)+, 542.15, found, 542.15.  TLC (1:3 EtOAc/Hexane), Rf = 0.45.  
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50b  
Purple solid (68%).  1H NMR (500 MHz, CDCl3), δ 8.44 (d, J = 8.5 Hz, 2H), 
8.11 (d, J = 8.5 Hz, 4H), 7.94 (d, J = 8.5 Hz, 4H), 7.80 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 
4.3 Hz, 2H), 6.73 (d, J = 4.3 Hz, 2H), 3.94 (s, 6H).  13C NMR (125 MHz, CDCl3), δ 
166.5, 158.9, 148.9, 140.7, 140.2, 136.2, 136.1, 131.4, 131.0, 130.8, 129.5, 129.4 (t, J = 
15 Hz), 123.6, 121.9, 52.3.  19F NMR (282 MHz, CDCl3), 40.9 (q, J = 33.6 Hz).  MS 
(ESI) calcd for C31H22BF2N3O6Li+ (M+Li)+, 588.16, found, 588.18. 
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Dimethyl ester 50b  (32 mg, 0.06 mmol) was dissolved in 3 mL THF at room 
temperature.  Then potassium trimethylsilanolate (30 mg, 0.23 mmol) was added to the 
reaction mixture.  The reaction was complete in 6 h as indicated by TLC.  Aqueous HCl 
(0.1 M, 10 mL) was added and the product was extracted out of water with 1:2 isopropyl 
alcohol/CH2Cl2 (10 mL x 2).  The organic solvent was dried over MgSO4 and then 
removed under reduced pressure to afford the desired product as a red solid (29 mg, 95 
%).  1H NMR (300 MHz, CD3OD), δ 8.42 (d, J = 8.9 Hz, 2H), 7.98 (d, J = 8.4 Hz, 4H), 
7.85 (d, J = 8.4 Hz, 4H), 7.81 (d, J = 8.9 Hz, 2H), 6.84 (d, J = 4.5 Hz, 2H), 6.71 (d, J = 
4.5 Hz, 2H).   19F NMR (282 MHz, CD3OD), 43.8 (q, J = 30.6 Hz). HRMS (ESI) calcd 
for C29H17N3O6- (M-H)- 552.1178, found 552.1174.  This compound is not very soluble 
in organic solvent, so 13C could not be obtained. 1:2 Hexane/EtOAc, Rf = 0.75. 
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The crude product obtained above 51, Pd/C (5 mg, 0.005 mmol) and hydrazine 
monohydrate (0.05 mL) were suspended in ethanol (2 mL).  The reaction mixture was 
heated to 82 oC for 25 min. The reaction solution was passed through celite, and the 
solvent was removed under reduced pressure to afford desired product as a dark red solid 
26 mg (95 %).  1H NMR (300 MHz, CD3OD 1:2), δ 7.98 (d, J = 8.9 Hz, 4H), 7.85 (d, J = 
8.9 Hz, 4H), 7.43 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 4.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 
6.75 (d, J = 4.4 Hz, 2H).  13C NMR (125 MHz, CDCl3), δ 180.2, 158.1, 153.2, 137.5, 
136.0, 134.2, 133.0, 131.8, 130.0, 129.9, 129.7, 123.9, 121.5, 115.1. 19F NMR (282 
MHz, CDCl3), 43.8 (q, J = 30.5 Hz).   HRMS (ESI) calcd for C29H19N3O4- (M - H)- 
522.1437, found 522.1434. 
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53  
A solution of 52 (18 mg, 0.034 mmol) in HCl (0.1 M, 2.5 mL) and HTF (2.5 mL) 
was cooled to 0 oC.  A solution of NaNO2 (5 mg, 0.072 mmol) in H2O (0.25 ml) was 
added slowly and the mixture was kept at 0 oC with stirring for 30 min.  A solution of 
NaN3 (21 mg, 0.34 mmol) in H2O (0.35 mL) was then added dropwise to the mixture.  
Stirring was continued at room temperature for 16 h after completion of the addition. 
The reaction mixture was acidified with HCl (0.1 M) carefully, then the product was 
extracted out of the water using 1:2 iPrOH/CH2Cl2. The product was achieved after 
removing the solvent under reduced pressure as a red solid (14 mg, 75 %).  1H NMR 
(500 MHz, 2:1 CD3OD/CDCl3), δ 8.06 (d, J = 8.5 Hz, 4H), 7.91 (d, J = 8.5 Hz, 4H), 
7.65 (d, J = 8.5 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H), 6.99 (d, J = 4.0 Hz, 2H), 6.74 (d, J = 
4.0 Hz, 2H), 19F NMR (282 MHz, 2:1 CD3OD/CDCl3), δ 44.6 (q, J = 33.6 Hz).  HRMS 
(ESI) calcd for C29H17BF2 N5O4- (M - H)-, 548.1342, found 548.1339.  
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54  
A solution of chlorosulfonic acid (23 μL, 0.35 mmol) in 2.0 mL of dry CH2Cl2 
was added dropwise to a solution of BODIPY Q (50 mg, 0.14 mmol) in dry CH2Cl2 over 
10 min under N2 at -40 oC.  The solution was slowly warmed to room temperature and 
an orange precipitate was formed.  The disulfonic acid was neutralized with 
triethylamine (48 μL, 0.35 mmol) and the solvent was removed under reduced pressure.  
The resulting salt was purified by reverse phase preparative-HPLC (gradient: 5% solvent 
B to 95% solvent B, 25 min) to afford the desired product as an orange solid (45 mg, 60 
%).  1H NMR (500 MHz, CD3OD), δ 7.69 (d, J = 8.5 Hz, 2H), 7.38 (d, J = 8.5 Hz, 2H), 
3.68 (s, 1H), 3.19 (q, J = 7.5 Hz, 12H), 2.78 (s, 6H), 1.69 (s, 6H), 1.29 (t, J = 7.5 Hz, 
18H), 13C NMR (125 MHz, CDCl3), δ 156.9, 145.7, 143.2, 136.3, 136.1, 134.2, 131.5, 
129.7, 125.3, 83.5, 80.6, 47.8, 14.5, 13.6, 9.2.  MS (ESI) calcd for C21H17BBrF2O6S22- 
(M - 2Et3NH)2-, 253.02, found 253.02.  
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55  
Copper (1 mg, 0.02 mmol) and CuSO4•5H2O (2 mL, 1 M, 0.002 mmol) were 
added to a solution of 53 (11 mg, 0.019 mmol) and 54 (12 mg, 0.07 mmol) in 1:1 
THF/H2O (2 ml).  The reaction mixture was stirred at room temperature for 48 h, and 
then was evaporated to dryness.  The residue was purified by reverse phase prep-HPLC 
(gradient: 10% solvent B to 90% solvent B, 25 min) to afford a red solid with retention 
time at 17 min (6 mg, 30%).  1H NMR (500 MHz, CD3OD), δ 9.28 (s, 1H), 8.28-8.27 
(m, 4H), 8.12 (d, J = 8.5 Hz, 4H), 8.03 (d, J = 8.5 Hz, 4H), 7.96 (d, J = 8.0 Hz, 2H), 7.56 
(d, J = 6.5 Hz, 2H), 7.16 (d, J = 4.0 Hz, 2H), 6.93 (d, J = 4.5 Hz, 2H), 2.83 (s, 6H), 1.81 
(s, 6H).  MS (ESI) calcd for C50H33B2F4N7O10S2 (M-2Na-2H)4-, 263.25, found 263.28.  
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APPENDIX C 
EXPERIMENTAL DATA FOR CHAPTER IV 
 
General Experimental Procedures 
NMR spectra were recorded on a VXP-300 MHz and Inova-500 MHz 
spectrometers (1H at 300 MHz or 500 MHz, and 13C at 75 or 125 MHz) at room 
temperature unless other mentioned.  Chemical shifts of 1H NMR spectra were recorded 
and chemical shifts are reported in ppm from the solvent resonance (CDCl3 7.26 ppm, 
CD3OD 3.30 ppm, CD3SOCD3 2.49 ppm).  Data are reported as follows: chemical shift, 
multiplicity (s = singlet, bs = broad singlet d = doublet, t = triplet, q = quartet, br = 
broad, m = multiplet), coupling constants, and number of protons.  Proton decoupled 13C 
NMR spectra were also recorded in ppm from tetramethylsilane resonance (CDCl3 77.0, 
CD3OD 49.1, DMSO-d6 39.5 ppm). Analytical thin layer chromatography (TLC) was 
performed on EM Reagents 0.25 mm silica-gel 60-F plates, and visualized with UV 
light.  Flash chromatography was performed using silica gel (230–600 mesh).  
UV/Visible and fluorescence (1.0 x10-6 M) spectra of compound 56 were taken in 
aqueous Ph = 10 buffer solution (Na2CO3, NaHCO3).  Absorption and fluorescence 
spectra of compound 57 were taken in dry DMF.  HPLC analysis of samples was 
preceded by subjecting the sample to reverse phase analytical HPLC [C18, 5:95 
(CH3CN/H2O)] unless other mentioned.  MS were measured (Thermofinnigan LC-Q 
Deca spectrometer) under ESI, MALDI or APCI conditions.  IR spectra were recorded 
on Bruker (Tensor 27). The total chemiluminescence intensity was calculated by 
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integrating the decay curve between the point of adding sample and the point where 
signal decays to the background level.  The background signal has been subtracted from 
the total chemiluminescence intensity during the calculation.  THF was distilled over 
Na/benzophenone. DMF and Et3N were distilled from CaH2.  Other solvents and 
reagents were used as received.  
 
Methods for Measuring the Chemiluminescence Spectra and Quantum Yields 
Instrument  
A confocal microscope was used with a sample cell volume of ~ 200 μl made by 
gluing a plastic cylinder on a clean microscope cover glass; this was used to hold 
samples and serves as the reaction chamber.  The sample cell was mounted on an 
inverted, epi-illumination microscope (Nikon, Diaphot 300).  A Nikon FLUOR X40, 1.3 
numerical aperture objective was used to collect the chemiluminescence.  The 670DCSP 
or 830DCSP dichroic filters (Chroma Technology) were used in the experiments 
depending on the emission wavelength.  A single-photon counting avalanche diode 
(APD) was used to collect time dependent chemiluminescent signal.  The 
chemiluminescence spectra of samples were obtained by means of a monochromator 
(Acton Research) equipped with a back-illumination liquid-nitrogen-cooled CCD 
camera (Princeton Instruments, Trenton, NJ).  This CCD array detector allows detection 
of  spectrally resolved signals simultaneously, which is useful for obtaining a dynamical 
spectrum, such as chemiluminescence which decays as function of time and its spectrum 
is not accessible by conventional scanning methods. 
  
270
Materials   
The sample solutions of luminol and luminol-fluorescein cassette (LFC) 56 at 
different concentrations were prepared by dissolving a luminol and LFC in pH=10 buffer 
solution (Na2CO3 and NaHCO3).  A second solution containing 1.5x 10-3 M CuSO4 and 
2x 10-3 M H2O2 was also prepared and used to react with sample solutions to generate 
light.  The sample solution of luminol-Nile Red cassette 57 (1.0 x 10-4 M) was prepared 
in dry DMF.  A second solution of 0.01M potassium tert-butoxide in dry THF was used 
to react with the sample solution of 57.  
Experiment 
Either 30 μl or 15 μl of the second solution containing 1.5x 10-3 M CuSO4 and 2x 
10-3 M H2O2 was first added into sample cell and the spectra collected by CCD or the 
total emission signal by APD, both as function of time.  When the computer started 
collecting data, a 100 μl of sample solution was added to the sample cell, which 
immediately reacts with H2O2 and emits lights. The intensity of light decays as the 
concentration of reactants decreases.  Data collection was stopped when the intensity of 
signal decayed to the background level.  
Spectrum of 2 was taken in dry DMF when adding 10 μl (0.01 M) potassium tert-
butoxide solution in dry THF to a sample cell containing 150 μl sample 2 (1 x 10-4M).  
Estimation of Quantum Yield of LFC 
In principle, the quantum yield of LFC was estimated by preparing two sample 
solutions containing equal amounts of luminol and LFC, and measuring the total 
chemiluminescence intensity under the same experimental conditions.  The quantum 
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yields of LFC at different concentrations have been calculated by simply dividing the 
total intensity of luminal chemiluminescence by that of the sample chemiluminescence, 
assuming the quantum yield of luminol is 100%. 
 
Calculation of the Overlap Integral J(λ), the Föster Distance R0, and the Energy 
Transfer Efficiency E.  
The degree of spectral overlap between donor emission and acceptor absorption 
expressed by the overlap integral J(λ).  It can be calculated according to the equation 
derived from classical and quantum mechanic considerations:  
                             ∫ FD(λ)εA(λ)λ4dλ 
J(λ) = ∫ FD(λ)εA(λ)λ4dλ =  ____________________            (1) 
                         ∫ FD(λ)dλ 
The overlap integral J(λ) is in units of M-1cm-1(nm)4. FD(λ) is the corrected normalized 
fluorescence intensity of the donor.  εA(λ) is the extinction coefficient of the acceptor at 
λ.  The Föster Distance R0 in angstroms, is expressed by 
      R0 =0.211[κ2n-4QDJ(λ)]1/6                           (2) 
κ2 is the orientation factor, which describes the orientation of the transition dipoles of the 
donor and acceptor.  n is the refractive index of the medium, which is 1.40 in aqueous 
solution and 1.43 in DMF. QD is the fluorescence quantum yield of the emitter generated 
from donor through chemiluminescent reactions in the absence of acceptor.  
The efficiency of the energy transfer (E) is the fraction of photons generated by 
the donor that are transferred to the acceptor.  If the energy transfer rate is much faster 
than the decay rate of the donor, then much transfer will occur and FRET will be 
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efficient. If the transfer rate is slower that the decay rate, then energy transfer will be 
inefficient.  The energy transfer efficiency E is given by: 
                                                             R06 
E =    _____________                          (3) 
                                                           R06 + r6 
r is the distance between donor and acceptor. 
 
Table S2. Calculated R0 values for FRET and Energy Transfer efficiency E. R0 was calculated using n 
= 1.4 (H2O), 1.43 (DMF), QD = 2.0 x 10-4 (data from reference 6 in the text) and κ2 = 1/4  
Compounds JDA (M-1cm3(nm)4) R0 (Å) r (Å) E (%) 
56 1.15 x1015 10.47 11.3 39 
57 6.95 x 1014 9.50 10.0 42 
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58  
6-Bromo-2, 3-dihydrophathalazine-1, 4-dione  5-Bromophthalic anhydride 
(11.8 g, 52 mmol) and 40 ml acetic acid were added into a 250 mL round bottom flask.  
The mixture was heated to 125 oC.  After 1h, the mixture was cooled to 25 oC.  
Hydrazine monohydrate (2.65 mL, 54.6 mmol) was added dropwise into the flask, and 
then the mixture was refluxed at 125 oC for 30 min.  The mixture was cooled to room 
temperature again and white solid precipitated out from the solvent.  The white solid was 
separated by filtration. The crude product was dissolved in 5% NaOH (30 mL), acidified 
with AcOH (3 mL), and white solid precipitated out.  The solid was washed with a large 
amount of water and then MeOH to afford 11.9 g 58 (95 %) as colorless powder.  1H 
NMR (300 MHz, DMSO), δ11.72 (s, 2H), 8.16 (d, J = 1.8 Hz, 1H), 8.05 (dd, J = 8.4 Hz, 
1.8 Hz, 1H), 7.98 (d, J = 8.4 Hz, 1H); 13C NMR (125 MHz, DMSO), δ153.9 (bs), 135.6, 
128.7, 127.7, 127.5, 126.4, 126.1. HRMS (ESI) calcd for C8H4BrN2O2Na (M-H)- 
238.9462, found 238.8779, 240.8754.  mp 358-361 oC. 
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1H NMR (DMSO-d6) 
 
 
13C NMR (DMSO-d6)
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59a  
6-Bromo-2, 3-bis(4-methoxybenzyl)-2, 3-dihydrophathazine-1, 4-dione   A 
mixture of 6-bromo-2, 3-dihydrophathalazine-1, 4-dione 3 (526 mg, 2.18 mmol) and dry 
DMF (15 mL) in a 100 mL flask were cooled to 0 oC, then NaH (183 mg, 4.58 mmol) 
was added.  The mixture was stirred for 30 min, and then PMBCl (0.63 mL, 4.58 mmol) 
was added into the flask dropwise.  The reaction mixture was warmed up to 25 °C 
slowly and stirred for 14 h.  Water (100 mL) was added to the reaction mixture, and the 
product was extracted from water with ethyl acetate (50 mL x 3).  The combined 
organics were concentrated under reduced pressure, and the resulting crude product was 
purified by flash chromatography eluting with hexane and ethyl acetate (10:1) to give 
430 mg (41%) 59a as a colorless solid. FTIR (neat) 2832, 1726, 1650 cm-1 .  1H NMR 
(300 MHz, CDCl3), δ 8.54 (bs, 1H), 7.81 (m, 2H), 7.41 (d, J = 8.7 Hz, 2H), 7.36 (d, J = 
8.7 Hz, 2H), 6.90 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 5.22(s, 2H), 5.22 (s, 2H), 
3.83 (s, 3H), 3.79 (s, 3H).  13C NMR (125 MHz, CDCl3), δ 159.6, 159.2, 157.1, 149.22, 
135.9, 130.5, 130.3, 130.1, 130.1, 129.1, 128.2, 126.7, 125.3, 123.4, 113.9, 113.8, 68.5, 
55.3, 55.2, 53.6. HRMS (ESI) calcd for C24H22BrN2O4+ (M+H)+, 481.0763, found, 
481.0757, 483.0741.  TLC (50 % EtOAc-Hexane) Rf = 0.78.  
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3) 
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59b  
6-Bromo-1, 4-bis (4-methoxybenzyloxy) phathalazine   The same procedure 
above for preparing 59a also afforded 59b  (471 mg, 45%) at the same time.  FTIR 
(neat) 2832, 1650, 1609 cm-1.  1H NMR (300 MHz, CDCl3), δ 8.24 (d, J = 8.2 Hz, 1H), 
8.08 (d, J = 2.0 Hz, 1H), 7.81 (dd, J = 8.2 Hz, 2.0 Hz, 1H), 7.41 (d, J = 8.4 Hz, 2H), 7.37 
(d, J = 8.5 Hz, 2H), 6.91 (d, J = 8.2 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 5.26 (s, 2H), 
5.21(s, 2H), 3.81 (s, 3H), 3.60 (s, 3H).  13C NMR (125 MHz, CDCl3), δ 159.5, 159.0, 
157.7, 148.1, 134.9, 130.1, 130.0, 129.0, 128.9, 128.0, 127.8, 127.7, 126.1, 125.9, 113.8, 
113.7, 68.5, 55.1, 55.1, 53.4. TLC (50 % EtOAc-Hexane) Rf = 0.52. 
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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60  
5-((2,3-Bis(4-methoxybenzyl)-1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-
yl)ethynyl)-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthene]-3’,6’-diyl diacetate  
Compound 59a (103 mg, 0.215 mmol), 5-ethynyl-3-oxo-3H-spiro[isobenzofuran-1,9’-
xanthene]-3’,6’-diyl diacetate C (104 mg, 0.236 mmol), PdCl2(PPh3)2 (8 mg, 0.02 
mmol), CuI (4 mg, 0.04 mmol), Et3N (0.3 mL, 2.15 mmol), and THF 2.0 mL were added 
to a sealed microwave tube.  This tube was subjected to microwave irradiation at 120oC 
for 20 min.  The solvent was removed under reduced pressure.  The crude product was 
purified by flash chromatography over silica gel eluting with hexane/ethyl acetate (2:1) 
to give 60 (104 mg, 58 %) as a colorless solid.  1H NMR (300 MHz, CDCl3), δ 8.57 (d, J 
= 0.9 Hz, 1H), 8.18 (m, 1H), 7.96 (d, J = 8.4 Hz, 1H), 7.86 (dd, J = 5.4 Hz, 1.8 Hz, 1H), 
7.83 (dd, J = 5.1 Hz, 1.5 Hz, 1H), 7.42 (d, J = 8.7 Hz, 2H)), 7.36 (d, J = 8.7 Hz, 2H), 
7.20 (dd, J = 8.1 Hz, 0.3 Hz, 1H), 7.11 (m, 2H), 6.84-6.92 (m, 8H), 5.29 (s, 2H), 5.25 (s, 
2H), 3.83 (s, 3H), 3.79 (s, 3H), 2.32 (s, 6H). 13C NMR (75 MHz, CDCl3), δ 168.8, 168.1, 
159.6, 159.1, 157.6, 152.5, 152.1, 151.5, 149.2, 138.4, 135.2, 130.6, 130.3, 130.1, 129.3, 
129.2, 128.9, 128.3, 126.6, 126.0, 125.0, 124.3, 124.2, 123.8, 117.9, 115.9, 113.9, 113.8, 
110.5, 90.3 (2C), 68.5, 55.3, 55.2, 53.5, 21.1. HRMS (MALDI) calcd for C50H36N2O11+ 
(M+H)+, 841.2397, found, 841.2381.  TLC (50 % EtOAc-Hexane) Rf = 0.60.  
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1H NMR (CDCl3) 
 
 
13C NMR (CDCl3) 
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56  
5-((1,4-Dioxo-1,2,3,4-tetrahydrophthalazin-6-yl)ethynyl)-2-(6-hydroxy-3-
oxo-3H-xanthen-9-yl)benzoic acid  5-((2,3-Bis(4-methoxybenzyl)-1,4-dioxo-1,2,3,4-
tetrahydrophthalazin-6-yl)ethynyl)-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthene]-3’,6’-
diyl diacetate 60 (45 mg, 0.055 mmol) and TFA 5 mL were added to a 25 mL flask.  The 
mixture was heated to 70 oC for 1h.  The solvent was removed under reduced pressure.  
The crude product was dissolved in 1 mL NaOH (1M), acidified with one drop of 
concentrated HCl, then a yellow solid precipitated out.  The crude product was separated 
by filtration, washed with 5 mL water and 10 mL ethyl acetate to afforded 24 mg (88%) 
desired product. IR (neat) 3428, 1638 cm-1.  1H NMR (500 MHz, DMSO), δ 8.26 (s, 
1H), 8.23 (s, 1H), 8.11 (d, J = 8.0 Hz, 1H), 8.00 (d, J = 7.5 Hz, 1H), 7.92 (d, J = 8.5 Hz, 
1H), 7.31 (d, J = 8.0 Hz, 1H), 6.65 (d, J = 9.0 Hz, 2H), 6.58 (s, 2H), 6.50 (d, J = 8.0 Hz, 
2H), HRMS (ESI) calcd for C30H15N2O7- (M-H)-, 515.0885, found, 515.0873.  Reverse 
phase analytical HPLC: R. T. = 5.533 min (UV detector), 5.483 min (fluorescence 
detector).   
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1H NMR (CDCl3) 
 
HPLC (UV detector) 
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61  
9-(Diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-yl 
trifluoromethanesulfonate.  A mixture of compound Q (230 mg, 0.689 mmol), N-
phenyltrifluoromethane sulfonamide (615 mg, 1.72 mmol) and Et3N (0.24 mL, 1.72 
mmol) was stirred at 20 oC in dry THF for 1 d.  The reaction solvent was removed under 
reduced pressure to afford dark red solid.  The crude product was purified by flash 
column eluting with 3% MeOH: CH2Cl2 to give the desired product as a dark red solid 
240 mg (75%).  FTIR (neat) 3077, 2985, 1642, 1622, 1589 cm-1.   1H NMR (300 MHz, 
CDCl3), δ 8.54 (d, J = 2.7 Hz, 1H), 8.41 (d, J= 8.4 Hz, 1H), 7.66 (d, J = 9.3 Hz, 1H), 
7.50 (dd, J = 8.7, 2.4 Hz, 1H), 6.72 (dd, J =9.0, 2.7 Hz, 1H), 6.50 (d, J = 2.7 Hz, 1H), 
6.41 (s, 1H), 3.50 (q, 4.5 Hz, 4H), 1.29 (t, J = 4.5 Hz, 6H), 13C NMR (75 MHz, CDCl3), 
δ 181.9, 152.6, 151.5, 151.5, 147.2, 137.8, 134.3, 131.7, 131.1, 128.7, 125.2, 122.2, 
116.6, 110.3, 109.8, 105.5, 96.2, 45.2, 12.6.  19F NMR (300 MHz, CDCl3), δ -73.1.   
HRMS (ESI) calcd for C21H18F3N2O5S (M+H)+ 467.0889, found, 467.0873.  TLC (50 % 
EtoAc-Hexane) Rf = 0.50. 
  
287
 
1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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19F NMR (CDCl3)
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9-(Diethylamino)-2-((trimethylsilyl)ethynyl)-5H-benzo[a]phenoxazin-5-one.  
A mixture of compound 61 (190 mg, 0.408 mmol), trimethylsilylacetylene (0.58 mL, 
4.08 mmol), Et3N (0.57 mL, 4.08 mmol), Pd(PPh3)4 (47 mg, 0.041 mmol), CuI (16 mg, 
0.082 mmol) were dissolved in 4.0 mL dry DMF.  After degassed three times via the 
freeze-thaw method, the mixture was heated up to 80oC for 4 h.  The reaction solvent 
was removed under reduced pressure and the crude product is purified by flash column 
eluting with 50% hexane : ethyl acetate to give the desired product as a dark red solid 
145 mg (80%).  1H NMR (300 MHz, CDCl3), δ 8.70 (d, J = 1.5 Hz, 1H), 8.21 (d, J = 8.1 
Hz, 1H), 7.67 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 6.57 (d, J = 9.3 Hz, 1H), 6.63 (dd, J = 9.3 
Hz, 3.0 Hz, 1H), 6.41 (d, J = 2.7 Hz, 1H), 6.35 (s, 1H), 3.43 (q, J = 7.2 Hz, 4H), 1.25 (t, 
J = 7.2 Hz, 6H), 0.30 (s, 9H), 13C NMR (75 MHz, CDCl3), δ 182.9, 152.2, 150.9, 146.8, 
138.9, 132.7, 131.9, 131.2, 130.9, 127.3, 126.1, 125.6, 125.0, 109.9, 105.8, 104.5, 97.1, 
96.2, 45.1, 12.6, -0.1.  HRMS (ESI) calcd for C25H27N2O2Si (M+H)+, 415.1842, found 
415.1795.  TLC (50 % EtOAc-Hexane) Rf = 0.73. 
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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9-(diethylamino)-2ethynyl-5H-benzo[a]phenoxazin-5-one.  Compound 62 
(130 mg, 0.313 mmol) was dissolved in 6mL dichloromethane at room temperature. 
TBAF (0.63 mL, 0.1M) in THF was added dropwise to the reaction mixture.  The 
reaction was complete in 5 min.  The solvent was removed under reduced pressure and 
the crude product was purified by flash column eluting with 50% hexane : ethyl acetate 
to provide dark red solid 102 mg (95%). FTIR (neat) 3095, 2974, 1622, 1597, 1580 cm-1.  
1H NMR (500 MHz, CDCl3), δ 8.75 (d, J = 1.5 Hz, 1H), 8.24(d, J = 8.1 Hz, 1H), 7.70 
(dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.57 (d, J = 9.3 Hz, 1H), 6.65 (dd, J = 9.3 Hz, 3.0 Hz, 1H), 
6.43 (d, J = 3.0 Hz, 1H), 6.36 (s, 1H), 3.45 (q, J = 7.2 Hz, 4H), 3.26 (s, 1H), 1.26 (t, J = 
7.2 Hz, 6H).  13C NMR (125 MHz, CDCl3), δ 182.9, 152.3, 151.0, 146.8, 138.8, 132.8, 
132.0, 131.3, 131.3, 127.7, 125.8, 125.1, 125.0, 109.9, 105.8, 96.2, 83.2, 79.5, 45.1, 
12.6.  HRMS (ESI) calcd for C22H19N2O2 (M+H)+ 343.1447, found 343.1441.  mp 203-
206 oC.  TLC (33 % EtOAc-Hexane) Rf = 0.32. 
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1H NMR (CDCl3) 
 
13C NMR (CDCl3) 
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6-((9-(Diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-ethynyl)-2,3-bis(4-
methoxybenzyl)-2,3-dihydrophthalazine-1,4,-dione.  A mixture of compound 63 (55 
mg, 0.161 mmol), 59a, (70 mg, 0.146mmol), Et3N (0.22 mL, 1.61 mmol), Pd(PPh3)4 (19 
mg, 0.016 mmol), CuI (6 mg, 0.032 mmol) were dissolved in 8 mL 25% DMF:THF.  
After the solution was degassed three times via the freeze-thaw method, the mixture was 
heated to 80 oC for 4 h.  The reaction solvent was removed under reduced pressure and 
the crude product was purified by flash column eluting with 50% hexane:ethyl acetate to 
give the desired product as a dark red solid 75 mg (69%).  1H NMR (300 MHz, CDCl3), 
δ 8.83 (d, J = 1.8 Hz, 1H), 8.61 (d, J = 1.5 Hz, 1H), 8.31 (d, J = 8.1 Hz, 1H), 7.97 (d, J = 
8.1 Hz, 1H), 7.89 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.78 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.65 
(d, J = 9.3 Hz, 1H), 7.46 (d, J = 8.7 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 8.4 
Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 6.70 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 6.46 (d, J = 2.4 Hz, 
1H), 6.41 (s, 1H), 5.30 (s, 2H), 5.28 (s, 2H), 3.86 (s, 3H), 3.82 (s, 3H), 3.49 (q, J = 7.2 
Hz, 4H), 1.29 (t, J = 7.2 Hz, 6H),  13C NMR (75 MHz, CDCl3), δ 182.8, 159.6, 159.1, 
157.6, 152.2, 151.0, 149.2, 146.8, 138.7,  135.2, 132.3, 132.0, 131.3, 131.2, 130.5, 
130.3, 130.0, 129.3, 129.2, 128.3, 127.4, 126.6, 125.9, 125.3, 125.1,  123.9, 123.7, 
113.9, 113.8, 110.0, 105.8, 96.1,  92.3, 90.4, 68.4, 55.3, 55.2, 53.4, 45.1, 12.6.  MALDI 
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MS calcd for C46H38N4O6 (M+H)+ 743.2864, found 743.3370.  TLC (67 % EtOAc-
Hexane) Rf = 0.70. 
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1H NMR (CDCl3) 
 
 
1H NMR (CDCl3) 
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57  
6-((9-(Diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-yl)ethynyl)-2,3-
dihydrophthalazine-1,4-dione.  Compound 64 (45 mg, 0.061 mmol) and 2 mL TFA 
were added to a 25 mL flask.  The mixture was heated to 70 oC for 1 h. The solvent was 
removed under reduced pressure, and the crude product was recrystalized from AcOH 
(1.5 mL) to afford dark red solid 25 mg (82%). 1H NMR (500 MHz, DMSO, 80 oC), δ 
8.73 (s, 1H), 8.26 (s, 1H), 8.17 (d, J = 8.5 Hz, 1H), 8.12 (d, J = 8.5 Hz, 1H), 8.06 (d, J = 
8.0 Hz, 1H), 7.87 (d, J = 8.5 Hz, 1H), 7.67 (d, J = 9.0 Hz, 1H), 6.86 (dd, J = 9.5 Hz, 2.0 
Hz, 1H), 6.65 (d, J = 2.0 Hz, 1H), 6.30 (s, 1H), 3.53 (q, J = 7.0 Hz, 4H), 1.20 (t, J = 7.0 
Hz, 6H).  13C NMR (125 MHz, DMSO, 80 oC), δ 180.6, 151.7, 151.0, 146.2, 137.1, 
134.5, 131.9, 131.7, 131.5, 130.9, 130.5, 128.0, 127.8, 126.2, 125.5, 125.2, 125.3, 124.3, 
110.6, 104.7, 104.4, 96.5, 95.8, 95.3, 91.3, 90.1, 44.1, 12.0.   HRMS (ESI) calcd for 
C30H23N4O4 (M+H)+ 503.1719, found 503.1687.  TLC (10 % MeOH-CH2Cl2) Rf = 0.57. 
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1H NMR (DMSO-d6 at 80 oC) 
 
 
13C (DMSO-d6 at 80 oC) 
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1H NMR (DMSO-d6 at 22 oC) 
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Dimethyl 4-((3', 6'-bis(ethanoyloxy)-3-oxo-3H-spiro[isobenzofuran-1,9'-
xanthene]-5-yl)ethynyl)benzene-1,2-dicarboate.  Dimethyl 4-bromobenzene-1,2-
dicarboate (29 mg, 0.107 mmol), 5-ethynyl-3-oxo-3H-spiro[isobenzofuran-1,9’-
xanthene]-3’,6’-diyl diacetate C (52 mg, 0.118 mmol), PdCl2(PPh3)2 (7 mg, 0.01 mmol), 
CuI (4 mg, 0.02 mmol), Et3N (0.15 mL, 1.07 mmol), and THF 1.0 mL were added to a 
sealed microwave tube.  This tube was subjected to microwave irradiation at 120 oC for 
30 min.  The solvent was removed under reduced pressure.  The crude product was 
purified by flash chromatography over silica gel eluting with hexane/ethyl acetate (3:1) 
to give (40 mg, 60 %) as a colorless solid.  1H NMR (300 MHz, CDCl3), δ 8.19 (m, 1H), 
7.92 (m, 1H), 7.84 (dd, J = 8.1 Hz, 0.9 Hz, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.73 (dd, J = 
8.1 Hz, 0.9 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 7.13 (m, 2H)), 6.87 (d, J = 0.9 Hz, 4H), 
3.96 (s, 3H), 3.95 (s, 3H), 2.34 (s, 6H). 13C NMR (75 MHz, CDCl3), δ 168.8, 168.0, 
167.3, 167.2, 152.6, 152.2, 151.5, 138.3, 133.9, 132.6, 132.0, 131.4, 129.2, 128.8, 128.3, 
126.6, 125.7, 124.9, 124.3, 117.9, 115.9, 110.5, 90.3, 89.8, 81.8, 52.8, 52.8, 21.1. HRMS 
(ESI) calcd for C34H25O11+ (M+H)+, 633.1397, found, 633.1379.  TLC (50 % EtOAc-
Hexane) Rf = 0.68. 
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66  
4-((3-Carboxy-4-(6-hydroxy-3-oxo-3H-xanthen-9-yl)phenyl)ethynyl)benzene 
-1,2-dicarboic acid.  Compound 65 (35 mg, 0.055 mmol) was dissolved in 2 mL THF at 
room temperature.  Potassium trimethylsilanolate  (140 mg, 1.11mmol) was added to the 
reaction mixture.  The reaction was complete in 15 h.  The solvent was removed under 
reduced pressure.  The crude product was dissolved in 2 mL water, acidified with two 
drops of concentrated HCl, then a yellow solid precipitated out.  The crude product was 
separated by filtration, washed with 5 mL water and 10 mL ethyl acetate to afforded 26 
mg (90%) desired product as an orange solid.  1H NMR (500 MHz, CD3OD), δ 8.19 (s, 
1H), 7.93 (d, J = 8.5 Hz, 1H), 7.92 (s, 1H), 7.81 (d, J = 7.5 Hz, 1H), 7.78 (dd, J = 8.0 
Hz, 1.3 Hz 1H), 7.26 (d, J = 8.0 Hz, 1H), 6.73 (d, J = 2.0 Hz, 1H), 6.68 (d, J = 9.0 Hz, 
1H), 6.60 (dd, J = 9.0 Hz, 2.0 Hz, 1H).  13C NMR (125 MHz, CD3OD), 
δ 170.5, 170.5, 170.4, 162.0, 154.5, 153.5, 139.5, 135.0, 134.9, 133.9, 132.9, 130.5, 130.
5, 129.3, 129.1, 126.8, 126.3, 126.2, 126.0, 114.2, 111.3, 103.7, 91.2, 90.5.  LRMS (ESI) 
calcd for C30H17O9 (M+H)+ 521.1, found 521.1. 
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Dimethyl 4-(2-(9-(diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-
yl)ethynyl)benzene-1,2-dioate.  A mixture of compound 63 (47 mg, 0.137 mmol), 
dimethyl 4-bromobenzene-1,2-dicarboate (34 mg, 0.125 mmol), Et3N (0.17 mL, 1.25 
mmol), Pd(PPh3)4 (15 mg, 0.013 mmol), CuI (5 mg, 0.026 mmol) were dissolved in 5 
mL 25% DMF:THF.  After the solution was degassed three times via the freeze-thaw 
method, the mixture was heated to 80 oC for 4 h.  The reaction solvent was removed 
under reduced pressure and the crude product was purified by flash column eluting with 
75% hexane : ethyl acetate to give the desired product as a dark red solid 31 mg (49%).  
FTIR (neat) 3066, 2977, 1728, 1622, 1594, 1580 cm-1.  1H NMR (500 MHz, CDCl3), δ 
8.84 (d, J = 1.5 Hz, 1H), 8.32 (d, J = 8.5 Hz, 1H), 7.94 (d, J = 1.5 Hz, 1H), 7.79 (d, J = 
8.0 Hz, 1H), 7.77 (dd, J = 8.5 Hz, 1.5 Hz, 1H), 7.74 (dd, J = 8.0 Hz, 2.0 Hz, 1H), 7.66 
(d, J = 9.0 Hz, 1H), 6.72 (dd, J = 9.0 Hz, 2.5Hz, 1H), 6.50 (d, J = 3.0 Hz, 1H), 6.42 (s, 
1H), 3.97 (s, 3H), 3.95 (s, 3H), 3.50 (q, J = 7.0 Hz, 4H), 1.29 (t, J = 7.0 Hz, 6H).  13C 
NMR (75 MHz, CDCl3), δ 182.8, 167.4, 167.3, 152.3, 151.0, 146.9, 138.8, 133.8, 132.5, 
132.4, 132.0, 131.3, 131.3, 131.0, 129.2, 127.3, 126.3, 126.0, 125.3, 125.1, 110.0, 105.9, 
96.2, 94.7, 92.2, 89.8, 52.8, 52.8, 45.2, 12.6.  LRMS (ESI) calcd for C32H27N2O6 (M+H)+ 
535.2, found 535.4.  mp 233-236 oC.  TLC (50 % EtoAc-Hexane) Rf = 0.29.
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68  
4-(2-(9-(diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-yl)ethynyl)benzene-
1,2-dioic acid.  Dimethyl 4-(2-(9-(diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-
yl)ethynyl)benzene-1,2-dioate 67 (15 mg, 0.024 mmol) was dissolved in 2 mL THF at 
room temperature.  Potassium trimethylsilanolate  (8 mg, 0.061mmol) was added to the 
reaction mixture.  The reaction was complete in 15 h.  The solvent was removed under 
reduced pressure.  The crude product was dissolved in 1 mL water, acidified with 0.2M 
HCl, then a dark red solid precipitated out.  The crude product was separated by 
filtration, washed with 5 mL water and 10 mL ethyl acetate to afforded 8 mg (65%) 
desired product as a red solid.  1H NMR (500 MHz, CDCl3), δ 7.79 (d, J = 1.5 Hz, 1H), 
8.21(d, J = 8.0 Hz, 1H), 8.02 (s, 1H), 7.88 (d, J = 8.0 Hz, 1H), 7.79 (dd, J = 4.5 Hz, 1.5 
Hz, 1H), 7.73 (dd, J = 4.5 Hz, 1.5Hz, 1H), 7.67 (d, J = 9.0 Hz, 1H), 6.80 (dd, J = 9.0 Hz, 
3.0Hz, 1H), 6.54 (d, 3.0Hz, 1H), 6.38 (s, 1H), 3.52 (q, J = 7.0 Hz, 4H), 1.28 (t, J = 7.0 
Hz, 6H).  13C NMR (125 MHz, CDCl3 : CDCl3 = 2:1), δ 184.1, 170.0 (bs), 153.6, 152.4, 
147.8, 138.1, 134.2, 133.1, 132.8, 132.7, 132.2, 131.3, 130.4, 129.0, 128.9, 127.8, 126.4, 
126.3, 126.3, 126.2, 116.6, 105.5, 96.6, 92.1, 90.8, 45.8, 12.8.    HRMS (ESI) calcd for 
C30H21N2O6  (M-H)- 505.1400, found 505.1303. TLC (10 % MeOH-CH2Cl2) Rf = 0.38. 
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APPENDIX D  
EXPERIMENTAL DATA FOR CHAPTER V 
 
General Procedures 
Anion Exchange Resin, IONAC A-554, Cl- Form, type II, beads (16-50 mesh) 
were bought from Sigma-Aldrich. Dry DMF, (< 50 ppm water) was purchased from 
Acros. THF was dried with molecular sieves and Et3N was distilled from CaH2. Other 
solvents and reagents were used as received. All reactions were carried out under an 
atmosphere of dry nitrogen.  Unless otherwise indicated, common reagents or materials 
were obtained from commercial source and used without further purification.  
NMR spectra were recorded on a VXP-300 MHz and Inova-500 MHz spectrometers (1H 
at 300 MHz or 500 MHz, and 13C at 75 or 125 MHz) at room temperature unless other 
mentioned.  Chemical shifts of 1H NMR spectra were recorded and chemical shifts are 
reported in ppm from the solvent resonance (CDCl3 7.26 ppm, CD3OD 3.30 ppm, 
CD3SOCD3 2.49 ppm).  Data are reported as follows: chemical shift, multiplicity (s = 
singlet, bs = broad singlet d = doublet, t = triplet, q = quartet, m = multiplet), coupling 
constants, and number of protons.  Proton decoupled 13C NMR spectra were also 
recorded in ppm from tetramethylsilane resonance (CDCl3 77.0, CD3OD 49.1, DMSO-d6 
39.5 ppm).  Analytical thin layer chromatography (TLC) was performed on EM 
Reagents 0.25 mm silica-gel 60-F plates, and visualized with UV light or stained with 
KMnO4.  Flash chromatography was performed using silica gel 60 (230–400 mesh).  
HPLC (Beckman Coulter) analysis of samples was subjected to reverse phase analytical 
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HPLC column [protein & peptide C18, VYDAC] eluting with solvents CH3CN (0.1 % 
TFA) and H2O (0.1 % TFA). Some compounds were purified using prep HPLC 
((Beckman Coulter, X Terra Prep-MS-C18 Column, 5mm, 19 x 160 mm) eluting with 
solvents A (H2O, 0.1 % TFA) and B (CH3CN, 0.1 % TFA).  MS were measured under 
ESI or MALDI conditions. 
 
Experimental 
Material and Methods 
Pep-1 was obtained from Active Motif.  Avidin-Alexa Fluor 488 conjugate, 
BSA-Alexa Fluor 488 conjugate, FM 4-64, BODIPY TR ceramide complexed to BSA 
and Hoechst 33342 were purchased from Invitrogen.  β-Galactosidase and the 
recombinant Streptavidin were purchased from Calbiochem and Roche, respectively and 
labeled with Alexa Fluor 488 5 SDP ester (purchased from Invitrogen) according to the 
procedure provided by Invitrogen. 
Fluorescence Quenching Experiment 
The fluorescence intensity of a solution of BSA-F* (1 μM in DMEM) was 
compared to the fluorescence intensity of a solution of azo-R8:BSA-F* complexe (1μM 
BSA-F*:10 μM azo-R8 in DMEM). Both solution were excited at 488 nm.  As a control 
experiment, the fluorescence quenching of a solution of fluorescein (0.1 μM) with azo-
R8 (1 μM) was also studied. 
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Cell Culture 
COS 7 cells were purchased from the American Type Culture Collection (ATCC) 
and cultured on 75 cm2 culture flasks in DMEM supplemented with 10% fetal bovine 
serum (FBS) in a humidified incubator at 37 ºC with 5% CO2.  Cells grown to 
subconfluence were plated 2-3 days prior to the experiments in Lab-Tek two well 
chambered coverglass slides (Nunc). 
Fluorescence Microscopy 
Subcellular protein localization was measured on living COS7 cells using a Zeiss 
Stallion Dual Detector Imaging System consisting of an Axiovert 200M inverted 
fluorescence microscope, CoolSnap HQ digital cameras and Intelligent Imaging 
Innovations (3I) software.  Digital images of Alexa Fluor 488-tagged proteins, FM 4-64 
labeled membranes and endosomes, BODIPY TR ceramide complexed to BSA labeled 
Golgi, and Hoechst 3342-labeled nuclear DNA were captured with a C-APO 63X/1.2 W 
CORR D=0.28M27 objective with the following filter sets: Exciter BP470/20, Dichroic 
FT 493, Emission BP 505-530 for Alexa Fluor 488; Exciter BP560/40, Dichroic FT 585, 
Emission BP 630/75 for FM 4-64 and BODIPY TR ceramide complexed to BSA;  and 
Exciter G 365, Dichroic FT 395, Emission BP 445/50 for Hoechst 3342.  Sequential 
optical sections (Z-stacks) from the basal-to-apical surfaces of the cell were acquired.  
Digital image acquisition was initiated approximately 1 μm below he basal surface of 
the cells and optical slices were collected at 0.5 μm steps through the apical surface of 
the cells with a high numerical objective lens (C-APO 63X/1.2 W CORR D=0.28M27).  
These wide-field images were subjected to deconvolution using 3I software. 
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The protein:carrier complexes were pre-formed at room temperature for 30 min 
by mixing (in a mol:mol ratio) the protein and the carrier in DMEM supplemented with 
10% fetal bovine serum (FBS).  A 1:10 mol:mol ratio of protein:carrier was used for 
avidin-F*, BSA-F* and rec. Streptavidin-F*, while a 1:20 mol:mol ratio was used for b-
gal-F*.  To study the cellular uptake of the proteins, the culture medium was removed, 
the preformed protein:carrier complex was added, and the cells were incubated for 
another hour at 4 or 37 ºC.  After the incubation period, the cells were washed with 
phosphate-buffered saline (PBS, pH 7.4) several times before imaging.  For experiments 
at 4 ºC, cells were preincubated at 4 ºC for 30 min before being incubated with the 
protein solution for 1h.  The cells were also co-stained with Hoescht (2 μg/mL), a 
nuclear marker, and FM-464, an endosome marker. 
Endosomal Colocalization 
COS7 cells were incubated with the protein:carrier complex for 1h at 37 ºC.  
After the cells were washed with PBS, FM 4-64 (5 μg/mL) was added and the cells were 
incubated for 15 min at 37 ºC.  The cells were washed again with PBS before imaging. 
Note:  when the cells were co-incubated with the labeled protein and FM 4-64 for 1h at 
37 ºC, predominant labeling of the mitochondria was observed. 
Golgi Colocalization 
After the protein was loaded into the COS7 cells, the cells were washed.  Then 
fresh DMEM medium was added, and the cells were incubated with 5 μM of BODIPY 
TR ceramide complexed to BSA for 30 min at 4 ºC.  The cells were then rinsed several 
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with ice-cold medium and incubated in fresh medium for 30 min at 37 ºC.  Finally, the 
cells were washed with PBS before imaging. 
Viability Assay 
Viability of cells was evaluated by searching for any changes in cellular 
morphology using Nomarski differential interference contrast (DIC) microscopy during 
and following analysis of cellular uptake of proteins.  Parallel cultures were also 
evaluated using DIC microscopy along with fluorescence analysis of the cell-
impermeant viability indicator ethidium homodimer-1 (EthD-1) (Invitrogen).  This high-
affinity nucleic acid stain is weakly fluorescent until bound to DNA.  Unlike Hoechst 
33342, EthD-1 can only penetrate cells in which the plasma membrane is compromised.  
Viability assessment was conducted by incubating cells at 4ºC for 1 h with a 1:10 mol 
ratio of protein:carrier, followed by washing cells with PBS with Ca2+ before imaging of 
proteins.  Following image capture of proteins, EthD-1 (1 μM final concentration) was 
added and images were recorded at 5, 10, 20 and 30 min using the 630/75 BP filter and 
revealed no EthD-1 fluorescence.  Cultures were returned to the incubator at 37ºC for 17 
hr before viability was again evaluated by EthD-1 staining.  Morphology of cells 
monitored by DIC and Hoechst 33342 staining was normal and no EthD-1 uptake into 
cell nuclei was detected.  Therefore, no cytotoxic effects of protein:carrier combinations 
were detected for up to 24 h of cell treatments. 
Flow Cytometry 
Protein internalization was measured by flow cytometry on living cells. COS 7 
cells were cultured as subconfluent monolayers on 25 cm2 cell culture plate with vent 
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caps in DMEM supplemented with 10% fetal bovine serum (FBS) in a humidified 
incubator at 37 ºC with 5% CO2.    Carrier/protein complexes were formed in 1 mL 
DMEM at a molar protein/carrier ratio of 1:10 for avidin and BSA and 1:20 for β-
galactosidase and incubated for 30 min at room temperature.  Cells grown to 60-70% 
confluency were then overlaid with the preformed complexes and incubated for 1 h at 37 
or 4 ºC. For experiments at 4 ºC, the cells were preincubated at 4 ºC for 30 min before 
addition of the protein/carrier complex. 
After 1h incubation, the cells were washed with PBS, and treated with trypsin  (2 
min) and heparin (0.5 mg/mL in PBS, 3 x 5 min) to remove extracellular bound protein.  
Samples were resuspended in 500 μL PBS and transferred to sterile tubes.  Cells were 
analyzed on a FACSCalibur (Becton Dickinson Immunocytometry Systems, San Jose, 
CA) flow cytometer, equipped with a 15 mW air-cooled argon laser, using CellQuest 
(Becton Dickinson) acquisition software..  Green fluorescence from Alexa Fluor 488 or 
fluorescein was collected through a 530/30-nm bandpass filter.  List mde data were 
acquired on a minimum of 10,000 cells or beads defined by forward and side light 
scattering light scatter properties.  Data analysis was performed in FlowJo (Treestar, 
Inc., Ashland, OR), using forward and side light scatter to gate on cells or single beads.  
The Calibrated Parameter platform of FlowJo was used to determine the molecules of 
equivalent soluble fluorescein (MESF).  Data are expressed as the median MESF. 
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69  
(E)-4-((4-((Trimethylsilyl)ethynyl)phenyl)diazenyl)phenol.  (E)-4-((4-
iodophenyl)diazenyl)phenol T (257 mg, 0.793 mmol), which was prepared by the 
coupling reaction of phenol and 4-iodophenyl diazonium salt, trimethylsilyl acetylene 
(1.12ml, 7.93 mmol), PdCl2(PPh3)2 (28 mg, 0.04 mmol), CuI (15 mg, 0.08 mmol), Et3N 
(1.1 ml, 7.93 mmol) and 8 ml THF were added into a 50 mL round bottom flask.  After 
degassed three times via the freeze-thaw method, the mixture was stirred at r.t. for 12 h.  
The reaction solvent was removed under reduced pressure and the crude product was 
purified by flash column eluting with 30% hexane : ethyl acetate to give the desired 
product as a red solid 115 mg (49%).  1H NMR (300 MHz, CDCl3), d 7.89 (d, J = 9.0 
Hz, 2H), 7.82 (d, J = 8.1 Hz, 2H), 7.59 (d, J = 8.1 Hz 2H), 6.96 (d, J = 6.3 Hz, 2H), 0.27 
(s, 9H). 
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(E)-4-((4-Ethynylphenyl)diazenyl)phenol.  Compound 69 (78 mg, 0.265 mmol) 
was dissolved in methanol (20 mL) in a 50 mL flask.  Then potassium carbonate (110 
mg, 0,796 mmol) was added to the solution and the mixture was stirred at r.t. until the 
reaction went to completion.  The solvent was removed under reduced pressure.  And the 
product was dissolved in CH2Cl2 (50 mL), which was then washed with water (25 mL x 
2).  The organic phase was dried with MgSO4 and the product was achieved as a pure 
orange solid after removing the organic solvent under reduced pressure.  1H NMR (300 
MHz, CD3OD), d 7.81 (d, J = 9.0 Hz, 2H), 7.78 (d, J = 8.5 Hz, 2H), 7.57 (d, J = 8.5 Hz, 
2H), 6.91 (d, J = 9.0 Hz, 2H); 13C NMR (125 MHz, CD3OD), d 162.6, 153.8, 147.6, 
134.0, 126.3, 125.5, 123.6, 116.9, 84.2, 80.8. MS (ESI) calcd for C14H11N2O (M+H)+ 
223.25, found 223.24. 
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71  
tert-Butyl 4-(azidomethyl)piperidine-1-carboxylate.  A mixture of tert-butyl 4-
((methylsulfonyloxy)methyl)piperidine-1-carboxylate U (2.90 mg, 0.1 mol), NaN3 
(1.95g, .0.3 mol) and dry DMF (100 mL) in a 250 mL flask were stirred at 60 oC until 
the reaction went to completion.  Water (200 mL) was added to the reaction mixture, and 
the product was extracted from water with ethyl acetate (50 mL x 3).  The combined 
organics were washed with water (50 ml x 3), and then dried over MgSO4.  The crude 
product after removing the organic solvent under reduced pressure was purified by flash 
chromatography eluting with hexane and ethyl acetate (4:1) to give desired product (2.37 
g, 99%) as colorless oil.  1H NMR (300 MHz, CDCl3), d 4.13 (bs, 2H), 3.19 (d, J = 6.3 
Hz, 2H), 2.69 (bs, 2H), 1.73-1.66 (m, 3H), 1.45 (s, 9H), 1.24-1.10 (m, 2H).  13C NMR 
(125 MHz, CDCl3), d 154.6, 79.3, 56.9, 43.7, 42.9, 36.4, 29.5, 28.3. MS (ESI) calcd for 
C11H21N4O2+ (M+H)+, 241.17, found, 241.16.  TLC (1:1 EtOAc:hexane) Rf = 0.78. 
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72  
(E)-tert-Butyl 4-((4-(4-((4-hydroxyphenyl)diazenyl)phenyl)-1H-1,2,3-triazol-
1-yl)methyl)piperidine-1-carboxylate.  A mixture of terminal alkyne 70 (100 mg, 
0.455 mmol), organic azide 71 (110mg, 0.455 mmol), Cu (29mg, 0.455 mmol) and 
CuSO4 (0.046 mL, 1M) in THF/H2O (1:1, 10 mL) was stirred in a flask for overnight. 
The product was isolated pure as an orange solid by filter out of Cu and other impurity 
through celite.  1H NMR (500 MHz, CD3OD), d 8.19 (s, 1H), 7.92 (d, J = 9.0 Hz, 2H), 
7.88 (d, J = 9.0 Hz, 2H), 7.81 (d, J = 9.0 Hz, 2H), 6.90 (d, J = 9.0 Hz, 2H), 4.32 (d, J = 
7.5 Hz, 2H), 4.10 (bs, 1H), 4.07 (bs, 1H), 2.71 (bs, 2H), 2.18-2.09 (m, 1H), 1.63 (bs, 
1H), 1.60 (bs, 1H), 1.42 (s, 9H), 1.27-1.08 (m, 2H), 13C NMR (125 MHz, CD3OD), d 
161.4, 155.8, 153.1, 147.7, 146.9, 132.6, 126.9, 125.6, 123.7, 122.5, 116.4, 80.8, 60.6, 
56.1, 37.8, 30.0, 28.6. MS (ESI) calcd for C25H31N6O3+ (M+H)+, 463.25, found, 463.15.  
TLC (1:1 EtOAc-Hexane) Rf = 0.30. 
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73  
(E)-4-((4-(1-(Piperidin-4-ylmethyl)-1H-1,2,3-triazol-4-yl)phenyl)diazenyl)- 
phenol.  BOC protected compound 72 (157 mg, 0.339 mmol), and one drop of 
triisopropylsilane (TIS) was dissolved in CH2Cl2/TFA (1:1, 20 mL) and the mixture was 
stirred for 5 h at room temperature.  The solvent was removed under reduced pressure.  
Then the residue was washed with ether (10 ml x 1) to provide the desired product as a 
yellow solid (117 mg, 95%).  1H NMR (500 MHz, CD3OD), d 8.44 (s, 1H), 7.97 (d, J = 
8.5 Hz, 2H), 7.91 (d, J = 8.5 Hz, 2H), 7.83 (d, J = 8.5 Hz, 2H), 6.92 (d, J = 9.0 Hz, 2H), 
4.45 (d, J = 7.0 Hz, 2H)), 3.42 (d, J = 13 Hz, 2H), 3.00 (td, J = 13 Hz, 2.5Hz, 2H), 2.37-
2.29 (m, 1H), 1.90 (d, J = 14Hz, 2H), 1.59-1.50 (m, 2H).  13C NMR (75 MHz, CDCl3), d 
162.4, 153.8, 147.5, 133.3, 127.3, 126.1, 124.1, 123.5, 123.5, 116.8, 55.6, 44.7, 36.0, 
27.4. MS (ESI) calcd for C20H23N6O+ (M+H)+, 363.19, found, 363.19. 
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74  
BocNH-(OrnNHCOCF3)8-azo.  To a 25 mL flask was added the known 
compound BocNH-(OrnNHCOCF3)8-CO2H W (324 mg, 0.18 mmol), AZO compound 
73 (86 mg, 0.18 mmol), 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide (EDC, 52 mg, 
0.27 mmol),1-hydroxybenzotriazol (HOBt, 26 mg, 0.189 mmol),  and CH2Cl2/DMF (5:1, 
6 mL).  The mixture was stirred at 0 oC for 10 min, then N-methyl morpholine (NMM, 
0.038 ml, 0.54 mmol) was added to the reaction mixture dropwise, which was then 
slowly warmed to r.t.,  and kept stirring for overnight.  The reaction mixture was treated 
with 100 mL CH2Cl2.  The organic solution was washed with NaHCO3 (1M, 50 mL x 3), 
and then washed with NaHSO4 (1M, 50 mL x 3).  At last, the dichloromethane phase 
was washed with brine (25 ml x 1) and then dried over MgSO4.  The product was 
afforded as a yellow solid (331 mg, 85%, > 90% purity) after removing the organic 
solvent under reduced pressure.  1H NMR (500 MHz, DMSO), d 8.39 (s, 1H), 7.96 (d, J 
= 8.5 Hz, 2H), 7.90 (d, J = 8.5 Hz, 2H), 7.83 (d, J = 9.0 Hz, 2H), 6.92 (d, J = 9.0 Hz, 
2H), 4.61-3.97 (m, 11H), 3.70-3.69 (m, 1H), 3.32-3.30 (m, 16H), 2.68-2.64 (bm, 2H), 
2.32-2.24 (m, 1H), 1.87-1.63 (m, 34H), 1.42 (s, 9H), 1.32-1.26 (M, 2H).  MS (MALDI) 
calcd for C81H102F24N22O19Na+ (M+Na)+, 2165.74, found, 2165.94. 
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BocNH-((Arg)8-azo (8•TFA).  A mixture of 74 (24 mg, 0.018 mmol), pyrazole-
1-carboxamidine hydrochloride (107 mg, 0.728 mmol), and Na2CO3 (77 mg, 0.728 
mmol) were dissolved in MeOH/H2O (8 mL, 1:1).  Then the mixture was heated up to 55 
oC for 48 h.  The reaction solvent was removed under reduced pressure and the crude 
product is purified by RP-prep HPLC (isocratic: 5% solvent B, 5 min; gradient: 5% 
solvent B to 50% solvent B, 19 min) to give the desired product as a yellow solid (25 
mg, 78%, retention time 11 min in analytical HPLC spectra, > 99% pure).  MS (MALDI) 
calcd for C73H127N38O11 (M+H)+, 1712.05 found 1712.24. 
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1H NMR (D2O) 
 
MS MALDI
  
329
N
H O
O
ClH3N
NH
N
NN
NN
N OH
4
NH
NH2H2N
NH2H2N
Cl
Cl
azo-R8
 
NH3-((Arg)8-AZO (9•Cl)  (azo-R8).  A solution of 75 (10 mg, 0.0058 mmol) in 
1 mL trifluoroacetic acid with one drop of triisopropylsilane (TIS) was stirred at room 
temperature for 2 h.  The solvent was removed under the reduced pressure and the crude 
product was purified by RP-prep HPLC (isocratic: 5% solvent B, 5 min; gradient: 5% 
solvent B to 50% solvent B, 19 min) to provide a yellow solid 9 mg (retention time is 11 
min, > 99% purity, 90%), which was dissolved in DI water (1 mL).  Then 500 mg Cl- 
exchange resin was added and the resulting mixture was stirred for 10 h to make sure 
that the Cl- and CF3CO2- exchange was complete.  The desired product with Cl- counter 
anions was achieved after removing the resin by filtration.  MS (MALDI) calcd for 
C69H119N38O9 (M+H)+ 1611.99, found 1612.04. 
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MS MALDI 
 
 
 
Analytical HPLC of azo-R8 after purification. 
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APPENDIX E  
DEVELOPMENT OF RATIOMETRIC PH PROBES BASED ON THROUGH-BOND 
ENERGY TRANSFER CASSETTES 
 
Ratiometric methods, especially dual emission method (excitation at single 
wavelength and observing emission at two different wavelengths), for determination of 
pHi values have many advantages, e.g. operation convenience, high sensitivity and 
accurate results, however there are only limited this type pH probes available in the 
market, and most of them exhibit the poor photophysical properties.  For instance, 
C.SNARF-1, a commonly used commercialized dual emission ratiometric pHi probe 
from Life Technologies, has very low quantum yield, especially in the acidic form (φ 
= 0.03).  Development of dual emission pHi indicators that have better spectral 
properties will benefit the biological research related to pH-dependent cell functions.   
As mentioned in the first chapter that all three types of benzoxanthene dyes, 
SNARFs, SNAFLs and SNAFRs, exhibit pH-dependent shifts in their fluorescent 
emission spectra (see chapter 1, intracellular pH indicators) indicating potential 
candidates as the ideal pHi indicators.  Benzoxanthene dyes also have desired 
characteristics for cell imaging including long-wavelength emissions (up to 825 nm), 
large Stoke’s shift between emission maxima of their acidic forms and basic forms (up 
to 200 nm), high photostability and good water-solubility.  The brightness of a dye is 
dependent on its molar absorptivity at the excitation wavelength and its quantum yield.  
One common problem when using benzoxanthene dyes as dual emission ratiometric pH 
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probes is that the small molar absorptivity at single excitation wavelength, which is close 
to absorbance isobestic point. This usually results in a bigger noise to fluorescence ratio 
(See Figure S1a).  For instance, compared to the maximum absorptivity of its basic form, 
the absorptivity of C.SNARF-1 at the absorbance isobestic point (534 nm) is only a half 
of that.  The ideal dual emission ratiometric pH probe should have a large pH-
independent absoptivity at the excitation wavelength as well as exhibit pH-dependent 
emission.  We would like to design such kind of ideal pH probes based on through-bond 
energy transfer cassettes, which is composed of a pH-independent donor, e.g. a 
BODIPY, and a pH-dependent benzoxanthene acceptor.  The hypothesis of through-
bond energy transfer cassettes is that when donor and acceptor systems are connected 
via conjugated bonds then rapid and efficient energy transfer from the donor to the 
acceptor may occur through-bonds.  Through-bond energy transfer (Figure S1b) is 
mechanistically different from FRET, and there is no known requirement for overlap of 
the emission of the donor fragment with the absorption of the acceptor part (Figure S1c).  
Thus, appropriately designed through-bond energy transfer cassettes could absorb 
photons via a donor part, or parts, at a convenient wavelength (e.g. 488 nm: excitation 
from an Ar-laser), and transfer the energy rapidly through the conjugated linker to the 
acceptor fragment that emits at a far longer wavelength.  Therefore, it is possible to 
design dyes that absorb strongly at a short wavelength and emit brightly from the 
acceptor when the overlap between donor emission and acceptor absorbance are changed 
with variation of pH (Figure S1d).  In summary, through-bond energy transfer cassettes 
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have the potential to become dual emission pHi probes excited by a laser source 
operating at a single wavelength. 
 
a 
450 500 550 600 650 700
A b s o r b a n c e
wavelength (nm)
acidic 
form
basic 
form
excitation
isobestic 
point
 
c 
 
 
b 
through-bond and 
through space energy transfer
hv
donor acceptor
hv'
energy transfer through 
bonds faciliates production of 
systems with large apparent 
Stoke's shifts
pH-independent 
absorbance
pH-dependent 
fluorescence
 
d 
450 500 550 600 650 700
wavelength (nm)
acidic 
form
basic 
form
excitation
donor
abs.
acceptor absdonoremiss.
Figure S1.  (a) typical excitation of a dual emission pH probe at the isobestic point.  (b) Through-bond 
energy transfer cassettes as a pH indicator with a pH-insensitive donor and a pH-dependent acceptor.  
(c) FRET-based cassettes only partially alleviate this problem because Förster energy transfer requires 
overlap of donor emission with the acceptor absorbance.  (d) pH-independent absorbance and 
fluorescence of the donor and pH-dependent absorbance of the acceptor in through-bond energy 
transfer cassettes-based pH indicators. 
 
As discussed in the first chapter of this dissertation, the pHi indicator 16, a 
through-bond energy transfer cassette, consisting of a pH-dependent donor and a pH-
independent acceptor, is able to overcome this issue.  Excitation at 488 nm is always 
close to the absorbance maxima of the donor.  However, compound 16 has two 
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drawbacks that limit its wide application for determination of intracellular pH values.  
First, the xanthene donor can be photobleached quickly in basic environment.  Second, 
the quantum yield of the donor (0.14) in basic media is quenched by the PeT (See 
Chapter 1).  The ideal pH indicators based on through-bond energy transfer cassette 
should have the following properties: 
1. The donor exhibits a large molar absorptivity that is not pH-dependent. 
2. The acceptor should be photostable, and its fluorescence spectrum should be 
significantly shifted with changing of pH.  
3. The acceptor should have a high quantum yield despite of changing of pH. 
4. The energy transfer efficiency should always be very efficient even the pHs of 
the solution is changed. 
5. The compound should be water-soluble and have a handle to attach to 
biomolecules. 
BODIPY dyes exhibit excellent photophysical properties, e.g. large molar 
absorptivity and high quantum yields, water-soluble sulfonated BODIPYs are also 
accessible, and are therefore the ideal donors for the cassettes.  Figure S2a shows two 
typical cassettes having water-soluble BODIPY dyes as the donor.  The pKa values of 
acceptors can be tuned by halogenation of the benzoxanthenes core.  And more of the 
possible acceptor fragments based on benzoxanthene fluorophores are shown in Figure 
S2b.
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Figure S2.  (a) Two typical pH-sensitive cassettes having a water-soluble BODIPY donor;  (b) a few 
of pH-sensitive benzoxanthene acceptors. 
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All of the cassettes can be synthesized via Cu(I) catalyzed cyclization reaction of 
the water-soluble BODIPY azide 78 and the acceptor with a terminal alkyne group.  Two 
methods can be used to construct the acceptors, and they are illustrated in Scheme S1b 
and S1c.  First, the acceptor 5’-Br.SNFAL-1 81 can be synthesized via condensation of 
1,6-dihydroxynaphthalene 79 with the appropriately substituted benzophenone 
derivatives 80; these in turn were made via coupling of resorcinol or 3-aminophenol with 
phthalic anhydride derivatives in toluene.  Second, lithiated dimethoxynaphthalene 82 
can react with a benzophenone derivative 83, followed by cyclization with BBr3, to 
afford 5’-Br.SNAFR-6 84.  The final alkyne for the click chemistry can be achieved via 
Sonogashira coupling reaction of aromatic bromide, e.g. 81 and 84, with 
trimetrylsilylacetylene, followed by removal of the trimethylsilyl group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
337
Scheme S1.  (a) Synthesis of Cassettes via Click chemistry; Ilustrative syntheses of two acceptors (b) 5’-
Br.SNAFL-1 81; and (c) 5’-Br.SNAFR-6 84. 
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Scheme S1.  Continued. 
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